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INTRODUCTION 
 
 
The twentieth century has witnessed an enormous increase in life expectancy. Whereas in 
the early 1900s, people from low-mortality countries could expect to live on average 
approximately 50 years from birth [1], in 2000, life expectancy at birth in record-holding 
country Japan rose to over 77 years among men, and almost 85 years among women [2].  
 
The epidemiological transition that lies behind this increase in life expectancy is 
characterized by different phases [3]. The early increases in life expectancy, up to about 
1930, were the result of "receding pandemics", i.e. huge declines in mortality from 
communicable diseases at younger ages [3,4]. These declines in mortality among younger 
ages gradually led to a shift in mortality towards older ages, with more weight to non-
communicable, or "degenerative and man-made" diseases. As a result, the development in 
life expectancy became more and more determined by trends in mortality at older ages [5]. 
 
In low-mortality countries, mortality at older ages has generally declined since the 1950s 
[6-11], due to decreasing mortality rates from mainly cardiovascular diseases [12]. This 
decline in old-age mortality did not only contribute to the general increase in life 
expectancy; it was also partly responsible for the current increase in the number, the 
proportion and the mean age of elderly people in these populations, i.e. the ageing of 
these populations. The far-reaching consequences of population ageing for demands of 
health care services and old-age benefit systems are widely known.  
 
Due to the increasing effect of old-age mortality trends on the current and future course of 
life expectancy, and due to its role in the ageing of populations [13-15], it is increasingly 
being recognized that old-age mortality should receive more attention in research. Next to 
emphasis on the age-trajectory of mortality among the elderly [16-19], a number of 
questions on possible future trends in life expectancy have gained interest. With respect to 
the latter, particularly the extent to which today’s populations are approaching a limit to 
human life expectancy is extensively being debated upon. On the one hand, proponents of 
"the limited-lifespan paradigm" state that biological and practical constraints to reducing 
old-age mortality imply that future gains in life expectancy will occur at a slower pace, and 
that the limit to life expectancy is almost reached [20-22]. On the other hand, "the 
mortality-reduction paradigm" is adhered to by researchers who argue that life expectancy 
will continue to increase for some time to come [2,23,24]. They support their view by 
referring to mortality developments in sub-populations with extreme good health, to 
foreseen biomedical progress, and to historical observations that old-age mortality has 
been decreasing continuously.  
 
In order to make inferences about possible future trends in old-age mortality, it is 
important to carefully study past trends and, even more importantly, to study the 
determinants of these past trends. The growing research focus on mortality among elderly 
populations, however, has until recently led to mostly descriptive studies on trends in old-
age mortality [8-10,25-27]. Although these studies reported important cross-national 
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variations in the pace of mortality decline among the elderly, with even stagnation of the 
mortality decline in the 1980s in the Netherlands and Norway [9,28], little is known about 
the mechanisms behind the observed trends.   
 
THIS THESIS 
 
This thesis encompasses a detailed study of mortality trends among the elderly in relation 
to a number of possible determinants at population level. 
 
Objective 
 
Aim of the study is to carefully describe trends in old-age mortality in seven European low-
mortality countries from 1950 to 1999, and to assess the role of specific factors in 
explaining the observed trends.  
 
Approach 
 
For this purpose, both trends in all-cause mortality and trends in specific causes of death 
are studied. Because many of the intermediate factors or risk factors that could determine 
mortality trends among the elderly are related to specific causes of death, studying the 
trends in cause-specific mortality can generate evidence on the determinants of the trends 
in all-cause mortality among the elderly. 
 
In addition, we adopt a life-course perspective, with emphasis on determinants occurring 
not only in late life but also in earlier phases of the life-course [29,30]. For the present 
population study, adopting a life-course perspective implies the study of not only period 
patterns in old-age mortality, but also its cohort patterns. Whereas period patterns indicate 
immediate and modifiable effects of conditions occurring in late life, cohort patterns may 
reflect unmodifiable long-lasting effects of determinants located earlier in life. This 
distinction is of crucial importance for making projections of future developments in 
mortality. If cohort effects prove to be important, cohort-wise projections may be used to 
explore possible future mortality trends. 
 
Comparative studies among seven selected countries are performed in order to reveal 
general patterns and possible country-specific deviations from these general patterns. We 
included seven low-mortality countries in northwestern Europe, i.e. Denmark, England and 
Wales, Finland, France, the Netherlands, Norway, and Sweden. For these countries, 
differences both in old-age mortality trends [8], and in the levels and trends of several 
potential determinants have been observed. In addition, these countries are among the few 
countries with the most accurate data on old-age mortality from 1950 onwards [9]. 
 
With regard to the determinants, we focus on the role of smoking, mortality selection, 
socio-economic developments throughout the life-course, and medical end-of-life decision-
making. Smoking is known for its strong negative effect on survival. Moreover, the impact 
of smoking on mortality trends may vary considerably between countries [31], due to, for 
example, cross-national differences in the development of lifetime exposure to smoking 
across the birth cohorts [32]. Mortality selection implies that when mortality decreases at 
younger ages, the increasing proportion of the elderly population might be expected to be 
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less healthy when compared to survivors of earlier cohorts [15]. Subsequently this elderly 
population could experience relatively higher morbidity and mortality. For example, 
mortality declines in cardiovascular diseases, predominantly ischaemic heart diseases, have 
been shown to lead to increased prevalence of chronic heart diseases at older ages [33], 
with subsequently higher mortality risks of related diseases [34]. Socio-economic 
developments may be a key factor in influencing mortality levels and trends [35]. During 
the 20th century, all European countries experienced dramatic increases in both economic 
prosperity and life expectancy. The increasing prevalence of medical end-of-life decisions 
over time in the Netherlands [36], might have contributed to the relatively unfavourable 
mortality trends among Dutch elderly. Moreover, medical end-of-life decisions could 
possibly contribute to cross-national differences in old-age mortality. 
 
Research questions 
 
The main research questions addressed in this thesis are: 
 
1. How did old-age mortality develop over the period 1950 to 1999 in seven European 
countries? 
 
2. Which role do different possible determinants, such as smoking, mortality selection, 
socio-economic developments throughout the life-course, and medical end-of-life 
decision-making, have in explaining the observed trends? 
 
Data and methods 
 
To answer these research questions, aggregate data on total mortality, the underlying 
cause of death, and population at risk, by year of death (1950-1999), sex, and five-year 
age groups (60+/80+) were included for Denmark, England and Wales, Finland, France, 
the Netherlands, Norway, and Sweden. These data were obtained from national statistical 
offices, and related institutes, the Kannisto-Thatcher Database on Old Age Mortality 
(http://www.demogr.mpg.de/databases/ktdb) [9], and the Human Mortality Database 
(http://www.mortality.org). To study the role of socio-economic developments throughout 
the life-course, we reconstructed trends in Gross Domestic Product per capita and infant 
mortality from 1865 onwards, based on historical overviews [37-40]. In addition, we 
included recent data on physicians’ practices and attitudes concerning medical end-of-life 
decisions from the EURELD consortium [41,42]. 
 
To these data, we applied different descriptive and analytical techniques. The old-age 
mortality trends were described by means of Poisson regression with linear splines. Spline 
functions divide the overall trend into a number of separate, adjacent segments [43], and 
enabled us to study trends within specific decades instead of broader periods, and to 
identify changes in the overall trend, such as a stagnation in mortality decline. To assess 
the role of period and cohort effects in old-age mortality trends we performed age-period-
cohort analyses. The role of different possible determinants to the observed trends was 
studied by means of multivariate Poisson regression analyses and correlation analyses.  
 
Structure of the thesis 
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The first part of the thesis, i.e. Chapters 2 to 5, deals with the description of trends in 
both all-cause and cause-specific old-age mortality, and the identification of the role of 
period and cohort effects in the observed trends. Chapter 2 explains and illustrates our 
new method to identify and adjust for cause-specific mortality discontinuities due to coding 
changes both between and within the different revisions of the International Classification 
of Diseases. In Chapter 3, we focus on the description of all-cause and cause-specific 
mortality trends among those aged 80 and over in the Netherlands. More specifically, we 
assess whether the stagnation of old-age mortality decline observed in the Netherlands in 
the 1980s continued in the 1990s, and for which causes of death stagnation can be 
observed. In Chapter 4, we extend the description of period trends in all-cause and cause-
specific old-age mortality to Denmark, England and Wales, Finland, France, the 
Netherlands, Norway and Sweden. Chapter 5 reports on our identification and description 
of cohort patterns in the mortality trends among elderly (60+) in the same seven countries. 
In Chapters 3 to 5, we moreover discuss the role of smoking to the observed trends, by 
focussing on old-age mortality trends in smoking-related diseases.  
 
In the second part of the thesis, Chapters 6 to 8, further explanations for the observed 
old-age mortality trends in the seven countries are explored by assessing the role of 
mortality selection, socio-economic developments throughout the life-course, and medical 
end-of-life decision-making. In Chapter 6, we test whether mortality selection is a 
dominant factor in determining trends in old-age mortality by empirically studying the 
possible existence of a negative correlation between trends in late middle-age mortality and 
trends in old-age mortality among the same cohorts. Chapter 7 reports on our exploration 
of the role of socio-economic developments throughout the life-course. We assess whether 
old-age mortality levels for subsequent cohorts are associated with levels of Gross 
Domestic Product prevailing at different ages of the same cohorts. In Chapter 8, we 
examine the association between physicians’ practices and attitudes concerning end-of-life 
decision-making and national mortality by age and cause of death across six European 
countries, i.e. Belgium, Denmark, Italy, the Netherlands, Sweden and Switzerland.  
 
The final chapter, Chapter 9, summarizes the main results, and evaluates the usefulness 
and possible limitations of our methodological approach in obtaining these results. In 
addition, we will further elaborate on the determinants of the stagnation in mortality 
decline among the elderly in the Netherlands, and on possible future trends in old-age 
mortality. Lastly, recommendations for further research are proposed. 
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2 
 
ICD CODING CHANGES AND DISCONTINUITIES IN TRENDS IN CAUSE-
SPECIFIC MORTALITY IN SIX EUROPEAN COUNTRIES, 1950-1999 
 
 
Objective To evaluate how often coding changes between and within revisions of the 
International Classification of Diseases (ICD) complicate the description of long-term trends 
in cause-specific mortality. Methods Data on cause-specific mortality between 1950 and 
1999 for men and women aged 60 and older were obtained from Denmark, England and 
Wales, Finland, the Netherlands, Norway and Sweden. Data were obtained by five-year age 
groups. We constructed a concordance table using three-digit ICD codes. In addition we 
evaluated the occurrence of mortality discontinuities by visually inspecting cause-specific 
trends and by country-specific background information. Evaluation was also based on 
quantification of the discontinuities using a Poisson regression model (including period 
splines). We compared the observed trends in cause-specific mortality with the trends after 
adjustment for the discontinuities caused by changes to coding. Results In 45 out of 416 
(10.8%) instances of ICD revisions to cause-specific mortality codes, significant 
discontinuities that were regarded as being due to ICD revisions remained. The revisions 
from ICD-6 and ICD-7 to ICD-8 and a wide range of causes of death, with the exception of 
the specific cancers, were especially affected. Incidental changes in coding rules were also 
important causes of discontinuities in trends in cause-specific mortality, especially in 
England and Wales, Finland and Sweden. Adjusting for these discontinuities can lead to 
significant changes in trends, although these primarily affect only limited periods of time. 
Conclusion Despite using a carefully constructed concordance table based on three-digit 
ICD codes, mortality discontinuities arising as a result of coding changes (both between 
and within revisions) can lead to substantial changes in long-term trends in cause-specific 
mortality. Coding changes should therefore be evaluated by researchers and, where 
necessary, controlled for. 
 
BACKGROUND 
 
The study of trends in cause-specific mortality is an important subject in epidemiology, 
demography and public health. However, assessment of long-term mortality trends in 
causes of death can be hampered by changes in coding. For example, numerous revisions 
of the International Classification of Diseases (ICD) have to be taken into account. Not only 
can these revisions lead to changes in coding rules but additionally each ICD classification 
can include a different number of items to code the causes of death, causing inconsistency 
over time. Solutions to overcome the bias that may result vary from simple and crude to 
elaborate and accurate. 
 
A simpler approach is to study mortality trends only in broad, aggregated groups of causes 
of death or in specific diseases for which the coding is known to have been consistent over 
time [1]. However, many specific causes of death cannot be studied appropriately with 
these approaches. 
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Bridge coding is an accurate approach. In bridge coding cross-classifications between 
successive ICD revisions are used; these are based on the double coding of all causes of 
death [2]. These cross-classifications, however, exist for only a small number of countries 
and ICD revisions, and their results may not be directly applicable to all countries owing to 
differences in coding practices and differences in the application of new ICD revisions 
between countries [3,4]. 
 
Vallin & Meslé [4–6] elaborately and accurately reconstructed coherent series of data for 
causes of death in France for the years 1925–94, according to ICD-9. They used carefully 
constructed concordance tables based on four-digit codes; these concordance tables linked 
the codes for a specific cause of death through each successive ICD revision. Transition 
coefficients were calculated to redistribute the numbers of causes of death, based on cross-
tabulation of the number of deaths for different revisions. Unfortunately, four-digit codes 
are not available in many countries. Furthermore, this method is quite time-consuming, and 
the redistribution of deaths in one country is not directly applicable to other countries.  
 
An intermediate approach is to use concordance tables based on three-digit codes without 
redistributing the numbers of deaths [7]. These concordance tables often underlie the 
selection of the codes used for successive ICD revisions in studies on long-term trends in 
cause-specific mortality [8–10]. However, it is unclear whether mortality discontinuities 
caused by changes in ICD codes can be avoided using this intermediate approach.  
 
Moreover, discontinuities in cause-specific trends can also result from incidental changes in 
coding rules, e.g. changes within ICD revisions in coding rules applied at statistical offices. 
The extent to which coding problems remain and may bias the study of trends in cause-
specific mortality have not yet been estimated systematically. An assessment of the 
experience in several countries may aid researchers intending to study these long-term 
trends.  
 
In this study, we evaluated how often coding problems complicate the description of long-
term trends in mortality despite the use of a carefully constructed concordance table that is 
based on the three-digit codes. We used data from six European countries covering a 
broad selection of specific causes of death between 1950 and 1999. We considered the 
effect of mortality discontinuities caused by coding changes both between and within ICD 
revisions. We assessed in which situations (countries, causes of death) these coding 
changes led to discontinuities and whether adjustment for these discontinuities resulted in 
different estimates of trends in cause-specific mortality.  
 
DATA AND METHODS  
 
Data were obtained on the underlying cause of death, total mortality and mid-year 
population for Denmark, England and Wales, Finland, the Netherlands, Norway and 
Sweden. These data were stratified by year of death (1950–99), sex and five-year age 
group for people aged 60 and older. Data were obtained from the National Institute of 
Public Health (Denmark), the Office for National Statistics (England and Wales), Statfin 
(Finland), Statistics Netherlands, NIDI (Netherlands), Statistics Norway, and the National 
Board of Health and Welfare (Sweden). Data were available from 1951 for Finland and 
Norway, and from 1952 for Sweden. Data for Denmark were available from 1951 to 1998.  
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The death counts for each cause of death in the oldest age groups (85+ for England and 
Wales and the Netherlands up until 1969, and 90+, 95+, and 100+ for all other countries 
and periods) were redistributed into five-year age groups up to the age of 100+ years 
using the distribution observed for total mortality among these age groups. Data on 
mortality for the oldest age groups were available from the Kannisto-Thatcher Database on 
Old Age Mortality [11]. 
 
We selected 26 causes of death, mainly on the basis of their relative importance in old-age 
mortality (Table 1). For Finland, the total registry of causes of death by three-digit code 
was not available and instead data from aggregated code groups were supplemented with 
data from specific three-digit codes for the selected causes of death.  
 
Five different revisions of the ICD occurred between 1950 and 1999 (Table 2), but because 
the codes remained identical in ICD-6 and ICD-7, only four revisions had to be bridged in 
order to reconstruct the causes of death. For this purpose, we carefully constructed a 
concordance table using three-digit codes, building on existing concordance tables 
[7,12,13] and using information from WHO [14–18] (Table 1). The basic rule we applied 
was that we aimed to safeguard the continuity of the medical content on the causes of 
death. For Denmark, a country-specific adjustment of the concordance table was made in 
order to include codes 260–265 for diabetes mellitus for the years 1965–68 (K. Juel, 
National Institute of Public Health, Denmark, personal communication about diabetes 
codes, June 2002).  
 
The first step in our evaluation was to visually inspect trends in cause-specific mortality for 
the combined data on men and women aged 60 years and older. In our evaluation of 
mortality discontinuities we distinguished between those that were the result of revisions to 
the ICD, those that were the result of incidental changes in coding rules that applied to 
many causes of death simultaneously, and those that were the result of incidental changes 
in coding rules that were applied only to a specific cause of death, for example less 
restrictive coding for diabetes mellitus. In addition, country-specific background information 
was obtained through personal communication with national statistical offices or related 
institutes on the possible cause of observed discontinuities and on national coding practices 
and coding problems.  
 
In the second step, mortality discontinuities resulting from ICD revisions and generally 
applied incidental changes in coding rules were quantified in cause-specific Poisson 
regression models and tested for statistical significance at the 95% significance level. The 
dependent variable was the number of deaths, with the mid-year population used as an 
offset variable. The independent variables were age (five-year age groups) and year of 
death (using splines). Spline functions divide the overall trend into a number of separate, 
adjacent segments [19] and allow a detailed description of long-term mortality trends to be 
made. In our analysis, we used five decade-specific segments (1950–59 to 1990–99). To 
these regression models we added transition variables indicating the ICD revisions (i.e. 
ICD-6 and ICD-7 to ICD-8, ICD-8 to ICD-9, or ICD-9 to ICD-10) or the general incidental 
changes in coding rules.  
 
In the third step, we used two criteria to judge whether significant mortality discontinuities 
were due to coding problems.  
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Table 2. Revisions of the International Classification of Diseases (ICD) in 1950-99, by country 
 
Country ICD-6 ICD-7 ICD-8 ICD-9 ICD-10 
      
Denmark 1951-1957 1958-1968 1969-1993 NAa 1994-1998 
England and Wales 1950-1957 1958-1967 1968-1978 1979-1999 NA 
Finland 1951-1957 1958-1968 1969-1986 1987-1995 1996-1999 
France 1950-1957 1958-1967 1968-1978 1979-1999 NA 
Netherlands 1950-1957 1958-1968 1969-1978 1979-1995 1996-1999 
Norway 1951-1957 1958-1968 1969-1985 1986-1995 1996-1999 
Sweden 1952-1957 1958-1968 1969-1986 1987-1996 1997-1999 
a NA = not applicable. 
 
The first criterion was to ensure that the significant effect could not be attributed to non-
linear trends or to a single outlier, for instance an influenza epidemic nearby. The second 
criterion was to determine whether the observed effect could be related to the coding 
problem, for example as a direct result of a change at the level of four-digit codes or as an 
indirect result of an opposite effect on a complementary cause of death. These judgements 
were based primarily on visual inspection of cause-specific mortality trends without the use 
of statistical tests. 
 
The identification of mortality discontinuities was based on the trends for men and women 
combined because changes in coding rules most likely operate in the same manner for both 
sexes, at least in regard to the direction of the effect. Outliers (i.e. single years of 
exceptional cause-specific mortality) were excluded from our analysis. For example, in the 
Netherlands in 1953 mortality from "external causes" increased as a result of a severe flood 
[20]. For a year to be classed as an outlier, the mortality rate had to be significantly 
different from mortality in the years within the decade, with rate ratios of the parameter 
estimates at least higher than 1.1 or lower than 0.9.  
 
In order to evaluate whether mortality discontinuities regarded as being related to changes 
in coding biased the description of long-term trends in cause-specific mortality, we 
compared observed mortality trends with trends after adjustment. Adjustment involved 
including the transition variables, that were associated with mortality discontinuities related 
to coding changes, in the cause-specific and sex-specific regression models. We stratified 
this analysis by sex because cause-specific mortality trends are likely to be different for the 
two sexes and consequently the description of the trends may be biased differently for men 
and women when coding changes are ignored.  
 
RESULTS  
 
When a concordance table based on three-digit codes is applied to the data, in 191 out of 
416 instances of ICD revisions to cause-specific mortality codes significant mortality discon-
tinuities remained (Table 3). Of these significant mortality discontinuities, 24% were not 
the result of non-linear trends or single outliers, and they were consequently regarded as 
being due to the ICD revisions. Thus, in 45 out of 416 (10.8%) revisions to cause-specific 
mortality codes, significant mortality discontinuities that were regarded as being due to ICD 
revisions remained. These ICD-related mortality discontinuities affected 11 out of 26 causes 
of death, primarily "other heart diseases", ischaemic heart disease, unspecified cancers, 
"other symptoms", infectious diseases, dementia, and "other circulatory diseases". 
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Table 3. Mortality discontinuities, by country, cause of death, and revision of the International 
Classification of Diseases (ICD), for men and women aged 60 years and older, 1950-99a 
 
Cause of death ICD revision Transition rateb 
  DKc E&W FIN NL NO S 
Infectious diseases 6/7 to 8 1.56 0.83 1.23 1.74 1.74 1.32 
 8 to 9 -d 1.07 NS NS NS NS 
 9 to 10 NS -e 1.20 NS NS 1.12 
Cancer of the oesophagus 6/7 to 8 NS NS NS NS NS NS 
 8 to 9 - NS NS NS NS NS 
 9 to 10 NS - NS NS NS NS 
Cancer of the stomach 6/7 to 8 NS NS NS 0.93 0.93 NS 
 8 to 9 - NS NS NS NS NS 
 9 to 10 NS - NS NS NS NS 
Cancer of the colorectum 6/7 to 8 NS 1.05 NS NS 0.92 1.07 
 8 to 9 - 0.97 NS NS NS NS 
 9 to 10 NS - NS NS NS NS 
Cancer of the pancreas 6/7 to 8 NS NS NS NS NS NS 
 8 to 9 - NS NS NS NS NS 
 9 to 10 NS - NS NS NS NS 
Cancer of the upper  6/7 to 8 NS 1.07 NS NS NS NS 
respiratory tract 8 to 9 - 1.04 NS NS NS NS 
 9 to 10 NS - NS NS NS NS 
Cancer of the lung 6/7 to 8 NS 0.98 NS 0.96 NS 1.06 
 8 to 9 - NS NS 0.97 NS NS 
 9 to 10 1.06 - NS NS NS NS 
Cancer of the breast 6/7 to 8 NS NS NS 0.95 0.90 1.15 
 8 to 9 - NS NS NS NS NS 
 9 to 10 NS - NS NS NS NS 
Cancer of the prostate 6/7 to 8 NS NS 1.15 0.88 NS 1.13 
 8 to 9 - NS NS NS NS NS 
 9 to 10 NS - NS 0.93 NS 1.05 
Cancer of the bladder 6/7 to 8 NS NS NS NS NS NS 
 8 to 9 - 0.96 NS NS NS NS 
 9 to 10 NS - 0.81 NS NS NS 
Cancer of the kidney 6/7 to 8 1.15 NS NS 0.90 NS 1.21 
 8 to 9 - NS NS NS NS NS 
 9 to 10 NS - NS NS NS NS 
Cancers, unspecified 6/7 to 8 0.77 1.07 NS 1.39 1.47 1.18 
 8 to 9 - 1.24 0.89 0.83 1.11 NS 
 9 to 10 0.90 - NS 1.05 0.88 1.06 
Other cancers 6/7 to 8 NS 0.98 0.93 0.85 0.89 1.03 
 8 to 9 - 0.99 NS 1.03 NS 1.07 
 9 to 10 NS - NS NS 1.08 Ns 
Diabetes mellitus 6/7 to 8 NS NS NS 0.67 NS 0.90 
 8 to 9 - 0.92 1.30 0.82 NS NS 
 9 to 10 0.84 - NS 1.20 NS NS 
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(Table 3, continued) 
 
Cause of death ICD revision Transition rateb 
  DKc E&W FIN NL NO S 
Dementia and Alzheimer 6/7 to 8 0.96 0.92 0.64 0.78 NS NS 
disease 8 to 9 - 1.92 0.93 0.55 1.91 1.48 
 9 to 10 1.05 - 1.37 0.73 NS 1.27 
Ischaemic heart disease 6/7 to 8 0.87 1.12 1.08 1.13 1.32 1.23 
 8 to 9 - 0.95 NS 0.94 NS 0.93 
 9 to 10 0.97 - 0.94 NS NS 0.97 
Other heart diseases 6/7 to 8 0.73 0.76 0.68 0.83 0.50 0.51 
 8 to 9 - 1.18 0.96 1.20 NS 1.29 
 9 to 10 1.10 - 1.06 0.89 NS 1.07 
Cerebrovascular diseases 6/7 to 8 0.91 1.03 0.88 NS 1.03 NS 
 8 to 9 - 0.99 0.93 0.97 NS NS 
 9 to 10 0.95 - NS 0.94 NS 1.05 
Other circulatory diseases 6/7 to 8 1.11 1.12 1.14 1.43 1.09 0.95 
 8 to 9 - 0.89 NS 0.92 0.89 NS 
 9 to 10 0.92 - 1.17 NS NS NS 
Pneumonia/influenza 6/7 to 8 0.94 1.19 1.53 2.08 1.14 NS 
 8 to 9 - 0.95 NS NS NS 0.84 
 9 to 10 0.77 - NS 0.89 0.62 0.82 
Chronic obstructive  6/7 to 8 0.77 0.99 0.87 0.86 NS 0.83 
pulmonary disease 8 to 9 - 1.17 0.93 0.86 NS NS 
 9 to 10 NS - 1.14 1.08 NS NS 
Senility 6/7 to 8 0.83 NS 0.76 1.06 0.84 NS 
 8 to 9 - 0.82 0.58 0.69 NS NS 
 9 to 10 0.86 - NS 0.93 0.76 NS 
Other symptoms and 6/7 to 8 NS 1.68 NS 1.13 0.90 0.74 
ill-defined conditions 8 to 9 - 0.31 0.51 0.47 1.10 NS 
 9 to 10 NS - NS 1.15 0.70 2.04 
Other diseases 6/7 to 8 0.80 NS 0.82 NS 0.89 NS 
 8 to 9 - NS 1.18 1.25 NS 1.15 
 9 to 10 1.05 - 0.83 0.98 1.09 0.92 
Accidental fall 6/7 to 8 0.84 1.13 NS 0.94 NS 1.41 
 8 to 9 - 0.96 NS NS NS 1.16 
 9 to 10 NS - 1.15 NS 1.11 1.38 
Other external causes 6/7 to 8 NS 0.91 NS NS NS NS 
 8 to 9 - 1.10 1.22 NS NS 0.94 
 9 to 10 NS - NS NS 1.18 NS 
a Values in bold indicate that the mortality discontinuity cannot be attributed to non-linear trends or a 
single outlier. 
b The relative size of the increase or lowering of the fitted mortality rate for the period immediately 
after the coding change compared with the mortality rate immediately before. 
c For Denmark the ICD revision 9 to 10 is actually from ICD-8 to ICD-10; ICD-9 was not used. 
d - = not applicable. 
e NS = parameter estimate is not significant.  
DK = Denmark; E&W = England and Wales; FIN = Finland; NL = the Netherlands; NO = Norway; S = 
Sweden. 
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In contrast, the specific cancers that were included in our study did not show ICD-related 
mortality discontinuities. The proportion of ICD-related mortality discontinuities ranged 
from 1.9% in Denmark to 16.7% in the Netherlands. The revision from ICD-6 and ICD-7 to 
ICD-8 was the revision most prone to showing ICD-related mortality discontinuities 
(16.0%). The proportion of discontinuities for the revision from ICD-8 to ICD-9 was 10.8% 
and for ICD-9 to ICD-10 the proportion was 4.6%.  
 
Two generally applied incidental changes in coding rules were identified. In England and 
Wales a broadening of coding rule 3 in the period 1984–92 caused the conditions directly 
leading to death being coded for less often. At the same time, conditions often mentioned 
in part II of the death certificate (conditions which contributed to the death but were not 
part of the direct causal sequence) were coded for more often as the underlying cause of 
death [21]. 
 
Table 4. Significant mortality discontinuities resulting from generally applied changes in coding rules 
in the International Classification of Diseases, 1950-99 by cause of death for men and women aged 60 
years and oldera 
 
Cause of death Transition rateb,c 
 England and Wales
1984 to 1992
Sweden from 
1981 onwards 
Infectious diseases 1.11 NS 
Cancer of the oesophagus NSd NS 
Cancer of the stomach 1.03 NS 
Cancer of the colorectum 1.03 0.89 
Cancer of the pancreas 1.04 NS 
Cancer of the upper respiratory tract NS 0.84 
Cancer of the lung 1.02 0.93 
Cancer of the breast 1.05 NS 
Cancer of the prostate NS 0.77 
Cancer of the bladder NS 0.85 
Cancer of the kidney 1.04 0.87 
Cancers, unspecified 0.96 1.07 
Other cancers 1.05 0.86 
Diabetes mellitus 1.45 0.50 
Dementia and Alzheimer disease 2.18 1.57 
Ischaemic heart disease 1.01 NS 
Other heart diseases 0.87 1.54 
Cerebrovascular diseases 1.08 0.96 
Other circulatory diseases 0.90 1.27 
Pneumonia/influenza 0.52 1.28 
Chronic obstructive pulmonary disease 1.08 0.86 
Senility 0.80 NS 
Other symptoms and ill-defined conditions NS 1.39 
Other diseases 1.23 0.86 
Accidental fall 1.03 0.53 
Other external causes 1.07 0.91 
a Table shows discontinuities at 95% significance. 
b The relative size of the increase or lowering of the fitted mortality rate for the period immediately 
after or during the coding change compared with the mortality rate immediately before or adjacent to 
the coding change. 
c Values in bold indicate that the mortality discontinuity cannot be attributed to non-linear trends or a 
single outlier. 
d NS = parameter estimate is not significant. 
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In Sweden, from 1981 onwards some additional coding rules were implemented that had 
the reverse effect (A. Edberg, National Board of Health and Welfare, Sweden, personal 
communication, July 2002). These generally applied coding rules affected approximately 
half of the causes of death under consideration, including the specific cancers. For 
pneumonia and other heart diseases, both conditions leading directly to death, an 
important lowering of mortality rates in England and Wales in the period 1984–92 occurred, 
whereas in Sweden from 1981 onwards mortality associated with these conditions 
increased. For diabetes mellitus, a disease that is not part of the direct causal sequence, 
the reverse effects appeared (Table 4). 
 
The remaining incidental changes in coding rules (n = 22) occurred primarily in Finland and 
Sweden (Table 5). Eleven of the 26 causes of death were affected, especially diabetes. In 
eight cases an additional mortality discontinuity occurred as a result of a one-year lag in 
applying a change in coding rules.  
 
For cerebrovascular diseases, controlling for the incidental change in the coding rules in 
England and Wales (1984–92) and Finland (1956–58) led to significant changes in annual 
decade-specific mortality in England and Wales in the 1980s and 1990s, but a change in 
trend did not occur in Finland in the 1950s (Table 6). A change in trend also occurred for 
other causes of death subject only to incidental changes (i.e. most specific cancers, chronic 
obstructive pulmonary disease and accidental falls). The changes, however, were often 
insignificant, and the major changes were restricted to a limited period (data not shown).  
 
For ischaemic heart disease, the revision from ICD-6 and ICD-7 to ICD-8 led to a 
significantly altered description of the mortality trend in all countries in the 1960s, and 
sometimes also affected the trends in the 1950s or the 1970s, or both. Controlling mainly 
for ICD revisions also led to significant changes in mortality trends for infectious diseases 
and unspecified cancers, although they were less pronounced (data not shown).  
 
For diabetes mellitus, controlling for a large number of mortality discontinuities changed 
the mortality trends significantly, affecting the annual changes not only in size but also in 
direction in a number of decades, especially in the Netherlands and Sweden. Controlling for 
a combination of different coding problems also led to a significant change in almost the 
entire trend for dementia, other heart diseases and pneumonia (data not shown).  
 
DISCUSSION  
 
Despite using a concordance table based on three-digit ICD codes, in 10.8% of the 
revisions to codes for cause-specific mortality, significant discontinuities, regarded as being 
due to ICD revisions, remained. Especially affected were the revisions from ICD-6 and ICD-
7 to ICD-8 and a wide range of causes of death, with the exception of the specific cancers. 
Incidental changes in coding rules were important causes of discontinuities in cause-
specific mortality trends as well, especially in England and Wales, Finland and Sweden. 
Adjusting for these discontinuities can lead to significant changes in trends in cause-specific 
mortality, although these primarily affect only limited periods of time.  
 
The range in differences between countries in terms of ICD-related mortality discontinuities 
(1.9% for Denmark to 16.7% for the Netherlands) could partly be due to an under-
estimation of the percentage for Denmark caused by the lack of implementation of ICD-9. 
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Table 5. Cause-specific mortality discontinuities resulting from incidental changes in coding rules in 
the International Classification of Diseases, 1950-99, for men and women aged 60 years and older, by 
country 
 
Country Cause of death Period Cause of the irregularity Transition 
    rate a 
Denmark Diabetes mellitus 1965 onwards Less restrictive practice in coding 
diabetes as the underlying cause of 
death from 1965 onwardsb 
2.30 
Denmark Other diseases 1965 onwards Less restrictive practice in coding 
diabetes as the underlying cause of 
death from 1965 onwardsb 
0.95 
England 
and Wales 
Diabetes mellitus 1984 One year lag in change in coding rule 
1984-92 
0.90 
Finland Infectious diseases 1956-58 Change in coding rule 1.21 
Finland Dementia/Alzheimer 1956-58 Change in coding rule 0.00 
Finland Other heart diseases 1956-58 Change in coding rule 0.85 
Finland Cerebrovascular dis. 1956-58 Change in coding rule 1.14 
Finland Other circulatory dis. 1962 onwards Change in coding rule 1.52 
Finland Other circulatory dis. 1962 One year lag in change in coding rule 
from 1962 onwards 
0.87 
Finland COPDc 1956-58 Change in coding rule 1.43 
Finland Other diseases 1956-58 Change in coding rule 1.21 
Netherlands Diabetes mellitus 1984 onwards More strict application of the ICD rule 
that codes diabetes as an underlying 
cause when circulatory diseases are 
intermediate causes [28] 
2.70 
Netherlands Diabetes mellitus 1984 One year lag in change in coding rule 
from 1984 onwards 
0.47 
Netherlands Diabetes mellitus 1985 Lag in change in coding rule from 1984 
onwards 
0.67 
Norway Diabetes mellitus 1997 onwards From 1997 onwards Statistics Norway 
asked for additional information when 
diabetes mellitus was unspecified (i.e. 
type, complication, duration, and 
whether it should be the underlying 
cause of death). This led to more specific 
diagnoses and to diabetes being coded 
more often as the underlying cause of 
deathd  
1.43 
Norway Dementia/Alzheimer 1986 One year lag in the introduction of ICD-9 0.82 
Sweden Ischaemic heart dis. 1970 onwards Change in coding rule 1.08 
Sweden Ischaemic heart dis. 1970 One year lag in change in coding rule 
from 1970 onwards 
0.93 
Sweden Other heart diseases 1970 onwards Change in coding rule 0.56 
Sweden Pneumonia/influenza 1970 onwards Change in coding rule 0.38 
Sweden Pneumonia/influenza 1970 One year lag in change in coding rule 
from 1970 onwards 
1.83 
Sweden Accidental fall 1981 One year lag in change in coding rule 
from 1970 onwards 
1.29 
a The relative size of the increase or lowering of the fitted mortality rate for the period immediately 
after or during the coding change compared with the mortality rate immediately before or adjacent to 
the coding change. 
b Background information derived from Knud Juel (National Institute of Public Health, Denmark). 
c COPD = chronic obstructive pulmonary disease. 
d Background information derived from Anne Gro Pedersen (Statistics Norway). 
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Table 6. Decade-specific mortality trends for selected causes of death, 1950-99, before and after 
controlling for mortality discontinuities resulting from coding problems, by country and sex for people 
aged 60 years and older (each cause of death considered is typical of a specific type of coding change) 
 
Disease  Trend Annual changes (%)a
and   Men Women 
country  1950s 1960s 1970s 1980s 1990s 1950s 1960s 1970s 1980s 1990s 
Cerebrovascular diseases    
England Observed -0.13 -1.17 -2.92 -2.30 -3.96 -0.52 -1.29 -2.69 -2.25 -3.43 
and Wales Contr. for coding 
change 1984-92 
-0.13 -1.16 -2.96 -3.22 -2.54 -0.52 -1.28 -2.73 -3.05 -2.19 
Finland Observed 0.25 -1.04 -4.10 -2.08 -2.77 -0.86 -2.21 -5.46 -1.35 -3.45 
 Contr. for coding 
change 1956-58 
0.18 -0.78 -4.16 -2.06 -2.78 -1.02 -1.73 -5.58 -1.32 -3.46 
Ischaemic heart disease    
England Observed 3.70 2.89 -0.09 -1.49 -3.83 3.43 3.87 -0.58 -1.04 -3.72 
and Wales Contr. for ICD 
revision 6/7 to 8 
3.95 2.10 -0.17 -1.47 -3.84 4.09 1.81 -0.77 -0.99 -3.73 
Finland Observed 3.77 4.22 -0.50 -1.44 -3.40 3.74 5.45 -1.12 -0.49 -2.60 
 Contr. for ICD 
revision 6/7 to 8 
3.98 3.73 -0.61 -1.41 -3.41 4.37 3.98 -1.41 -0.42 -2.62 
Nether- Observed 5.96 4.18 -0.43 -2.68 -3.88 4.45 3.40 -1.56 -3.08 -3.25 
lands Contr. for ICD revi-
sion 6/7 to 8, 8 to 9 
6.39 3.12 -0.14 -2.44 -3.97 5.37 1.06 -1.36 -2.73 -3.38 
Norway Observed 5.89 5.45 -0.49 -0.71 -4.11 2.29 6.52 -1.50 -1.01 -3.32 
 Contr. for ICD 
revision 6/7 to 8 
6.91 3.15 -0.97 -0.58 -4.16 4.20 1.91 -2.34 -0.79 -3.40 
Sweden Observed 2.77 6.40 0.81 -3.93 -3.69 -0.24 6.23 -0.83 -4.88 -3.25 
 Contr. for coding 
change since 1970, 
ICD revision 6/7 to8 
4.02 3.82 -0.02 -3.72 -3.78 1.39 2.72 -1.81 -4.63 -3.35 
Diabetes mellitus    
Denmark Observed b 4.34 6.17 -1.36 3.07 0.85 0.59 6.52 -3.72 0.51 -0.48 
 Contr. for coding 
change since 1965  
4.50 -3.09 -0.19 2.74 1.11 0.58 -4.40 -2.31 0.10 -0.12 
England Observed -0.84 3.72 -0.33 5.34 -5.55 -1.76 1.89 -2.82 4.56 -6.55 
and Wales Contr. for coding 
change 1984-92 
-0.87 3.79 -0.55 1.50 0.08 -1.78 1.95 -3.02 0.43 -0.47 
Nether- Observed c 3.77 -1.68 -4.52  10.2 -3.65 2.84 -3.47 -6.86 8.79 -5.14 
lands Contr. for ICD 
revision 6/7 to 8,  
8 to 9, and coding 
change since 1984  
2.87 0.93 -1.02 -2.19 -1.82 1.84 -0.52 -3.40 -3.12 -3.38 
Norway Observed 0.69 -1.60 4.12 1.68 2.54 2.27 -4.40 1.84 0.72 1.62 
 Contr. for coding 
change since 1996  
0.67 -1.53 3.91 2.31 -0.63 2.24 -4.32 1.54 1.67 -3.31 
Sweden Observed d 4.28 1.89 -2.58 1.57 1.32 2.37 0.92 -4.01 -1.11 0.04 
 Contr. for coding 
change since 1981  
3.03 4.38 0.96 3.67 0.69 1.14 3.45 -0.14 1.30 -0.74 
a Trend estimates in bold denote a significant difference between observed annual changes and annual 
changes after controlling for mortality discontinuities arising from coding problems. 
b Data for 1995-1998 were excluded due to very erratic trend. 
c Data for 1971 were excluded due to exceptionally high mortality rate. 
d Data for 1970-1980 were excluded due to very erratic trend. 
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As for the revision of ICD-8 to ICD-9, in general fewer mortality discontinuities were 
observed. However, it is most likely that the differences between countries are related to 
differences in applying the ICD revisions.  
 
Evaluation of data and methods  
 
In this paper we developed a method to evaluate and adjust for mortality discontinuities 
caused by coding problems. A major advantage of our method when compared to the 
bridge coding method [2] is that our method can detect incidental changes in coding rules. 
In comparison to the method developed by Vallin & Meslé our method can be easily applied 
to other countries and can be extended to new ICD revisions fairly easily. Moreover, 
estimates of discontinuities observed using our method can easily be taken into account in 
trend analyses using regression or related techniques.  
 
Inherent in our adjustment method is the assumption that the relative increase or decrease 
in mortality is equal in all years prior to or after the transition. For ischaemic heart disease, 
however, inclusion of code 422.1 in ICD-6 and ICD-7 for England and Wales and Norway, 
which was done to ensure better comparability with codes in ICD-8 [22], gave different 
results than our adjustment, primarily due to a change in the frequency of use of this code 
throughout ICD-6 and ICD-7. Although we could not explicitly check this assumption for 
other causes of death, note that the mortality discontinuity for ischaemic heart disease that 
appeared during the transition to ICD-8 is much more pronounced in absolute terms than 
the transitions for other causes of death.  
 
The transition coefficients we found for people aged 60 and older cannot be applied 
directly to other age groups. A comparison of the transition rates for people aged ≥60 and 
≥80 yielded changes greater than 10% in almost half of the cases (data not shown). 
Therefore, adjustment should be age-specific.  
 
Persisting problems in studies of long-term mortality trends  
 
The comparability of cause of death statistics over time is affected not only by ICD 
revisions or incidental changes in coding rules but also by changes in the reporting of the 
cause of death on death certificates and by changes in the number of deaths from ill-
defined causes and other unspecified causes [1,4].  
 
Changes in the reporting of causes of death on the death certificate may be the result of 
developments in medical science or the use of new diagnostic techniques as well as 
changes in concepts of diseases [1]. For example, a growing propensity for physicians to 
report dementia as an underlying cause of death may have contributed to the large annual 
increases in mortality from "dementia and Alzheimer disease" among elderly people aged 
80 years and older in a number of north-western European countries in the 1980s and 
1990s [23]. Part of the increase in mortality rates from chronic obstructive pulmonary 
disease may be the result of increased diagnosis and changes in how physicians code for 
the disease [24,25].  
 
An increase in the number of deaths from "symptoms and ill-defined conditions" may be 
the result of both stricter diagnostic criteria for a given specific disease and a real increase 
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in unknown causes [26]. However, mortality trends in "symptoms and ill-defined 
conditions" are also often closely related to the quality and the accuracy of the diagnosis 
[1,26] (F. Meslé, unpublished data presented October 2000). For example, the increase in 
"symptoms and all ill-defined conditions" among people aged 80 years or older in Denmark, 
England and Wales, the Netherlands and Sweden from the 1980s onwards [23] may partly 
be the result of less detailed and less accurate diagnosis and reporting by physicians.  
 
Both problems can bias mortality trends in other causes of death as well. For example, the 
increasing tendency to report "symptoms and ill-defined conditions" such as "sudden 
death" as the underlying cause of death may result in an underestimation of an increase 
(or overestimation of a decrease) in mortality from cardiovascular diseases [26]. 
Unfortunately, there are no formal methods that can be used to cope with changes in the 
reporting of causes of death on the death certificate because they result in gradual shifts 
that are difficult to detect and quantify [4]. The number of deaths attributed to ill-defined 
or unknown causes are increasingly being redistributed by researchers among specific 
causes [5,27]. This applies especially to heart disease; it is less common for cancer-related 
deaths (F. Meslé, unpublished data presented October 2000). However, it remains unclear 
whether these reclassifications, which are based on assumptions about, among others, the 
distribution of ill-defined or unknown causes among specific causes of death, actually lead 
to improvements in assessing long-term trends in cause-specific mortality. Aggregating ill-
defined causes of death with specific causes probably will improve the comparability of 
data over time but information on specific causes of death will be lost, and this may be an 
unacceptable loss in many cases. 
 
Conclusions 
 
When describing long-term trends in cause-specific mortality, evaluating and adjusting for 
mortality discontinuities caused by coding changes between and within ICD revisions is 
essential because these changes can substantially bias the description and analysis of 
cause-specific trends in mortality. An accurate and fairly easy method for evaluating and 
adjusting for these coding-related mortality discontinuities has been proposed in this paper 
— that is, a combination of visual inspection of the trends and the use of a formal 
regression method after application of a concordance table based on three-digit ICD codes. 
The other problems that remain when studying long-term trends in cause-specific 
mortality, such as changes in the reporting of causes of death by physicians, should always 
be taken into account when interpreting these trends.  
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3 
 
STAGNATION IN MORTALITY DECLINE AMONG ELDERS IN THE 
NETHERLANDS 
 
 
Objective This study assesses whether the stagnation of old-age (80+) mortality decline 
observed in The Netherlands in the 1980s continued in the 1990s and determines which 
factors contributed to this stagnation. Emphasis is on the role of smoking. Methods 
Poisson regression analysis with linear splines was applied to total and cause-specific 
mortality data by age, year of death (1950-1999) and sex. An age-period-cohort analysis 
was carried out to determine whether the trends followed period or cohort patterns. ICD 
revisions were bridged by use of a concordance table. Results A sudden reversal in old-
age mortality decline occurred around 1980, leading to a stagnation of the decline and 
even increases in mortality thereafter. Smoking-related cancers, chronic obstructive 
pulmonary disease, and diseases specifically related to old age contributed to this 
stagnation. Trends in smoking-related cancers and chronic obstructive pulmonary disease 
showed a cohort pattern - especially for men. When these smoking-related diseases were 
excluded, the trends in old-age mortality in The Netherlands showed an increasing 
stagnation for both sexes. Conclusion Smoking behavior can only partly explain the 
stagnation of mortality. Other factors, such as increased frailty and changes in medical and 
social services for elderly people, probably played a more decisive role in the recent 
stagnation. 
 
BACKGROUND 
 
In almost all low-mortality countries, mortality among the elderly population has shown a 
decrease since 1950, with an accelerated improvement from 1970 onward [1-4]. This trend 
has contributed to the current increase in both the proportion and the mean age of elderly 
people in these populations. Furthermore, the ongoing reduction in old-age mortality raises 
interesting questions concerning the extent to which today’s populations are approaching a 
limit to human life expectancy [5-14].  
 
However, the general pattern of sustained mortality decline among the elderly population 
since 1970 was not observed in all low-mortality countries. In The Netherlands and 
Norway, old-age mortality even showed signs of an increase [3,15,16]. This raises the 
question of whether The Netherlands and Norway can be regarded as precursors of trends 
in old-age mortality, implying that the same stagnation will happen in other low-mortality 
countries in the future, or that the stagnation as observed in The Netherlands and Norway 
is unique and is not likely to occur elsewhere. This led us to study the determinants 
underlying the stagnation of mortality decline. More specifically, are these unfavorable 
mortality trends the result of determinants specifically operating in The Netherlands and 
Norway, or are they the result of factors that may be expected to influence trends in other 
countries as well?   
 
Here we focus on trends in old-age mortality in The Netherlands. A stagnation of the 
decrease in mortality in The Netherlands in the 1980s was described by Nusselder and 
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Mackenbach (2000) [15]. They found that life expectancy at the age of 85 had decreased 
for men and had stagnated for women. One of the possible reasons suggested relates to 
smoking histories. In The Netherlands, smoking rates among men were exceptionally high 
during the 20th century [17]. In particular men born between 1897 to 1917 had a high 
lifetime exposure to smoking [18], and these are the men who reached old age at the end 
of the 20th  century. 
 
Here we describe in more detail the mortality trends among Dutch elderly people in the 
second half of the twentieth century. We will (a) determine whether the stagnation of old-
age mortality has persisted in more recent years and (b) explore possible explanations for 
recent trends in old-age mortality. The contribution of smoking will be emphasized. 
Because smoking behavior in The Netherlands has been shown to vary markedly between 
birth cohorts, we assess whether mortality trends are dominated by cohort patterns.  
 
In this analysis we go one step farther than most prior analyses of old-age mortality by 
analyzing both period and cohort patterns in total mortality as well as in an extensive range 
of causes of death. We cover trends in the period 1950-1999. Furthermore, in our analysis 
we made an effort to carefully bridge the different revisions of the International 
Classification of Diseases (ICD).  
 
DATA AND METHODS 
 
Data 
 
In this study, total mortality and population data by single year of age (up to 112), sex, 
and year of death (1950-1999) have been included for the total Dutch population. In 
addition, for the causes of death, data were available by three digit codes, 5-year age 
groups (up to 85+ for 1950-1969, thereafter up to 95+), sex, and year of death (1950-
1999). All data were originally obtained from Statistics Netherlands [19-21]. The deaths per 
cause in the older age groups (85+ or 95+) were redistributed over 5-year age groups up 
to 100+ on the basis of the distribution of total mortality among these age groups.  
 
We distinguished 26 (groups of) specific and homogeneous causes of death, which were 
selected predominantly on the basis of their relative importance in old-age mortality. In 
addition we selected (a) cancers that are strongly (population attributable risk [PAR] larger 
than 0.50) or moderately (PAR between 0.25 and 0.50) related to smoking (PARs from the 
American Cancer Study) [22], and (b) causes that could indicate changes in coding 
practices. Table 1 lists the causes of death, their accompanying ICD10 codes, and their 
relative share in all-cause mortality among those aged 80 and older in 1950 and 1999. 
 
Statistical analysis  
 
We analyzed the data by means of a (log-linear) Poisson regression model. The dependent 
variable was the number of deaths, with the person-years at risk as offset. As independent 
variables, we used age (5-year age groups) and year (year of death in the period analysis 
or birth year in the cohort analysis). 
 
The use of 5-year age groups in all of our analyses, except the one on which Figure 1 is 
based, was due to the restriction that data on the causes of death were available by 5-year 
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age groups instead of single years of age. To evaluate to what extent a possible change 
over time in the distribution of deaths within a 5-year age group could affect our results, 
we compared the results for total mortality by using data by 5 years of age with the results 
from data by single years of age.  
 
Table 1. Causes of death, accompanying ICD10 codes, and their relative share in all-cause mortality in 
1950 and 1999, for people aged 80 and older, by sex  
 
Cause of death ICD10 (1996-1999) 80+ in 1950 (%) 80+ in 1999 (%) 
  Men Women Men Women 
Strongly smoking-related cancers    
   Esophagus C15 0.68 0.40 0.55 0.27 
   Upper respiratory / digestive system C00-C14,C30-C32  0.46 0.10 0.34 0.13 
   Lung C33-34 0.45 0.15 5.18 0.73 
    
Moderately smoking-related cancers    
   Pancreas C25 0.12 0.09 0.60 0.81 
   Bladder C67 0.28 0.23 1.25 0.44 
   Kidney C64-C66,C68 0.05 0.05 0.53 0.27 
   Other cancersa Rest(C00-D48) 1.63 2.83 3.08 3.75 
    
Other specific cancers    
   Stomach C16 4.40 3.44 1.11 0.73 
   Colorectum C18-C21 1.86 2.00 2.39 2.28 
   Breast C50 0.01 1.00 0.05 2.31 
   Prostate C61 2.15 0.00 4.75 0.00 
   Unspecified C76-C80,C97,D37-D48  0.57 0.59 2.09 2.14 
    
Cardiovascular diseases    
   IHD I20-I25 11.29 9.71 13.45 10.98 
   Other heart diseases I00-I13,I15,I27,I30-I52 18.68 20.77 11.53 14.33 
   Cerebrovascular diseases I60-I69 14.40 16.91 9.51 12.55 
   Other circulatory diseases Rest(I00-I99) 6.04 5.45 3.56 2.63 
    
Other causes of death    
   Infectious diseases A00-B99 0.64 0.74 1.01 1.05 
   Pneumonia/influenza  J10-J18 5.71 6.11 7.70 7.97 
   COPD  J40-J47 2.79 2.26 8.39 3.23 
   Accidental fall  W00-W19,X59 1.24 1.67 1.40 2.27 
   Other external causes Rest(V01-Y98) 0.96 0.42 0.63 0.30 
    
Diseases strongly sensitive to coding practices   
   Diabetes mellitus E10-E14 0.70 1.47 1.63 2.81 
   Dementia and Alzheimer’s F00,F01,F03,G30 3.37 3.67 3.97 8.35 
   Senility R54 9.55 11.81 1.87 3.48 
   Other symptoms & ill-defined  
   Conditions 
Rest(R00-R99) 1.99 1.78 2.83 2.84 
    
Other diseases Rest(A00-R99) 9.96 6.34 10.59 13.33 
    
All causes 80+ (n)  7,532 8,665 22,791 40,214 
ICD = International Classification of Diseases; IHD = ischaemic heart disease; COPD= chronic 
obstructive pulmonary disease.  
a This excludes all the cancers listed in this table. 
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Because this comparison generated virtually the same results, we expect that, although 
age patterns can differ for the specific causes of death, the bias when the data by 5-year 
age groups are used will be minimal. 
 
For the period analysis, linear splines were used in the regression model to describe 
mortality trends by year of death. Spline functions accommodate piecewise fits connected 
with one another at the transition from one segment to the next [23]. For the period 
analysis, we used five segments, each covering a period of 10 years (1950-1959, 1960-
1969, 1970-1979, 1980-1989, 1990-1999). The analysis including splines yielded estimates 
of annual changes in mortality within each ten-year period. Comparison of these five 
decade-specific rates of change enabled us to detect and quantify changes in the secular 
trend in mortality, such as a stagnation of the decrease in mortality. 
 
For the cohort analysis, the year of birth was used as independent variable. For this 
purpose we determined the mean birth year for every combination of a single calendar 
year and a 5-year age group, taking into account the distribution of the population within 
this age group. To obtain equal degrees of freedom compared with the age-period model, 
we divided the range of birth years into five segments as well (1848-1879, 1880-1889, 
1890-1899, 1900-1909, 1910-1936). These five cohort segments were chosen in such a 
way that approximately the same number of deaths (for those aged 80 and older) occurred 
in each segment.  
 
In a last step, we fitted a regression model including age, year of death, and birth year, 
that is a full age-period-cohort (APC) model. This model was based on the same period and 
cohort splines as just described. By comparing the scaled deviances (a measure of 
unexplained variance) of the different models (age, age-period, age-cohort, age-period-
cohort), we evaluated the extent to which the secular trends followed a cohort or period 
pattern. It should be noted that our analysis differs from traditional APC analyses, because 
we evaluate the effects of year of birth by means of splines instead of a nominal variable 
for 5- or 10-year periods. 
 
The use of splines helped us to overcome the identification problem or drift in APC analysis. 
Drift has been described as a common linear trend that cannot be ascribed to either period 
or cohort influences [24]. Because the splines enabled us to identify nonlinear trends we 
avoided the identification problem, especially for causes of death showing these nonlinear 
trends.  
 
We focused in most of these analyses on deaths among people aged 80 and older. We 
made an exception when identifying underlying cohort patterns (in APC analyses) and 
analyzing these cohort patterns (in cohort analyses). Because it would not be possible to 
separate period and cohort effects in an analysis of those 80 years and older, we decided 
to use the data on deaths among people aged 60 and older.  
 
Concordance 
 
In analyzing the trends for the selected causes of death, we had to bridge four different 
ICD revisions: ICD6/7 (1950-1968), ICD8 (1969-1978), ICD9 (1979-1995) and ICD10 
(1996-1999). To do this, we built on the work of Wolleswinkel-van den Bosch to construct 
a concordance table in which the different codes for a specific cause of death in successive 
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ICD revisions are linked [25]. Available information from the World Health Organisation, for 
example the ICD9 to ICD10 translator [26], and Statistics Netherlands [27] was used, 
among others, to extend the existing concordance tables to ICD10. The basic rule applied 
was that continuity of the medical content of the causes of death should be safeguarded.  
 
Using a prefinal version of the resulting concordance table we looked at the trends in 
mortality to check whether sudden changes in mortality at ICD transitions still occurred. 
Whenever irregularities were found, we checked whether the concordance table could be 
improved. The final concordance table is presented in Appendix I. We made special efforts 
to accurately bridge the change from ICD6/7 to ICD8 for ischaemic heart disease (IHD) by 
using published data on the four-digit code for IHD under ICD6/7 [28]. 
 
After application of the final concordance table, irregularities in the trends caused by ICD 
transitions persisted for a number of causes of death. We judged these irregularities in our 
regression model (age-period) by adding variables indicating the three ICD transitions, that 
is ICD6/7 to 8, ICD8 to 9, or ICD9 to 10. For nine causes of death, these variables had to 
be included in the model for one or two transitions. We selected these cases on the basis 
of the following criteria: (a) the parameter estimate corresponding to this variable had to 
be statistically significant; (b) the significant effect could not be attributed to nonlinear 
trends or to a single outlier, for instance an influenza epidemic; and (c) the observed effect 
could be explained, for example, by a four-digit code not included in the concordance table 
or an effect on one cause of death mirrored by an opposite effect on a complementary 
cause of death.  
 
Another problem in analyzing trends by cause of death related to changes within ICD 
revisions, such as changes in the reporting of causes of death by physicians or in coding 
rules applied at Statistics Netherlands. This again might have caused irregularities in 
mortality trends [29]. For diabetes mellitus, we had information on the presence of 
incidental changes in coding rules, that had a demonstrable effect on trends in mortality 
from this cause in the 1980s [30]. To control for it, we included an extra variable in the 
regression model for this specific cause of death.  
 
For three causes of death, one single year exhibited exceptional mortality levels. For 
example, in 1953, "external causes" showed an enormous increase in mortality because of 
a flood disaster. In 1980, a strike of medical specialists resulted in high mortality rates for 
"other symptoms and ill-defined conditions" [31]. Another outlier occurred in 1971 for 
diabetes mellitus. These outliers were excluded from the cause-specific analyses. 
 
RESULTS 
 
Total mortality rates for those aged 80 and older (Figure 1) showed a general tendency of 
a moderate decline in the period 1950-1969 (except for the highest age group), and a 
steep decline between 1970 and 1979. Around 1980, a sudden reversal of the trend led to 
stagnation of the decline and even increases in mortality, especially among the highest age 
groups and for men in the 1980s.  
 
In the first row of Tables 2a and 2b, the pace of mortality decline within each of the five 
decades is quantified by means of annual rates of change. Male old-age mortality 
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decreased from 1950 to 1979 by annual percentage changes of –0.57, -0.31, and –0.89 for 
the successive decades. In the 1980s, however, mortality increased by 0.37% per year. 
The annual percentage change of –0.18 for 1990-1999 suggests a modest reemergence of 
the decrease in old-age mortality. The confidence intervals for successive decades do not 
overlap (except for 1950-1959 to 1960-1969), implying that the changes in the pace of 
mortality decline are statistically significant. 
 
 Among women, mortality showed generally the same secular trends, but with important 
differences. The annual percentage changes indicate a pronounced decrease in the 1970s 
(-2.67). This decline was followed by a levelling off of the mortality decline between 1980 
and 1989 (-0.42) and by stagnation in the 1990s (+0.06). 
 
Table 2 moreover shows widely different trends for the different causes of death for both 
sexes. A number of causes of death exhibited unfavorable trends. First, some causes of 
death underwent a stagnation of an initial mortality decline. For men (Table 2a), this 
applies for cancer of the esophagus, "other heart diseases", infectious diseases, pneu-
monia, dementia, and senility. 
Figure 1. Observed and fitted all-cause mortality rates, for people aged 80 and older, 1950-1999, by 
sex and 5-year age groups. 
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Second, some causes of death underwent a sustained increase in mortality until the 1980s 
or even the 1990s, such as lung cancer, all the moderately smoking-related cancers, 
prostate cancer, unspecified cancers, chronic obstructive pulmonary disease (COPD), and 
"other symptoms and ill-defined conditions". As a result of their long-term increase, these 
causes gradually had an increased share in total mortality (see also Table 1) and thus their 
trends had increasingly more effect on the trends observed for all-cause mortality. 
 
For women (Table 2b), the causes of death with an unfavorable trend were almost the 
same as those for men. However, cancer of the bladder and "other cancers" did not show 
unfavorable trends, and accidental fall exhibited a stagnation of the decrease. Mortality 
from unspecified cancers and COPD showed a recent increase, instead of the long-term 
increase observed for men. 
 
To assess whether the trends in both total and cause-specific mortality among those aged 
60 and older followed predominantly a period or a cohort pattern, we conducted an APC 
analysis. In Table 3 the scaled deviances – a measure of the unexplained variance - are 
given for the age-period (AP) model, the age-cohort (AC) model, and the APC model. They 
are expressed as percentages of the scaled deviance of the model using age only. The 
lower the scaled deviance of a model, the better the model is able to describe the trends 
observed. 
 
For total male mortality the scaled deviance of the AC model (32%) was much lower than 
the scaled deviance of the AP model (52%), indicating that the trends predominantly 
followed a cohort pattern. For women, the scaled deviance of the AC model (11%) was 
higher than the scaled deviance of the AP model (6%); here, therefore, period patterns 
contributed more to the trends observed. 
 
For most causes of death, the scaled deviance for the AP model was much lower than the 
scaled deviance for the AC model, indicating that the secular trends followed a period 
rather than a cohort pattern. Moreover, the little difference between the scaled deviance 
for the AP model and that for the APC model suggests that cohort effects, if any, were 
small. However, for some causes of death, the scaled deviances indicate that secular trends 
can be explained largely by cohort patterns. This applies to all smoking-related cancers 
(except for pancreatic cancer among men), prostate cancer, "other circulatory diseases" 
(men only), COPD (men only), and "other diseases".  
 
Figure 2 shows the fitted mortality rates by birth year for all-cause mortality and a selection 
of causes of death, for men aged 80-84. The fitted mortality rates are based on the cohort 
analysis for those aged 60 and older as a whole. This analysis generated equal parameter 
estimates for each age group. Figure 2 therefore illustrates the overall cohort pattern for 
those aged 60 and older.  
 
Total male mortality showed a reversal between birth cohorts 1880-1890 and 1890-1899, 
with annual percentage changes of –0.49 and 0.78 respectively. An annual percentage 
change of 0.78 indicates that mortality among those aged 60 and older increased by 0.78% 
per birth year between 1890 and 1899. Among the cohorts born between 1900 and 1909, 
mortality stagnated (-0.01); among the youngest birth cohorts, the mortality decline 
reemerged (-1.31).  
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Although the trends for the selected causes of death tended to vary, some general 
tendencies can be distinguished. "Other diseases" exhibited an increasing rate of decline in 
the youngest birth cohorts.  
 
Table 3. Scaled deviances of different models for total and cause-specific mortality, for people aged 
60 and older, by sex 
 
Scaled deviancea Men Women 
 Age AP AC APC Age AP AC APC 
   
Total mortality 14,773 52 32 14 83,429 6 11 4 
   
Strongly smoking-related cancers   
   Esophagus 1,392 49 28 25 613 76 65 60 
   Upper respiratory / digestive system 497 94 86 74 482 92 77 75 
   Lung 30,838 23 5 2 6,952 15 8 7 
   
Moderately smoking-related cancers   
   Pancreas 2,000 22 33 17 1,311 41 37 33 
   Bladder 1,431 39 33 27 447 93 90 87 
   Kidney 1,950 27 18 17 944 49 44 43 
   Other cancersb 3,706 14 11 10 862 88 66 60 
   
Other specific cancers   
   Stomach 14,652 4 4 4 19,646 3 3 2 
   Colorectum 554 81 88 77 1,302 39 40 35 
   Breast 645 77 73 68 
   Prostate 1,917 44 39 35   
   Unspecified 2,234 36 55 33 1,589 44 78 40 
   
Cardiovascular diseases   
   IHD 21,417 13 56 6 16,509 9 33 8 
   Other heart diseases 18,773 10 9 7 46,804 8 11 2 
   Cerebrovascular diseases 16,899 7 7 5 43,900 8 6 3 
   Other circulatory diseases 7,155 70 27 13 20,387 8 8 5 
   
Other causes of death   
   Infectious diseases 5,070 27 64 11 5,966 20 65 8 
   Pneumonia/influenza  19,383 16 46 11 27,661 17 44 9 
   COPD  13,007 46 15 10 2,971 26 70 21 
   Accidental fall  2,159 27 36 20 10,919 11 17 5 
   Other external causes 4,296 13 18 11 1,492 41 49 35 
   
Diseases strongly sensitive to coding practices   
   Diabetes mellitus 23,786 8 27 8 8,883 19 16 14 
   Dementia and Alzheimer’s 7,680 17 66 16 19,980 11 56 10 
   Senility 13,588 14 27 8 22,328 17 34 7 
   Other symptoms & ill-defined 
conditions 
7,206 13 22 12 5,285 16 26 16 
   
Other diseases 4,562 60 50 20 9,852 86 59 12 
AP = regression model with age and period splines as independent variables; AC = regression model 
with age and cohort splines as independent variables; APC = regression model with age, period and 
cohort splines as independent variable; IHD = ischaemic heart disease; COPD= chronic obstructive 
pulmonary disease. 
a Expressed as percentage of the scaled deviance of the model including only age. 
b This refers to the cause of death "other cancers" as listed in Table 1. 
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Figure 2. Fitted mortality rates by cohort for total mortality, smoking-related cancers, chronic 
obstructive pulmonary diseases, and other diseasesa for men aged 80-84 
 
a This refers to the cause of death "other diseases" as listed in Table 1. 
 
Lung cancer and COPD followed a pattern of an increase in the oldest birth cohorts up to 
1890-1899, changing to a decrease for those born after 1910. For cancer of the pancreas, 
bladder, and kidney, the same pattern applies, although it is less clear. Cancer of the 
esophagus and cancer of the upper respiratory or digestive system followed a different 
pattern, with a clear stagnation of the mortality decline and an increase among the 
youngest cohorts. 
 
For total female mortality, the cohort trends did not show an increase in mortality for a 
particular cohort group but instead a declining trend throughout, with only a modest 
stagnation of the mortality decline for the youngest birth cohort. The annual percentage 
changes were –0.45, -1.86, -1.35, -1.57, and –1.08 for the successive cohort groups. 
 
Table 4 shows the period trends that would be observed for all-cause mortality when 
smoking-related cancers and COPD are excluded. 
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After their exclusion, stagnation of mortality decline during the 1980s and 1990s still 
prevailed. For men, the annual percentage changes would be –0.21 in the period 1980-
1989 and 0.00 in the period 1990-1999. For women, these percentages would be –0.63 
and 0.06 in the successive decades. Thus, after a number of causes of death specifically 
related to smoking were excluded, the trends in all-cause mortality for men and women 
showed a uniform pattern of a leveling off of the mortality decline in the 1980s and 
complete stagnation in the 1990s. 
 
Further analysis revealed that, when the smoking-related cancers and COPD are excluded, 
the period and cohort models both can describe the observed trends for all-cause mortality. 
The scaled deviance for the AP model (as compared to the model with age only) was 6% 
for men and 7% for women. For the AC model, the scaled deviances were only slightly 
higher, that is, 11% for men and 10% for women. 
 
DISCUSSION 
 
Compared with previous research [15], this study has provided important new findings on 
the stagnation of old-age mortality in The Netherlands. First, a sudden reversal occurred 
around 1980, when the marked mortality decline of the 1970s turned into stagnation and in 
some cases even an increase during the 1980s and 1990s. Second, the causes of death 
contributing to the stagnation of the mortality decline are predominantly smoking-related 
diseases and diseases specifically related to old age. Third, among men, trends for 
smoking-related cancers and COPD followed a cohort pattern, which suggests an important 
role for differences between successive generations in exposure to smoking. Fourth, when 
these smoking-related diseases are excluded, the trends in all-cause mortality were found 
to follow a pattern of increasing stagnation for both men and women.  
 
These results strongly suggest that, even though cohort changes in smoking exposure 
influenced the trends in mortality among older men in the 1980s, these changes do not 
fully explain the recent stagnation of mortality observed among elderly Dutch men and 
women. Before we can speculate on the role of other specific factors, possible bias caused 
by data problems or the methods used in our analysis should be evaluated. 
 
Evaluation of data problems 
 
The mortality and population data used in this study come from the municipal population 
registers. Data from the Dutch population registers are considered reliable and consistent 
[32]. The use of an individual-based register, which is started at the birth of an individual 
and contains all major demographic events throughout life, ensures that age misstatement 
cannot have affected our mortality rates. Because both population and mortality data are 
derived from the same source, the mortality rates are not subject to numerator-
denominator bias [1].  
 
Analyses of long-term trends in causes of death have to deal with several transitions 
between ICD revisions. We made considerable effort to bridge these ICD revisions by 
carefully constructing a concordance table and by controlling for the few remaining jumps 
in our regression analysis. Further checks showed minimal sensitivity. Thus, even though 
some residual effects of ICD transitions could not be excluded, we believe that these 
problems did not affect the results to any substantial extent. 
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More difficult to tackle were changes within an ICD revision, either in the reporting of 
causes of death by physicians or in coding practices at the Statistical Office. The causes of 
death expected to suffer substantial effects are diabetes mellitus, dementia, senility, and 
"other symptoms and ill-defined conditions". The recent observed increase in mortality 
from "other symptoms" could indicate less detailed and less accurate diagnoses. The 
increase in senility and dementia, however, is probably due to the growing propensity of 
physicians to report these diseases as underlying causes of death. An increase in the 
doctor’s tendency to list only one cause on the death certificate may have the effect that 
diseases that were formerly reported mainly as secondary causes of death are increasingly 
listed as primary causes of death. In particular, this might influence trends in mortality 
from diabetes and pneumonia, which are common secondary causes of death in The 
Netherlands [33].  
 
In view of these possibilities, we should be cautious about interpreting the marked 
increases in mortality observed for the causes of death mentioned herein. In addition, 
these increases in mortality will in some cases have an opposite effect on other diseases. 
For example, an increasing tendency to report diabetes mellitus as the underlying cause of 
death may result in an underestimation of an increase (or overestimation of a decrease) in 
mortality from cardiovascular diseases. However, the potential for bias should not be 
generalized to all causes. Some causes of death may be relatively resistant to changes in 
coding practices, especially those diseases that have a more straightforward diagnosis. This 
applies to most of the smoking-related cancers and probably COPD as well.  
 
Evaluation of methods 
 
As far as the APC analysis was concerned, we were aware of the identification problem. We 
solved this problem by assessing predominantly nonlinear trends, using splines within our 
regression models. Moreover, by comparing the scaled deviances of the AP model and the 
AC model, we could make valid statements on the role of period or cohort patterns in the 
trends observed, especially when the scaled deviances of these two models showed large 
differences. Such a large difference was observed in several cases, including smoking-
related cancers and COPD.  
 
Explanations of the observed trends 
 
Smoking is frequently mentioned in the literature [5,16,34] to explain some of the 
unfavorable trends in mortality in The Netherlands compared with other European or low-
mortality countries. In our analysis, we found that although smoking contributed to the 
stagnation of the mortality decline among men in the 1980s, mortality from smoking-
related cancers and COPD decreased in the 1990s and among the youngest birth cohorts. 
In addition, when smoking-related cancers and COPD were excluded from all-cause 
mortality, the stagnation of mortality still occurred and was consistent among both men 
and women. It should be noted that only smoking-related diseases with a clear cohort 
pattern were excluded, thus ignoring the period effects of smoking on some other causes 
of death. In The Netherlands, the period pattern of recent changes in smoking behavior is 
likely to have a favorable effect on mortality in the 1980s and 1990s [17], especially for 
cardiovascular diseases. This is due to a decline in smoking prevalence observed among 
Dutch men (65+) since the 1970s [35]. If these period effects were to be taken into 
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account, then an even stronger increase in old-age mortality might become apparent. 
Thus, to explain the stagnation of old-age mortality in The Netherlands, we should look 
beyond the role of smoking.  
 
The first possible explanation is that there is simply no room for further improvement in 
mortality among the Dutch elderly population, because low levels of mortality have already 
been reached. Although mean life expectancy at age 80 in The Netherlands in the period 
1980-1990 was quite high, that is 7.60 years, this level was already surpassed by other 
countries, for example, in Iceland (e80 = 8.18) or Japan (e80 = 7.67) [36]. Moreover, in 
those countries with equal or higher levels of life expectancy, the decrease in mortality 
persisted (Vaupel et al., 1998). This suggests that the unfavourable trends in old-age 
mortality as observed in The Netherlands cannot be simply understood from low levels of 
mortality already attained or a limit to life expectancy being approached. 
 
A second possible explanation for the stagnating trends could be mortality selection. As a 
result of the reduction in old-age mortality in the decades before the 1980s, an increasing 
proportion of people born in successive generations has reached old age. It is likely that 
this increasing proportion of elderly people does not include only the fittest but also those 
who are more frail. Improvements in medical care are frequently mentioned as an 
important reason for the marked mortality decline in the 1970s [37-39], which strengthens 
our hypothesis on the decline in mortality selection. This decline in mortality selection could 
perhaps explain the relatively strong increase in mortality from diseases related to frailty – 
such as infectious diseases – compared with the continued mortality decline in 
cardiovascular diseases. However, even though mortality selection may have played a role 
in the stagnation of the mortality decline, it cannot explain why mortality trends are much 
less favorable in The Netherlands than in other low-mortality countries.  
 
A particular feature of Dutch society is the relatively liberal attitude toward euthanasia and 
related end-of-life decisions. The most frequently made end-of-life decision for elderly 
people in The Netherlands is the decision to withhold life-prolonging treatment [40]. These 
decisions refer not only to technological interventions but also and most frequently to the 
withdrawal or withholding of antibiotics and artificial nutrition or hydration [41]. Whereas in 
1990, 33% of all deaths among those aged 80 and older were preceded by a nontreatment 
decision, this had increased to 36% in 1995 [41,42]. This increasing incidence might reflect 
the growing autonomy of patients, who want to decide for themselves whether or not to 
undergo treatment. However, it is likely that the growing incidence is also the result of 
increased possibilities for treatment. With more alternatives available, the decision to 
withhold a particular treatment will be made more often. In addition, the estimated effect 
of the decision to withhold treatment on the patient’s life expectancy was less than 1 
month in approximately 90% of cases [41]. From more detailed data, we estimated that 
the effect on life expectancy among the Dutch elderly population is a loss of approximately 
0.01 year. The effects of medical decisions related to the end of life on Dutch mortality 
trends thus seem to be negligible.  
 
The abrupt reversal around 1980, from a marked mortality decline in the 1970s to 
stagnation thereafter, raises the question of which parallel changes occurred in The 
Netherlands at the same time or shortly before. In the period 1975-1985, concern focused 
on health care costs, and budget cuts were proposed by the Dutch government [43]. When 
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health care resources become limited, elderly people are often the first group to suffer, 
because medical costs rise exponentially with age. However, it is unclear when and to what 
extent the concern prevalent in this period had an effect on the health care services 
delivered to the elderly population.  
 
Changes also occurred in the health care and social services available for elderly people. In 
The Netherlands between World War II and 1975, care for elders was a central issue of the 
welfare state. Considerable effort and resources were spent on institutionalization and 
intramural care for elderly people [44]. Since 1975, however, Dutch policies have shifted 
and the emphasis has changed to facilities for elders that enable them to stay at home 
longer – in parallel with the growing autonomy among the elderly population. This trend 
could have made this group more reliant on informal or private care [44]. Combined with 
the increase in the number of elderly people living alone and the decrease in social support 
with age [45], this may have resulted in more elderly people without sufficient care, which 
ultimately might have a negative effect on their length of life. In contrast, the decline in 
institutionalization might also have had positive effects on old-age mortality, for example as 
a result of physical activity and self-sufficiency. It is unclear whether these positive effects 
can outweigh the negative effects.  
 
Although the factors discussed herein remain somewhat speculative, they suggest that 
several developments contributed to the unfavorable mortality trends among the oldest old 
in The Netherlands. The stagnation of mortality decline is most likely explained by a 
combination of the growing frailty of the Dutch elderly population together with changes in 
the medical and social services available to them. Because these factors are determined by 
developments that are not necessarily restricted to The Netherlands, this implies that a 
continuing decline in old-age mortality in other low-mortality countries should no longer be 
taken for granted. Although mortality at old age is remarkably plastic and has the potential 
for further reduction [46], changes in the possible determinants discussed here may well 
result in an increase in old-age mortality. 
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TRENDS IN OLD-AGE MORTALITY IN SEVEN EUROPEAN COUNTRIES,  
1950-1999 
 
 
Objective Different from the general observed decline in old-age mortality, for The 
Netherlands and Norway there have been reports of stagnation in the decline since the 
1980s. We detect periods of stagnation in recent old-age mortality trends, and explore for 
which causes of death the recent stagnation is most apparent. Methods We applied 
Poisson regression analysis to total and cause-specific mortality data by age (80+), period 
(1950–1999), and sex, for seven European low-mortality countries. Results We found 
large heterogeneity in the pace of decline in the countries under investigation, with periods 
of stagnation being widespread. In the 1980s and 1990s, stagnation was observed in 
Denmark, The Netherlands, and Norway (males). Continued mortality decline was observed 
especially in France. Although smoking has had a marked influence on the trends in old-
age mortality, the role of smoking in the recent stagnation seems only modest and 
restricted to Norway. Mortality from cardiovascular diseases showed important cross-
national variations in the pace of decline. Mortality from diseases specifically related to old 
age increased recently in all countries, except France. Conclusion Old-age mortality seems 
highly plastic and susceptible to many factors, with both favorable and unfavorable effects 
on trends over time. 
 
BACKGROUND 
 
The general tendency in the trends in old-age mortality (80+) in low-mortality countries 
since the 1950s has been a declining one [1–4]. This tendency has contributed to the 
current increase in the number, the proportion, and the mean age of elderly people in 
these populations.  
 
Because these developments will have huge implications for policy, society, and the 
demand of health care services, there has been much interest in possible future trends in 
life expectancy, especially in the debate on the limit to life expectancy [5–12]. On the one 
hand, proponents of "the limited-lifespan paradigm" state that biologic and practical 
constraints on reducing old-age mortality set an upper limit to life expectancy of 
approximately 85 years [5,9,10]. On the other hand, "the mortality-reduction paradigm" is 
adhered to by researchers who argue that life expectancy will continue to increase - at 
least for some time to come - due to substantial reductions in mortality rates at all ages, 
including the oldest old [6,8,11]. They support their view by referring to mortality 
development in subpopulations with extreme good health, to foreseen biomedical progress, 
and to historic observations that old-age mortality has been decreasing continuously.  
 
Recently, however, research on old-age mortality has shown some exceptions to this 
continuous decline in old-age mortality. For The Netherlands and Norway, there have been 
reports of stagnation or even increases in old-age mortality since the 1980s [2,13,14]. This 
raises the question of whether the mortality decline among elderly in low-mortality 
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countries has been as consistent as previously reported, and whether these developments 
coincide with the idea that life expectancy continues to increase in the future. 
 
However, before making inferences about future trends in old-age mortality, it is important 
to investigate the determinants of trends in old-age mortality. Although there have been 
studies on old-age mortality in the past that acknowledge the heterogeneity of the trends 
between countries [2,15,16], they were mostly descriptive in nature. As a result, little is 
known about the reasons behind the crossnational differences in the pace of mortality 
decline among the elderly. Knowing about the determinants of trends in old-age mortality 
could provide important clues on future mortality among the elderly population, especially 
in the short and medium term.  
 
Studying the trends in cause-specific mortality can generate evidence on the determinants 
of the trends in all-cause mortality among the elderly, because many of the intermediate 
factors or risk factors that could determine mortality trends among the elderly are related 
to specific causes of death. In doing so, we will emphasize the role of smoking. It is 
commonly known that smoking has a strong negative effect on survival. The impact of 
smoking on mortality trends may vary considerably between countries [17]. In fact, the 
stagnation observed in some countries could be the result of the increased lifetime 
exposure to smoking for those birth cohorts who reached old age at the end of the 20th 
century [18,19].  
 
The objective of this article is to describe mortality trends among the elderly in Denmark, 
England and Wales, Finland, France, The Netherlands, Norway, and Sweden, and to 
contribute to the explanation of these trends. Focus will be on the trends from 1980 
onwards. The research questions we will address are: (a) in which countries did trends in 
mortality at old age show signs of stagnation instead of continued decline, (b) to what 
extent did mortality increase for causes of death related to smoking, and (c) for which 
other specific causes of death did an increase occur? 
 
In this analysis, we will extend earlier studies on trends in old-age mortality by using 
detailed mortality data over a long period of time (1950–1999), with a distinction by 
specific causes of death and 5-year age groups up to 100+. Furthermore, in our analysis an 
extensive effort was made to carefully bridge the different revisions of the International 
Classification of Diseases (ICD). 
 
DATA AND METHODS 
 
Data 
 
Data were obtained from national statistical offices and related institutes on total mortality, 
cause-specific mortality, and population at risk for Denmark, England and Wales, Finland, 
France, The Netherlands, Norway, and Sweden, for the years 1950–1999 (National 
Institute of Public Health [Denmark], ONS [CD-Rom Twentieth Century Mortality] [England 
and Wales], Statfin [Finland], INED and INSERM [France], Statistics Netherlands and NIDI 
[The Netherlands], Statistics Norway, and National Board of Health and Welfare 
[Sweden]).For Denmark, Finland, and Norway data were available only from 1951, for 
Sweden from 1952. Data for France were available until 1997 and for Denmark until 1998. 
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The selection of countries was restricted to low-mortality countries in North Western 
Europe. The seven countries we included were selected on the basis of the quality of the 
data [1,2] and on the availability of cause of death data. 
 
For most countries, data on the total number of death by 5-year age groups were available, 
with a maximum age ranging from 85+ to 100+. For The Netherlands and France, deaths 
by single year of age were available to us (no maximum age)(see for France 
http://www.ined.fr/publications/cdrom_vallin_mesle/continu.htm. Tables de mortalité fran-
çaises 1806–1997 et projections jusqu’en 2102 by J. Vallin and F. Meslé (INED)). To 
calculate mortality rates we used the midyear-population at risk. Population data were 
available either by single year of age (France, The Netherlands, Finland, Sweden, England, 
and Wales 1961–1999), or by 5-year age groups (Denmark, Norway, England, and Wales 
1950–1960), with the maximum age ranging from 85+ to no maximum age. 
 
For those aged 80 and over, we had additional data on total mortality data and population 
data available from the Kannisto-Thatcher Database on Old Age Mortality (K-T Database) at 
the Max Planck Institute for Demographic Research (http://www.demogr.mpg.de/data-
bases/ktdb) [2]. The data were grouped by both year of death and year of birth of the 
deceased and by single year of age (no maximum age). We used these data (a) to 
redistribute the population numbers and deaths in the older age groups over 5-year age 
groups up to 100+, (b) to redistribute the population numbers and total deaths for those 
aged 80 and over from 5-year age groups into data by single year of age, and (c) to check 
whether the population and mortality data from the different data sources (Kannisto-
Thatcher Database and national data) were consistent. 
 
For the causes of death, we obtained data on their prevalence as the underlying cause of 
death. These data were available by three-digit codes, 5-year age groups, sex, and year of 
death for all countries. The maximum age ranged from 85+ for England and Wales and 
The Netherlands (until 1969), and 90+, 95+, and 100+ for all other countries and periods. 
The deaths per cause in the older age groups were redistributed over 5-year age groups up 
to 100+ based on the distribution of total mortality in these age groups. Table 1 lists the 
causes of death we selected and their relative share in all-cause mortality among those 
aged 80 and over in 1995–1999. Cancers have been designated "smoking-related" if their 
population attributable risk was larger than 0.25 (according to the American Cancer Study) 
[20]. 
 
Statistical analysis 
 
We analyzed the mortality data by means of a (log-linear) Poisson regression model with 
linear splines. The dependent variable was the number of deaths, with the person-years at 
risk as offset variable. As independent variables, we used age (single year of age for total 
mortality and 5-year age groups for cause-specific mortality) and year of death. Spline 
functions divide the overall trend into a number of separate, adjacent segments [21]. In 
our analysis, we used five segments each covering a period of 10 years (1950–1959, 1960–
1969, 1970–1979, 1980–1989, 1990–1999). The analysis using splines thus yielded 
estimates of annual changes in mortality within each 10-year period, thereby taking into 
account the overall trend. Comparison of these five decade-specific rates of change 
enabled us to detect and quantify changes in the secular trend in mortality, such as a 
stagnation of the decrease in mortality for a specific country. 
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"Stagnation" of the mortality decline was defined as either a leveling off of the mortality 
decline leading to small declines or a reversal into increasing mortality. All our analyses 
were conducted using SAS package version 8. In addition, for total mortality, directly 
standardized observed and fitted mortality rates were calculated, using the total population 
of England and Wales in 1999 as the reference.  
 
The use of 5-year age groups in the cause of death analyses was due to the restriction that 
these data were not available to us by single year of age. To evaluate to what extent a 
possible change over time in the distribution of deaths within a 5-year age group could 
affect our results, we compared the results for total mortality using data by 5 years of age 
with the results for total mortality using data by single year of age. Because this 
comparison generated virtually the same results, we expected that, although age patterns 
can differ for the specific causes of death, the bias when using the data by 5-year age 
groups will be minimal. 
 
Concordance 
 
When analyzing trends in causes of death for a longer period, numerous revisions of the 
World Health Organization (WHO) International Classification of Diseases (ICD) have to be 
taken into account, because they can lead to biases in the trends. In our analysis, we had 
to bridge four or five different ICD revisions per country. For this purpose we constructed a 
general concordance table in which the different three-digit codes for a specific cause of 
death in successive ICD revisions were linked (see Janssen et al. (2003) [14] for more 
information)(see Appendix I). To accurately bridge the revision from ICD6/7 to ICD8 for 
ischemic heart disease (IHD) we obtained the numbers of death for one additional four-
digit code (422.1) under ICD6/7. These numbers were not available for Finland until 1963, 
and Sweden until 1961. We estimated them on the basis of the ratio of the number of 
deaths from ischemic heart disease with and without 422.1 calculated for the first year in 
which 422.1 was coded. 
 
On the basis of this general concordance table, data on the required three-digit codes were 
obtained from the different countries. For Finland, however, not all causes of death were 
available by three-digit code and part of the data we had to request by short list consisting 
of slightly different groups of causes of death. In depth analysis of the Finnish mortality 
trends suggested that this approximation has not led to irregularities. 
 
Cause-specific trends based on the concordance table can, however, still contain 
irregularities due to (1) remaining problems with ICD revisions, because at the level of 
three-digit codes the continuity of the medical content of some causes of death could not 
always be optimized; (2) incidental changes in coding rules, for example, changes within 
ICD revisions in the reporting of causes of death by physicians or in coding rules applied at 
the statistical offices; and (3) incidental outliers, that is, causes of death with a single year 
of exceptional mortality levels. In addition to the use of the concordance table, it was 
therefore necessary to trace these irregularities and to control for them when assessing 
long-term trends in mortality. 
 
We identified outliers and incidental changes in coding rules on the basis of visual analysis 
of cause-specific trends for males and females combined for those aged 60 and over, and 
using country-specific background information on the irregularities observed. To evaluate 
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the existence of remaining problems with ICD revisions, we identified possible mortality 
jumps due to the ICD revisions, using cause-specific regression models (with splines) 
applied to data for males and females combined, aged 60 and over. To these regression 
models we added transition variables indicating the ICD revisions, that is, ICD6/7to8, 
ICD8to9 or ICD9to10. In this way, these regression models generated parameter estimates 
for the transition variables. 
 
A transition variable was included in our final regression model if: (1) the parameter 
estimate corresponding to this variable was statistically significant, (2) the significant effect 
could not be attributed to nonlinear trends or to a single outlier, for instance, an influenza 
epidemic nearby; and (3) the observed effect could be traced back to a ICD transition 
problem, for example, due to a four-digit code not included in the concordance table or an 
effect on one cause of death mirrored by an opposite effect on a complementary cause of 
death.  
 
For France, no check on the concordance was needed, because J. Vallin and F. Meslé 
reconstructed coherent series of data for causes of death, the results of which are available 
from a Web site (http://matisse.ined.fr/%7Etania/causfra/data/) [22,23]. From this Web 
site the cause of death data we distinguished could be extracted using ICD9 codes. 
 
RESULTS 
 
Old-age mortality showed an overall decline and a convergence in the mortality level 
between countries over time (Figure 1). However, there was a large heterogeneity in the 
pace of decline, with periods of stagnation (defined as either a leveling off of the mortality 
decline leading to small declines or a reversal into increasing mortality) being widespread. 
In the 1950s, and to a lesser extent in the 1960s, mortality in the Nordic countries declined 
slightly or even increased. From the 1980s onwards, small declines or even increases were 
observed in Denmark, The Netherlands, and among Norwegian males. In contrast, 
mortality decline continued in England and Wales (females), and especially in France, 
resulting in the lowest mortality level in the 1990s. Striking is the huge mortality decline in 
Finland in the 1970s, which was followed by a much more modest decline in the 1980s. 
The mortality rates were higher among males compared to females, with the mortality level 
of males in the 1990s being about equal to the mortality level of females in the 1950s. 
 
To identify the periods of stagnation more precisely, we quantified the pace of all-cause 
mortality decline within each of the 5 decades by means of annual changes (%) (Table 2). 
If the confidence intervals for successive decades do not overlap the changes in the pace 
of mortality decline are statistically significant. Stagnation was more widespread among 
males compared to females. In Denmark, mortality decline leveled off from the 1970s 
onwards for males, and from the 1980s onwards for females. Mortality decline among 
Dutch males turned into increase in the 1980s, followed by a small decline in the 1990s. 
Among Dutch females mortality decline leveled off in the 1980s and 1990s. Among 
Norwegian males the small (nonsignificant) increase in the 1980s changed into a modest 
decline in the 1990s. 
 
The annual trends for the "smoking-related diseases", that is, smoking-related cancers and 
chronic obstructive pulmonary disease (COPD), showed an overall pattern of long-term 
increases (Table 3).  
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Figure 1a. Trends in standardized observed and fitted all-cause mortality rates in seven countries, 
1950-1999, males, aged 80 and over 
 
DK = Denmark; E&W = England and Wales; FIN = Finland; F = France; NL = The Netherlands; NO = 
Norway; S = Sweden. 
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Figure 1b. Trends in standardized observed and fitted all-cause mortality rates in seven countries, 
1950-1999, females, aged 80 and over 
 
DK = Denmark; E&W = England and Wales; FIN = Finland; F = France; NL = The Netherlands; NO = 
Norway; S = Sweden. 
The Nordic countries
80
100
120
140
160
180
200
220
240
1950 1960 1970 1980 1990 year
st
an
da
rd
is
ed
 ra
te
 (x
 1
00
0)
DK FIN NO S
DK_fit FIN_fit NO_fit S_fit
Remaining countries
80
100
120
140
160
180
200
220
240
1950 1960 1970 1980 1990 year
st
an
da
rd
is
ed
 ra
te
 (x
 1
00
0)
E&W F NL
E&W_fit F_fit NL_fit
O
LD
-A
G
E 
M
O
R
TA
LI
TY
 T
R
EN
D
S 
IN
 E
U
R
O
PE
 
 
57
      Ta
bl
e 
2
. A
nn
ua
l t
re
nd
s 
in
 t
ot
al
 m
or
ta
lit
y 
by
 c
ou
nt
ry
 a
nd
 d
ec
ad
e 
(1
95
0-
19
99
),
 m
al
es
 a
nd
 f
em
al
es
, a
ge
d 
80
 a
nd
 o
ve
r 
  
An
nu
al
 c
ha
ng
es
 
 
19
50
-5
9 
19
60
-6
9 
19
70
-7
9 
19
80
-8
9 
19
90
-9
9 
 
%
 
95
%
CI
 
%
 
95
%
CI
 
%
 
95
%
CI
 
%
 
95
%
CI
 
%
 
95
%
CI
 
M
al
es
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D
en
m
ar
k 
0
.5
8
 
(+
0.
32
;+
0.
84
)
-1
.1
6 
(-
1.
33
 
;
-0
.9
9)
-0
.4
5 
(-
0.
60
 
;
-0
.3
0)
 
-0
.1
9 
(-
0.
33
 
;
-0
.0
4)
-0
.2
0 
(-
0.
41
 
;+
0.
01
)
En
gl
an
d 
an
d 
W
al
es
 
-0
.6
5 
(-
0.
71
 
;
-0
.5
8)
-0
.7
9 
(-
0.
84
 
;
-0
.7
3)
-0
.4
4 
(-
0.
49
 
;
-0
.3
9)
 
-1
.4
4 
(-
1.
48
 
;
-1
.3
9)
-1
.2
0 
(-
1.
26
 
;
-1
.1
4)
Fi
nl
an
d 
-0
.5
4  
(-
0.
91
 
;
-0
.1
7)
0
.2
7
 
(+
0.
02
;+
0.
53
)
-2
.4
6 
(-
2.
67
 
;
-2
.2
4)
 
-0
.5
5 
(-
0.
75
 
;
-0
.3
6)
-1
.1
1 
(-
1.
33
 
;
-0
.8
8)
Fr
an
ce
 
-1
.2
7 
(-
1.
34
 
;
-1
.2
0)
-0
.9
8 
(-
1.
03
 
;
-0
.9
2)
-0
.7
3 
(-
0.
78
 
;
-0
.6
7)
 
-1
.8
2 
(-
1.
87
 
;
-1
.7
7)
-1
.6
6 
(-
1.
74
 
;
-1
.5
8)
Th
e 
N
et
he
rla
nd
s 
-0
.6
0  
(-
0.
76
 
;
-0
.4
4)
-0
.3
5 
(-
0.
47
 
;
-0
.2
4)
-0
.9
3 
(-
1.
03
 
;
-0
.8
2)
 
0
.3
8
 
(+
0.
29
;+
0.
48
)
-0
.1
9 
(-
0.
31
 
;
-0
.0
7)
N
or
w
ay
 
0
.7
6
 
(+
0.
48
;+
1.
04
)
0
.1
4
 
(-
0.
04
 
;+
0.
33
)
-0
.8
2 
(-
0.
98
 
;
-0
.6
5)
 
0.
02
 
(-
0.
13
 
;+
0.
18
)
-0
.5
1 
(-
0.
71
 
;
-0
.3
2)
Sw
ed
en
 
-0
.1
7 
(-
0.
39
 
;+
0.
04
)
-0
.8
5 
(-
0.
98
 
;
-0
.7
3)
-0
.2
0 
(-
0.
31
 
;
-0
.0
9)
 
-0
.9
2 
(-
1.
02
 
;
-0
.8
1)
-0
.9
8 
(-
1.
11
 
;
-0
.8
5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fe
m
al
es
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D
en
m
ar
k 
-0
.0
9 
(-
0.
32
 
;+
0.
15
)
-2
.2
5 
(-
2.
41
 
;
-2
.1
0)
-1
.6
7 
(-
1.
81
 
;
-1
.5
4)
 
-0
.4
7 
(-
0.
59
 
;
-0
.3
5)
-0
.5
6 
(-
0.
72
 
;
-0
.3
9)
En
gl
an
d 
an
d 
W
al
es
 
-0
.9
6 
(-
1.
02
 
;
-0
.9
1)
-1
.3
0 
(-
1.
34
 
;
-1
.2
6)
-0
.8
8 
(-
0.
91
 
;
-0
.8
4)
 
-1
.9
0 
(-
1.
94
 
;
-1
.8
7)
-0
.6
5 
(-
0.
69
 
;
-0
.6
0)
Fi
nl
an
d 
-0
.1
8  
(-
0.
44
 
;+
0.
09
)
-0
.7
0 
(-
0.
88
 
;
-0
.5
2)
-3
.8
5 
(-
4.
00
 
;
-3
.7
0)
 
-0
.3
4 
(-
0.
48
 
;
-0
.2
1)
-1
.4
7 
(-
1.
63
 
;
-1
.3
2)
Fr
an
ce
 
-1
.4
2 
(-
1.
48
 
;
-1
.3
7)
-1
.4
0 
(-
1.
45
 
;
-1
.3
6)
-1
.0
7 
(-
1.
10
 
;
-1
.0
3)
 
-2
.2
3 
(-
2.
27
 
;
-2
.2
0)
-1
.7
2 
(-
1.
78
 
;
-1
.6
6)
Th
e 
N
et
he
rla
nd
s 
-1
.1
1 
(-
1.
26
 
;
-0
.9
7)
-0
.8
5 
(-
0.
96
 
;
-0
.7
4)
-2
.7
2 
(-
2.
81
 
;
-2
.6
3)
 
-0
.4
7  
(-
0.
55
 
;
-0
.3
9)
0.
01
 
(-
0.
08
 
;+
0.
10
)
N
or
w
ay
 
0
.4
3
 
(+
0.
19
;+
0.
68
)
-0
.9
7 
(-
1.
13
 
;
-0
.8
1)
-1
.8
0 
(-
1.
94
 
;
-1
.6
6)
 
-0
.7
4 
(-
0.
87
 
;
-0
.6
1)
-0
.7
1 
(-
0.
86
 
;
-0
.5
5)
Sw
ed
en
 
-0
.6
1 
(-
0.
81
 
;
-0
.4
2)
-1
.8
6 
(-
1.
97
 
;
-1
.7
4)
-1
.5
1 
(-
1.
61
 
;
-1
.4
1)
 
-1
.1
4 
(-
1.
22
 
;
-1
.0
5)
-1
.0
5 
(-
1.
15
 
;
-0
.9
4)
Bo
ld
 in
di
ca
te
s 
a 
si
gn
ifi
ca
nt
 in
cr
ea
se
. 
U
nd
er
lin
ed
 in
di
ca
te
s 
an
nu
al
 c
ha
ng
es
 (
%
) 
≥
 –
0.
60
. 
     
OLD-AGE MORTALIITY TRENDS IN EUROPE
57
CHAPTER 4 
 58 
Table 3. Annual trends in mortality from smoking-related diseases by country and decade (1950-
1999), males and females, aged 80 and over 
 
 Annual changes (%) 
 Males Females 
 1950s 1960s 1970s 1980s 1990s 1950s 1960s 1970s 1980s 1990s 
Denmark    
Smoking-related diseases 7.51 1.74 4.34 1.64 0.20 5.45 0.35 1.07 1.00 3.04 
Lung cancer 12.15 4.63 6.66 1.36 -0.06 7.02 1.64 2.96 2.27 3.49 
Other smoking-related cancers 2.92 -0.56 3.47 0.09 -0.59 3.48 -0.50 2.17 -1.33 -0.53 
COPD 12.87 2.32 3.56 2.93 0.81 7.87 0.88 -1.11 3.23 5.54 
    
England and Wales    
Smoking-related diseases 1.12 1.68 1.23 0.24 -3.48 -2.74 -1.49 -0.55 1.76 0.43 
Lung cancer 10.33 6.52 5.22 0.02 -3.47 3.70 4.27 4.91 3.48 1.21 
Other smoking-related cancers 0.50 -0.33 0.72 0.69 -0.87 1.99 0.15 0.56 0.98 -0.32 
COPD 0.06 1.05 -0.50 0.16 -4.54 -4.58 -3.14 -2.98 1.49 0.68 
    
Finland    
Smoking-related diseases 8.30 3.65 0.87 -2.17 -1.15 5.51 2.22 -0.89 -1.07 0.79 
Lung cancer 9.21 4.68 3.92 -1.10 -1.77 5.03 2.20 3.19 0.55 3.62 
Other smoking-related cancers 0.07 1.76 1.30 -0.89 -1.72 2.31 1.61 0.15 -0.64 -0.51 
COPD 16.84 4.59 -1.07 -3.81 -0.21 14.33 3.38 -4.24 -3.19 1.94 
    
France    
Smoking-related diseases 1.75 2.60 3.75 -0.07 -0.62 0.96 0.50 1.17 1.23 1.38 
Lung cancer 10.69 6.91 6.63 1.88 0.02 6.73 3.71 1.26 1.98 2.02 
Other smoking-related cancers 3.84 2.57 1.34 0.12 -1.29 2.93 1.78 0.27 1.20 0.48 
COPD -1.12 1.17 4.62 -1.37 -0.40 -0.76 -1.09 1.88 1.11 1.87 
    
The Netherlands    
Smoking-related diseases 1.59 4.48 3.78 3.08 -1.13 -0.62 0.74 -0.15 2.62 0.61 
Lung cancer 6.96 8.19 7.55 1.85 -1.97 5.39 -0.47 4.92 0.87 2.63 
Other smoking-related cancers 1.46 2.26 1.31 1.25 -0.81 1.02 1.72 0.88 1.00 -1.22 
COPD 0.03 4.11 2.40 4.86 -0.69 -2.43 0.18 -2.21 4.61 1.38 
    
Norway    
Smoking-related diseases -1.09 2.15 4.62 2.38 2.06 -3.19 0.26 1.62 1.26 3.34 
Lung cancer 8.20 5.76 8.22 4.24 1.61 3.23 3.27 2.55 4.81 3.39 
Other smoking-related cancers 0.31 2.89 1.65 1.34 -0.22 -0.01 2.64 2.05 0.17 0.19 
COPD -3.93 -0.07 7.04 2.39 4.13 -5.73 -3.10 0.57 1.95 6.87 
    
Sweden    
Smoking-related diseases 4.49 5.18 3.61 -1.18 0.59 3.20 3.62 0.06 -1.19 2.08 
Lung cancer 9.06 9.33 6.52 -1.81 -1.05 4.99 5.42 2.75 -1.23 2.93 
Other smoking-related cancers 3.71 3.72 1.62 -2.38 0.42 4.46 3.37 0.06 -1.43 -0.64 
COPD 4.26 5.38 4.16 0.51 1.64 0.69 3.40 -1.32 -0.54 5.55 
Bold indicates an increase. 
COPD = chronic obstructive pulmonary disease. 
 
Due to this overall increase these diseases had an increased share in total mortality, and 
thus their trends had increasingly more effect on the trends observed for all-cause 
mortality. Since the 1980s, mortality from smoking-related diseases among men decreased 
in Finland and France, whereas in Denmark, The Netherlands, and Norway in the 1980s 
mortality still increased rapidly. However, only Norway showed a clear persistence of the 
increase among males in the 1990s. For females, recent increases were more frequent, and 
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were most pronounced in Norway, Denmark, and The Netherlands. Overall, lung cancer 
revealed the strongest increases, but COPD showed a more unfavorable trend in the 1990s. 
 
Mortality from cardiovascular diseases declined, at least after the 1960s (Table 4). During 
the last 2 decades, declines were largest in France and England and Wales, and smallest in 
Norway and The Netherlands. 
 
Table 4. Annual trends in mortality from cardiovascular diseases by country and decade (1950-1999), 
males and females, aged 80 and over 
 
 Annual changes (%) 
 Males Females 
 1950s 1960s 1970s 1980s 1990s 1950s 1960s 1970s 1980s 1990s 
Denmark    
All cardiovascular diseases 0.86 -0.44 -1.66 -0.79 -2.60 -0.06 -1.58 -2.58 -0.75 -3.43 
Ischemic heart disease 5.17 3.60 -1.32 -1.71 -5.03 4.03 2.81 -2.29 -1.87 -6.03 
Cerebrovascular diseases 0.14 -2.93 -3.02 -0.25 -0.98 -0.37 -3.53 -3.20 -0.13 -1.65 
Other cardiovascular diseases -2.19 -6.60 -1.83 1.93 1.25 -2.56 -7.11 -3.14 1.72 -0.53 
    
England and Wales    
All cardiovascular diseases -1.05 -1.30 -1.70 -2.03 -2.36 -0.98 -1.52 -1.94 -2.67 -2.60 
Ischemic heart disease 0.92 0.15 -0.27 -0.78 -2.67 0.83 -0.26 -0.98 -0.94 -3.08 
Cerebrovascular diseases 0.99 -0.59 -3.11 -2.24 -2.10 0.99 -0.28 -2.51 -2.81 -1.78 
Other cardiovascular diseases -3.80 -3.70 -2.65 -5.87 0.09 -3.29 -3.84 -2.45 -6.48 -0.80 
    
Finland    
All cardiovascular diseases 2.80 0.17 -3.05 -1.41 -1.79 3.65 -0.53 -4.05 -1.42 -2.36 
Ischemic heart disease 5.57 2.20 -1.21 0.84 -0.77 6.08 0.98 -1.46 1.09 -0.89 
Cerebrovascular diseases 2.19 -0.70 -4.18 -1.68 -1.98 1.71 -1.68 -4.57 -1.07 -2.73 
Other cardiovascular diseases 1.36 -1.04 -4.41 -5.83 -5.20 3.99 -0.61 -5.86 -5.52 -5.68 
    
France    
All cardiovascular diseases 0.15 -0.29 -0.99 -2.93 -1.98 0.13 -0.45 -0.69 -3.07 -2.33 
Ischemic heart disease 6.50 3.13 2.90 -0.24 -1.71 6.84 3.45 3.48 -0.50 -2.72 
Cerebrovascular diseases 0.41 0.50 -1.77 -4.97 -4.25 0.52 0.31 -0.87 -4.79 -4.35 
Other cardiovascular diseases -0.87 -1.69 -1.77 -2.89 -0.80 -0.79 -1.72 -1.80 -2.90 -0.93 
    
The Netherlands    
All cardiovascular diseases 0.51 -1.09 -1.46 -1.17 -1.40 0.15 -1.71 -2.81 -1.69 -1.85 
Ischemic heart disease 3.85 1.32 -0.32 -1.41 -2.41 3.19 0.32 -0.95 -2.18 -3.02 
Cerebrovascular diseases 0.81 -1.86 -2.78 -0.99 -1.76 0.53 -2.35 -3.62 -0.90 -1.70 
Other cardiovascular diseases -1.62 -3.04 -0.94 -0.75 -0.27 -1.53 -2.97 -2.77 -1.53 -1.19 
    
Norway    
All cardiovascular diseases 2.46 0.21 -1.46 -0.43 -0.92 1.92 -1.00 -1.95 -1.39 -0.81 
Ischemic heart disease 9.63 2.01 -1.61 0.16 -1.88 10.09 0.97 -2.59 -0.74 -2.07 
Cerebrovascular diseases 2.66 -0.20 -3.08 -1.55 -1.68 2.64 -1.13 -2.99 -1.78 -2.21 
Other cardiovascular diseases -4.07 -3.09 1.63 -0.23 1.55 -4.05 -4.10 0.78 -1.82 2.35 
    
Sweden    
All cardiovascular diseases 1.01 -0.82 -0.23 -1.76 -1.74 0.73 -1.78 -1.32 -2.04 -2.03 
Ischemic heart disease 3.18 2.28 -0.63 -3.97 -2.41 2.11 1.51 -1.63 -4.95 -2.70 
Cerebrovascular diseases 0.58 -3.72 -1.20 -0.83 -0.31 0.41 -3.62 -1.44 -0.87 -1.13 
Other cardiovascular diseases -1.31 -4.10 0.02 -0.84 -1.30 -0.79 -4.27 -1.32 -0.94 -1.62 
Bold indicates an increase.  
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Trends in mortality from ischemic heart disease (IHD) were least favorable with increases 
in mortality in the 1950s and 1960s. Mortality from IHD also increased in the 1980s in 
Norway (males) and Finland. Mortality from cerebrovascular diseases increased in the 
1950s, followed by a sustained decrease in mortality. Striking were the enormous 
decreases in mortality from stroke in France since the 1980s. For both IHD and stroke, the 
mortality decrease in France sets in later compared to the other countries. Mortality from 
"other cardiovascular diseases" decreased, especially in Finland and England and Wales, 
whereas in Denmark and Norway mortality increased since the 1980s. 
 
For the "other causes of death", that is, total mortality minus "smoking-related diseases" 
and all cardiovascular diseases, mortality increased since the 1980s in all countries, except 
France (Table 5). The increases are most pronounced in Denmark and The Netherlands, in 
the 1990s. Especially mortality from diseases specifically related to old age (infectious 
diseases, pneumonia, dementia, and ill-defined conditions) increased substantially. 
Differences between the countries, however, exist in which of these causes showed the 
largest mortality increases. In France, the increase in diseases specifically related to old 
age has been offset by the continuation of the strong decline for "other diseases". Caution, 
however, should be exercised when interpreting the annual changes for causes of death 
with a low mortality level in 1980 and 1990, especially infectious diseases, diabetes 
mellitus, dementia (males), and all ill-defined causes (in England and Wales, Finland, and 
Sweden). Annual changes for such causes tend to be large, even though the change is 
small in absolute terms.  
 
DISCUSSION 
 
This article provides important new findings on the trends in old-age mortality (80+) in 
seven low-mortality countries. First, although old-age mortality tends to decline and to 
converge, there is large heterogeneity in the pace of decline in the countries under 
investigation, with periods of stagnation being widespread. Since the 1980s, stagnation 
was observed in Denmark, The Netherlands, and Norway, whereas England and Wales and 
especially France showed a continuation of a strong mortality decline. Second, the long-
term mortality increase for smoking-related cancers and COPD turned into declines since 
the 1980s among males. Only for Norway the mortality increase among males clearly 
persisted. Third, mortality from cardiovascular diseases showed clear crossnational 
variations in the general decline since the 1970s. Fourth, mortality from diseases 
specifically related to old age (infectious diseases, pneumonia, dementia, and ill-defined 
conditions) increased recently in all countries except France. 
 
Previous studies on trends in old-age mortality also report some heterogeneity in the speed 
of the mortality decline, but found only rare periods of stagnation [2,15]. The overall 
conclusion reached in most of these studies therefore has been a continued decline in old-
age mortality [2,4,15,24,25]. The present study, however, shows that periods of stagnation 
are more frequent than previously observed. This conclusion could be reached by, on the 
one hand, extending the observation period to the 1990s, and on the other hand, by 
looking in more detail at the trends within specific decades in stead of broader periods. Our 
results thus show a more differentiated picture than suggested by previous analyses on 
old-age mortality. 
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The heterogeneity between countries and periods as observed in this analysis and in 
previous analyses suggests that the findings obtained in this study may not be considered 
to be representative of other countries nor of earlier periods. 
 
 
Table 5. Annual trends in mortality from "other causes of death" by country and decade (1980-1999), 
males and females, aged 80 and over 
 
 Annual changes (%)  Annual changes (%) 
 Males Females  Males  Females 
 1980s 1990s 1980s 1990s  1980s 1990s  1980s 1990s 
Denmark  The Netherlands     
Other causes of death 0.24 2.94 0.05 3.01 Other causes of death 1.13 1.36  0.83 1.72 
Other cancers 0.02 0.87 -0.96 0.13 Other cancers 0.80 0.00  -0.32 -0.76 
Infectious diseases 0.80 6.26 1.84 14.25 Infectious diseases 2.97 6.32  4.81 5.31 
Diabetes mellitus 1.56 1.99 -1.47 1.29 Diabetes mellitus 0.21 -2.38  -1.39 -2.79 
Pneumonia -6.31 10.06 -6.46 7.64 Pneumonia 0.07 5.28  -0.89 4.69 
Dementia 9.30 10.07 7.41 7.62 Dementia 14.14 15.63  15.69 15.24 
All ill-defined causes 3.52 12.65 4.04 13.73 All ill-defined causes 2.19 3.20  0.80 4.17 
Other diseases -0.17 3.22 -0.04 4.36 Other diseases 1.79 -1.92  2.02 -1.67 
All external causes 3.48 -0.79 2.52 -2.13 All external causes -1.17 -2.57  -3.78 -2.17 
       
England and Wales  Norway     
Other causes of death -1.29 1.31 -1.18 1.56 Other causes of death 0.22 -0.55  0.12 -0.91 
Other cancers 2.64 -1.05 1.06 -1.89 Other cancers 0.18 0.78  -1.02 0.31 
Infectious diseases 1.31 3.04 3.35 2.91 Infectious diseases -0.48 7.19  0.34 7.89 
Diabetes mellitus 2.83 0.39 0.98 0.64 Diabetes mellitus 1.90 -0.44  1.70 -3.24 
Pneumonia -3.51 -0.75 -2.65 -1.21 Pneumonia -0.90 0.74  -0.70 -0.89 
Dementia 3.90 5.26 2.75 5.91 Dementia 4.15 1.63  4.91 1.20 
All ill-defined causes 8.97 14.29 9.81 15.14 All ill-defined causes -3.14 1.34  -1.28 2.29 
Other diseases -0.72 1.03 -0.55 1.55 Other diseases 0.94 -0.22  1.46 0.04 
All external causes -3.07 -0.79 -5.36 -0.07 All external causes 0.91 -1.12  -2.62 -1.70 
       
Finland  Sweden     
Other causes of death 1.31 -0.07 1.73 -0.32 Other causes of death 0.61 0.01  0.79 0.36 
Other cancers 0.04 -0.30 -0.71 -1.60 Other cancers -1.66 1.44  -2.13 0.50 
Infectious diseases -4.46 0.12 -2.74 -1.53 Infectious diseases -2.39 6.08  2.65 4.14 
Diabetes mellitus -3.89 0.07 -3.96 -3.26 Diabetes mellitus 3.64 -0.22  1.71 -0.90 
Pneumonia -1.19 -0.44 -1.27 -0.81 Pneumonia 2.19 -4.70  2.05 -5.04 
Dementia 17.64 0.03 14.57 -0.16 Dementia 12.08 6.01  12.92 5.26 
All ill-defined causes 0.03 -12.09 2.41 -12.24 All ill-defined causes 12.62 -1.98  13.06 1.87 
Other diseases 2.28 0.67 3.05 0.64 Other diseases 0.64 0.33  0.90 2.24 
All external causes 1.82 -0.99 0.18 -0.82 All external causes 0.62 -0.84  -0.77 -2.26 
        
France        
Other causes of death -1.16 -1.17 -1.61 -1.12       
Other cancers 0.73 -0.96 -0.44 -1.00       
Infectious diseases -0.07 0.03 0.88 -0.26       
Diabetes mellitus -1.13 0.07 -1.94 -0.71       
Pneumonia 0.84 1.38 -0.15 1.26       
Dementia 8.06 -1.82 7.44 -1.14       
All ill-defined causes -3.27 -3.06 -3.08 -2.23       
Other diseases -3.63 -0.86 -3.01 -0.14       
All external causes -1.16 -2.26 -3.16 -3.83       
Bold indicates an increase. 
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Evaluation of data and methods 
 
The mortality and population data used in this study stem from countries considered to 
have good or excellent population and vital registries [1,2]. Reported survivorship counts 
are highly accurate [2,26]. Comparison of our mortality data to the mortality data from the 
Kannisto-Thatcher Database—in which the data was checked for age-heaping and were 
subjected to a number of checks for plausibility— showed only small discrepancies, that 
had no appreciable effects on our results. 
 
Analyses of long-term trends in causes of death have to deal with several transitions 
between ICD revisions. Considerable effort was made to bridge these ICD revisions by 
carefully constructing a concordance table and by controlling for the remaining biases due 
to these revisions in our regression model. Further checks showed minimal sensitivity. 
Thus, even though some residual effects of problems with ICD revisions could not be 
excluded, we expect that these problems do not affect the results to any substantial extent. 
 
More difficult to tackle were changes within an ICD revision, either in coding practices at 
the Statistical Offices or in the reporting of causes of death by physicians. Although all 
countries under investigation use the coding rules of the WHO, the national statistical 
offices might change, over time, their interpretation of these international coding rules. 
Because changes in coding practices most probably led to quite abrupt and sometimes 
temporal changes, the changes could be traced and controlled for. Changes in the 
reporting of causes of death on the death certificate by physicians, however, result in more 
gradual shifts that could not be controlled for. The causes of death expected to suffer 
substantial effects are diabetes mellitus, dementia, and "all ill-defined causes". The huge 
increases for dementia that were observed especially in the 1980s could partly be explained 
by a growing propensity of physicians to report dementia as an underlying cause of death. 
The recent increases in "all ill-defined causes" (especially in England and Wales, Denmark, 
Sweden, and The Netherlands) could be the result of less detailed and less accurate 
diagnosis and reporting by physicians. An increase in the doctor's tendency to list only one 
cause on the death certificate could perhaps explain the huge increases observed for 
pneumonia in The Netherlands and Denmark in the 1990s, because diseases that were 
formerly reported mainly as secondary causes of death could increasingly be listed as 
primary causes of death. The more stable trends for diabetes mellitus seem to be less 
affected by this coding problem. 
 
Thus, especially the recent increases found for dementia, "all ill-defined causes" and 
pneumonia should be viewed with caution. Moreover, one should be aware of the opposite 
effects these increases in mortality might have on other diseases. For example, an 
increasing tendency to report these diseases as the underlying cause of death may result in 
an overestimation of the recent decreases observed for cardiovascular diseases. However, 
this cannot account for the recent declines observed for cardiovascular diseases, because 
in absolute terms, the decline in cardiovascular diseases was much larger than the 
increases for diseases prone to changes in reporting causes of death (data not shown). 
Diseases that have a more straightforward diagnosis, like smoking-related cancers and 
likely COPD as well, are probably relatively resistant to changes in coding practices. 
 
Explanations of the trends observed 
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Our findings suggest both favorable trends in old-age mortality (e.g., the continued decline 
in England and Wales, and especially France, and the huge decline in Finland in the 1970s), 
but also unfavorable trends (e.g., stagnation since the 1980s in Denmark, The Netherlands, 
and to a lesser extent Norway). In this section, we will discuss possible explanations of 
these trends. 
 
Although many smokers die already before the age of 80, our results indicate that smoking 
is a possible determinant of mortality trends even among the oldest old. Smoking-related 
cancers and COPD contributed to the recent stagnation, especially in Norway, for which 
mortality from these causes of death increased recently. The absence of clear increases in 
Denmark and The Netherlands in the 1990s suggests that the contribution of smoking-
related diseases to the recent stagnation as observed in The Netherlands and Denmark was 
more modest. However, by looking merely at the trends in these smoking-related diseases, 
other diseases, of which smoking is a risk factor as well, would be neglected. The recent 
declines observed for cardiovascular diseases—that are not correlated with the trends for 
lung cancer—suggest that smoking did not contribute much to the recent stagnation as 
observed in The Netherlands and Denmark. On the contrary, the significant decline in 
smoking prevalence among elderly men in recent periods [27], suggests a favorable effect 
of smoking on recent trends in mortality from cardiovascular diseases (and other causes of 
death), for which current smoking levels are more important than life-time smoking 
exposures [28]. Thus, although smoking has had a marked influence on the trends in old-
age mortality, the role of smoking in the stagnation since the 1980s seems only modest 
and restricted to Norway. 
 
Another explanation for the recent stagnation in Denmark, The Netherlands, and Norway 
could be that further improvement in old-age mortality in these countries is no longer 
possible, due to low levels of mortality already attained and a limit to life expectancy being 
approached. However, we observed further improvements in old-age mortality in both 
England and Wales and France, who had reached the same low level of mortality as 
Denmark, The Netherlands, and Norway around the 1980s. Life expectancy at age 80 in 
1980–1990 was slightly higher in France (7.52) compared to Denmark (7.43) and Norway 
(7.49), suggesting that the limit to life expectancy is not yet being approached in the latter 
countries [29]. 
 
Mortality trends were unfavorable for infectious diseases, pneumonia, dementia, and ill-
defined causes of death. The recent increase of mortality from these causes of death—
which were not only restricted to Denmark and The Netherlands but appeared in all 
countries except France—could be partly artificial due to changes in the coding and 
reporting of causes of death (as discussed above). However, part of the recent increase in 
these causes, which are specifically related to old age, might be real, and perhaps due to 
increased frailty. Increased comorbidity or increased frailty among elderly in itself could 
easily lead to an in-creased occurrence of symptoms or comorbid conditions as causes of 
death. Increased frailty could be due to decreased mortality selection as a result of the 
declines in all-cause mortality and cardiovascular mortality in earlier periods and ages, and 
indirectly due to improvements in medical care. The increasing proportions of elderly 
people surviving to old ages might be expected to be less healthy compared to their more 
selected predecessors [30], resulting in increases in (cardiovascular) morbidity [31] and in 
mortality increases from diseases specifically related to old age. Although recent studies on 
CHAPTER 4 
 64 
disability among the elderly suggest that disability among the elderly is declining [32–34], 
we still think that increased frailty might have played a role in explaining the recent 
increases in diseases specifically related to old age. 
 
Another important finding from our study is the crossnational variation in the pace of 
decline in cardiovascular disease, which is still the most important cause of death among 
the elderly. In the last 2 decades, declines for cardiovascular disease mortality were 
highest in England and Wales and France and lowest in Norway, The Netherlands, and 
Denmark (1980s only). Previous research on trends in cardiovascular mortality [35–37] 
suggested the importance of several factors like physical activity, hypertension control, 
diet, smoking, and accessibility of medical care. It might be possible that the developments 
in some of these risk factors were more beneficial in England and Wales and France 
compared to the other countries. 
 
Strikingly favorable were the trends in old-age mortality in France and Finland (1970s). 
France showed the strongest decline for cardiovascular diseases, and, contrary to the other 
countries, did not witness an increase from "other causes of death". Within "other causes 
of death" the declining trend for "other diseases" is striking. The latter trend seems the 
result of the reported declines of acute respiratory diseases and digestive diseases among 
the French elderly [38]. Changes in alcohol consumption might be one of the factors 
involved. The sharp decline in all-cause mortality in the 1970s in Finland was also observed 
among those aged 60 and over [39], and seems the result of rapid economic and social 
progress in this period [39–41]. Together with the development of a national health and 
social care system, this has resulted in improvements in the living conditions and health 
care, also for the elderly [41]. In addition, a favorable effect of rapid declines in behavioral 
risk factors, like diet, blood pressure, and serum cholesterol levels, in part caused by 
preventive campaigns, can be expected [42]. In Finland, old-age mortality thus seems to 
have been highly susceptible to improvements in living conditions and in both preventive 
and secondary health care. 
 
Implications 
 
Our finding that periods of stagnation were widespread both in the 1950s and since the 
1980s, challenges the idea that mortality at old age is bound to decline steadily in the near 
future [6,8,11]. Old-age mortality seems highly plastic and susceptible to many factors, 
both favorable and unfavorable. These factors should be taken into account when making 
projections of future old-age mortality and its implications on social and health care 
policies. 
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COHORT PATTERNS IN MORTALITY TRENDS AMONG THE ELDERLY IN 
SEVEN EUROPEAN COUNTRIES, 1950-1999 
 
 
Objective Secular trends in old-age mortality are of crucial importance to population 
ageing. For the understanding and prediction of these trends, it is important to determine 
whether birth cohort effects, i.e. long-lasting effects of exposures earlier in life, are 
important in determining mortality trends up to old age. This study aimed to identify and 
describe cohort patterns in trends in mortality among the elderly (>60 years of age) in 
seven European countries. Methods A standard age-period-cohort analysis was applied to 
all-cause and cause-specific mortality data by 5-year age groups and sex, for Denmark, 
England and Wales, Finland, France, The Netherlands, Norway and Sweden, in the period 
1950-1999. Results Cohort patterns were identified in all countries, for both the sexes and 
virtually all causes of death. They strongly influenced the trends in all-cause mortality 
among Danish, Dutch, and Norwegian men, and the trends in mortality from infectious 
diseases, lung cancer (men only), prostate cancer, breast cancer, and chronic obstructive 
pulmonary disease (COPD). All-cause mortality decline stagnated among Danish, Dutch and 
Norwegian male birth cohorts born between 1890 and 1915, among French men born after 
1920, and among women from all countries born after 1920. Where all-cause mortality 
decline stagnated, cohort patterns in mortality from lung cancer, COPD, and to a lesser 
extent ischaemic heart diseases, were unfavourable as well. For infectious diseases, 
stomach cancer, and cerebrovascular diseases, mortality increased among cohorts born 
before 1890, and decreased strongly thereafter. Conclusion Cohort effects related to 
factors such as living conditions in childhood and smoking in adulthood were important in 
determining the recent trends in mortality among the elderly in seven European countries. 
 
BACKGROUND 
 
With the increase in life expectancy there has been a shift in the trend from dying at 
younger ages to dying at older ages. Consequently, the mortality trends among the elderly 
gained more and more importance in determining the mortality patterns and the extent of 
ageing of national populations [1], with its far-reaching consequences to the individual, 
society, and health care policies. Therefore, it is crucial to carefully study old-age mortality 
trends and their determinants. 
 
Trends in mortality among the elderly in Europe have been characterized by an overall 
decline since the 1950s [2-5]. However, a recent study on old-age mortality trends from 
1950-1999 in seven European countries showed that the pace of decline varied strongly by 
country and over time [6]. In Denmark, The Netherlands, and for Norwegian men, 
mortality declines even stagnated during the 1980s and 1990s [6].  
 
In order to identify the determinants of national trends in mortality, it is essential to 
distinguish between period and cohort patterns. Whereas period patterns indicate 
immediate effects of conditions occurring in late life, cohort patterns may reflect long-
lasting effects of determinants located earlier in the life course, e.g. in infancy, childhood, 
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or adulthood. This distinction is of crucial importance in making projections of future 
developments in mortality. If cohort effects prove to be important, cohort-wise projections 
may be used to explore the possible future mortality trends. 
 
Interest in cohort effects dates back to the influential works by Kermack et al. in 1934 [7] 
and by Case and MacMahon et al. in the 1950s [8,9]. Since the 1980s, there has been a 
renewed interest in cohort effects. In epidemiology, this interest was stimulated by results 
from the new studies on the effects of living conditions in early life on health in later life 
[10,11]. At the same time, a number of demographic studies reported on the debilitating 
effects of war and famine during early ages on mortality in adulthood [12-14]. Despite this 
revival of interest, it remains unknown whether cohort effects are important in determining 
the recent trends in mortality of national populations, partly because the identification of 
cohort effects is complicated by the generally linear nature of the mortality decrease in 
Europe since the turn of the century [15]. Moreover, it is as yet not known whether cohort 
effects also extend into old age.  
 
Our hypothesis is that cohort effects are important factors in determining old-age mortality 
trends, and that these effects are especially visible in mortality from causes of death that 
are known to be related to smoking or to early life circumstances. In addition, we expect 
that the importance and patterns of cohort effects might differ between countries, due to, 
for example, differences in the development of the smoking epidemic among adults [16].  
 
In this paper, we aimed to identify and describe cohort patterns in all-cause and cause-
specific mortality trends among the elderly populations of seven European countries. Using 
data on old-age mortality trends during the second half of the twentieth century, we 
assessed for each country individually (i) whether cohort patterns are strong enough to 
determine trends in all-cause and cause-specific mortality, and (ii) the timing of these 
cohort patterns.  
 
In our study, we included both all-cause mortality and cause-specific mortality for seven 
European countries. Previous studies on cohort patterns in causes of death did not always 
compare the results for different causes of death or different countries. Furthermore, the 
comparison of the results between different studies is complicated by the application of 
different techniques to identify the importance of cohort effects. Our approach enabled us 
to observe not only commonalities but also dissimilarities in the importance and patterns of 
cohort effects. 
 
DATA AND METHODS 
 
Data 
 
Data on total mortality, the underlying cause of death and population at risk, by year of 
death (1950-99), sex, and 5-year age groups were obtained for Denmark, England and 
Wales, Finland, France, The Netherlands, Norway, and Sweden, from national statistical 
offices and related institutes. For Denmark, Finland, and Norway, data were available from 
1951, and for Sweden from 1952. For France data until 1997 were available and for 
Denmark until 1998. Data on total mortality and population for the highest age groups (80-
100+, by single year of age) were obtained from the Kannisto-Thatcher Database on Old 
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Age Mortality (http://www.demogr.mpg.de/databases/ktdb) [3]. See Janssen et al., 2004 
for a more detailed description of the included data [6]. 
 
In our analysis, we included data for those aged ≥60 years in order to address the 
question whether the influence of cohort effects extends into old age. The study was not 
restricted to the very old in order to include sufficient age groups to distinguish between 
period and cohort effects.  
 
With regard to the causes of death, we selected infectious diseases (ICD-9 001-139), 
cancer of lung (ICD-9 162), cancer of stomach (ICD-9 151), cancer of prostate (ICD-9 
185), cancer of breast (ICD-9 174-175), ischaemic heart disease (ICD-9 410-414), 
cerebrovascular diseases (ICD-9 430-434, 436-438), and chronic obstructive pulmonary 
diseases (ICD-9 490-494, 496). These are all causes of death occurring frequently among 
elderly. Together they accounted for on average 46 % of all deaths among those aged ≥60 
years in the late 1990s (see Table 1). 
 
To reconstruct mortality trends from these specific causes of death over the period 1950 to 
1999, we had to bridge five different revisions of the International Classification of Diseases 
(ICD-6 to ICD-10), for all countries except France for which coherent series of causes of 
death were already available [17]. For this purpose, we constructed a general concordance 
table based on three-digit codes of the ICD, and the four digit code 422.1 for ischaemic 
heart diseases under ICD-6/ICD-7 (see Janssen et al., 2004) [18]. Remaining mortality 
discontinuities - caused by the use of three-digit instead of four-digit codes and by 
incidental changes in coding rules – were identified and adjusted for in our analysis. These 
discontinuities were identified by (i) visual analysis of cause-specific mortality trends, (ii) 
country-specific background information on these mortality discontinuities, and (iii) a 
regression-based method that quantified the size of the discontinuities (see Janssen et al., 
2004) [18]. Mortality discontinuities that were regarded as owing to changes in coding 
rules were controlled for in our regression method, by means of cause- and sex-specific 
transition coefficients. These transition coefficients are the parameter estimates of variables 
associated with a coding change (e.g. ICD-8toICD-9) and obtained through sex-specific 
age-period regression models, applied to cause-specific mortality among those aged 60 and 
over [6,18]. Lung cancer and stomach cancer were not affected by coding changes. 
Infectious diseases showed a mortality discontinuity associated with the revision from ICD-
6/7 to ICD-8 in five countries. For the remaining causes of death, adjustments had to be 
made in one or two countries, mainly for incidental coding changes, for example the 
generally applied coding change in England and Wales between 1984 and 1992 (see 
Janssen et al., 2004)[18]. 
 
Statistical analysis 
 
For statistical analysis, we aggregated the data into 5-year age groups, 5-year periods and 
consequently 10-year overlapping cohort groups. To these data we applied log-linear age-
period-cohort (APC) models through the GENMOD procedure of the SAS 8.0 package. 
 
In APC analyses, it is impossible to identify the role of age, period, and cohort separately, 
owing to the interdependency between these variables. We dealt with this identification 
problem [19-21] by using the standard Clayton & Schifflers procedure.  
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Box 1  
 
Model parameters Statistical notation 
  
Age (A) E[lnYa]= αa 
Age + drift (AD) E[lnYad]= αa + δ 
Age + period (AP) E[lnYap]= αa + δ + βp 
Age + period + cohort (APC) E[lnYapc]= αa + βp + γc  
 
E[lnY] is the expected value of the natural log of the mortality rate, with the number of deaths 
being Poisson distributed. α, δ, β, and γ are the age, drift, period, and cohort effect, respectively. 
The variables for age (a) and cohort (c) had one baseline class. For period (p) a second baseline 
class was chosen. c = A – a + p. The variables were indexed a = 1,2,…,7,8, p = 1,2,…,9,10, and c 
= 1,…,13. 
 
 
With this procedure, mortality is decomposed in a common linear trend (drift), a non-linear 
period effect and a non-linear cohort effect [20,21]. See Box 1 for the different models that 
we fitted accordingly. 
 
We measured the contribution of drift, the non-linear period effects, and the non-linear 
cohort effects in the mortality trends by assessing the reduction in scaled deviances (a 
measure of unexplained variance) when comparing the subsequent models (i) AD with A, 
(ii) AP with AD, and (iii) APC with AP, respectively. We expressed these reductions as 
percentages of the reduction in scaled deviance observed between the model with age only 
and the full APC model. These percentage reductions were used to measure the 
contribution of the different effects to systematic mortality trends, and to make 
comparisons of this contribution between countries and causes of death. The statistical 
significance of the difference in scaled deviances between the subsequent models was 
assessed by a log-likelihood ratio test, resulting in one-sided p-values.  
 
In order to describe the timing of the identified non-linear cohort effects, we calculated 
cohort-specific mortality levels derived from the parameter estimates of the cohort 
variables out of the full age-period-cohort model. We thus controlled for age and period, 
and by choosing two baseline period groups (1950-54 and 1995-99) and only one baseline 
cohort group (1920-29), we included the drift parameter in the measurement of cohort 
differences in mortality. In our description of the cohort patterns we focused on the 
(cohort) deviations from linearity in the observed patterns. The cohort-specific mortality 
risks were calculated relative to the unweighted average of the mortality levels of all 
cohorts together. As not all birth cohorts have complete death counts for those aged ≥60 
years (e.g. for those born in 1865 we have observations only for those aged ≥85 years, 
and those born in 1935 were aged 60-64 at the end of our observation period) we were 
cautious when describing the mortality levels of the extreme cohorts.   
 
RESULTS 
 
In all-cause mortality, drift (the linear component of both period and cohort effects) 
contributed to a large extent to the systematic trends, especially among elderly women 
(Figure 1). However, for men in Denmark, The Netherlands, and Norway, non-linear cohort 
effects and non-linear period effects contributed substantially to old-age mortality trends. 
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 Figure 1. The contribution of drift, non-linear period effects and non-linear cohort effects to all-cause 
mortality trends, by sex and country 
 
Drift = the reduction in scaled deviance by adding drift to the model including only age; Period (non-
linear) = the reduction in scaled deviance by adding the non-linear period effect to the age-drift 
model; Cohort (non-linear) = the reduction in scaled deviance by adding the non-linear cohort effect to 
the age-period model. We measured the reduction in scaled deviance relative to the total reduction in 
scaled deviance of the full age-drift-period-cohort model compared with the model including only age. 
All effects are significant at the p = 0.05 level (one-tailed). DK = Denmark; E&W = England and 
Wales; FIN = Finland; F = France; NL = The Netherlands; NO = Norway; S = Sweden. 
 
For all selected causes of death, the contribution of the non-linear cohort effect to the 
systematic trends was statistically significant in each country and for both sexes, except for 
mortality from stomach cancer among Norwegian women (Table 2). Non-linear cohort 
effects contributed substantially to the mortality trends in the majority of countries for 
infectious diseases, lung cancer (men only), prostate cancer, cancer of breast, and chronic 
obstructive pulmonary diseases (COPD). For Finland and France, the non-linear cohort 
effects also contributed considerably to the mortality trends for ischaemic heart diseases 
(IHD).  
 
Turning to the timing of the identified cohort effects (including drift), all-cause mortality 
generally declined among subsequent cohorts (Figure 2). For men, the decline stagnated 
among Danish, Dutch and Norwegian birth cohorts born between 1890 and 1915, and 
among French generations born after 1920. For women, the decline in all-cause mortality 
accelerated among cohorts born after 1880, but stagnated among the cohorts from 1920 
onwards. This stagnation was most pronounced in Denmark and did not occur in England 
and Wales or Finland.  
 
The increase in mortality from lung cancer among men accelerated among cohorts born 
from 1880 onwards. This increase levelled off again among those born after 1895, except 
for Norway and France, and resulted in a decrease for The Netherlands, England and Wales 
and Finland later on. For women, the increase in lung cancer mortality accelerated from 
1915 onwards in The Netherlands, Denmark, Norway and Sweden, while this mortality 
increase levelled off among women in the other countries.  
Men
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Table 2. The contribution of non-linear cohort effects to all-cause and cause-specific mortality trends, 
by sex and country 
 
 Share of scaled deviancea explained by adding the non-linear 
cohort effect to the age-period model 
 DK E&W FIN F NL NO S 
Men   
   
All-cause mortality 34.8 4.6 4.8 1.8 44.9 20.3 5.2 
   
Cancer of lung 12.2 44.1 41.2 6.4 21.0 7.1 18.5 
COPD 7.3 31.2 20.2 73.5 40.4 17.3 15.5 
Ischaemic heart disease 1.9 8.5 28.7 36.6 8.5 7.4 1.0 
Infectious diseases 9.0 13.4 10.8 43.4 19.5 23.6 35.0 
Cancer of stomach 1.1 6.7 4.0 5.5 0.4 2.0 1.3 
Cancer of prostate 4.3 11.4 24.8 28.3 15.6 18.3 10.9 
Cerebrovascular diseases 0.9 4.1 1.9 7.2 1.6 4.1 4.2 
   
Women   
   
All-cause mortality 7.8 1.1 3.3 5.8 2.9 3.1 3.8 
   
Cancer of lung 3.6 3.3 8.9 7.5 9.7 2.3 9.0 
COPD 13.9 22.6 43.0 64.7 6.8 16.8 20.1 
Ischaemic heart disease 5.1 3.3 43.5 59.5 1.3 6.1 1.4 
Infectious diseases 6.8 18.0 17.1 62.0 14.0 19.7 40.9 
Cancer of stomach 1.1 1.7 3.1 6.5 0.9 (0.4) 1.0 
Cancer of breast 46.5 11.0 11.8 5.4 33.1 31.3 16.7 
Cerebrovascular diseases 5.2 8.3 6.0 18.1 6.0 10.3 14.2 
a The scaled deviance that is explained by the full age-period-cohort model as compared with the 
model including only age.  
DK = Denmark; E&W = England and Wales; FIN = Finland; F = France; NL = The Netherlands; NO = 
Norway; S = Sweden. 
( ) No statistically significant reduction in the scaled deviance ( p < 0.05 one sided). 
COPD = chronic obstructive pulmonary diseases. 
 
For men in The Netherlands, Norway, Sweden and Denmark, the cohort patterns for COPD 
resembled that for lung cancer, i.e. initial modest increases accelerated among the birth 
cohorts from 1880 onwards, and decelerated later on. The onset of mortality decline was 
later as compared with lung cancer. For men in England and Wales, France and Finland, 
the increase in COPD mortality was initially strong, but reversed into mortality decline from 
birth cohorts 1895 onwards. For women, the cohort trends in COPD mortality were 
heterogeneous and erratic until birth cohort 1900. From cohort 1905 onwards, mortality 
generally increased, especially in Denmark.  
 
For France, Finland, and Norway, IHD mortality increased for both men and women up to 
cohorts 1900-15, and declined thereafter. In Denmark, mortality increased until birth 
cohort 1880, but declined thereafter, especially among women. IHD mortality in Sweden, 
England and Wales, and The Netherlands declined among all birth cohorts, although this 
decline stagnated among male birth cohorts from 1890 onwards, especially among Dutch 
men. 
 
For infectious diseases, stomach cancer, and cerebrovascular diseases, mortality generally 
declined after an initial increase among cohorts born in the nineteenth century (Figure 3). 
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Figure 2. Cohort trends (including drift) for all-cause mortality, lung cancer, COPD, and ischaemic 
heart disease, by country and sex, for those aged ≥60 years 
a Mortality level of each individual cohort relative to the unweighted average of the mortality levels of 
all cohorts together. 
COPD = chronic obstructive pulmonary diseases. DK = Denmark; E&W = England and Wales; FIN = 
Finland; F = France; NL = The Netherlands; NO = Norway; S = Sweden. 
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Figure 3. Cohort trends (including drift) for infectious diseases, stomach cancer, prostate cancer, 
breast cancer, and cerebrovascular diseases, by country and sex, for those aged ≥60 years 
a Mortality level of each individual cohort relative to the unweighted average of the mortality levels of 
all cohorts together.  
DK = Denmark; E&W = England and Wales; FIN = Finland; F = France; NL = The Netherlands; NO = 
Norway; S = Sweden.  
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This initial mortality increase was most pronounced for infectious diseases, for which the 
increase persisted until cohorts born around 1890 (men) and 1885 (women). Stomach 
cancer increased only among the earliest birth cohorts of Finland, France, England and 
Wales (men), and Sweden (men). For cerebrovascular diseases, mortality increased among 
cohorts born before 1880 (men) and before 1885 (women). This initial increase was 
stronger for women. 
 
Mortality from prostate cancer and breast cancer generally increased among subsequent 
cohorts, with only small deviations from the linear trend. For prostate cancer, mortality 
increases were strongest among the earlier birth cohorts, especially in Sweden.   
 
DISCUSSION 
 
Cohort patterns were identified in all countries, for both the sexes and virtually all causes of 
death. Non-linear trends in mortality among subsequent birth cohorts contributed 
substantially to the trends in all-cause mortality among Danish, Dutch, and Norwegian 
men, and especially to the trends in mortality from infectious diseases, lung cancer (men 
only), prostate cancer, breast cancer, and COPD in most countries. We found that the 
secular decline in all-cause mortality stagnated among Danish, Dutch and Norwegian male 
birth cohorts born between 1890 and 1915, among French men born after 1920, and 
among women from all countries born after 1920. Where the decline in all-cause mortality 
stagnated, cohort-specific trends in mortality from lung cancer, COPD, and IHD were 
generally unfavourable as well. For infectious diseases, stomach cancer, and cerebro-
vascular diseases, mortality increased among cohorts born before 1890, and decreased 
rapidly among later generations. 
 
The substantial (non-linear) cohort effects that we found in all-cause mortality trends 
among elderly Danish, Dutch and Norwegian men were not identified in the few previous 
studies on cohort effects in all-cause mortality trends among the elderly [3,22]. Kannisto 
suggested that cohort patterns do not have important effects on trends in all-cause 
mortality among the elderly of developed countries [3]. However, his time series analyses 
did not include Denmark and The Netherlands, and his shorter observed period (1950-84) 
did not fully represent the birth cohorts that experienced a stagnation of mortality decline 
[6,23]. Jacobsen et al. did not identify non-linear cohort effects in mortality trends among 
Danish men aged 40-84 during 1960-99 [22]. However, their analysis was restricted to 
birth cohorts born after 1895, and therefore missed the important non-linearities that 
would become visible when extending the observation to cohorts born before 1895. The 
non-linearities that we observed for women born from 1910 onwards were found in their 
study as well.  
 
Previous cohort studies on mortality from specific causes of death observed the same 
general tendencies as were observed in our study [24-37]. However, in some cases, the 
exact timing and form of the observed cohort trends differed, probably because of the use 
of different techniques, shorter study periods, or different age groups. By applying the 
same technique to an identical selection of eight different causes of death among men and 
women in seven European countries, we were able to observe not only commonalities but 
also dissimilarities between these different countries. 
 
Evaluation of data and methods 
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The mortality and population data used in this study stem from countries considered to 
have good or excellent population and vital registries [2,3], and highly accurate reported 
survivorship counts [3,38]. Total mortality and population data for those aged ≥80 years 
were obtained from the Kannisto-Thatcher Database in which the data were checked for 
age-heaping and were subjected to a number of checks for plausibility [3]. 
 
Particularly at older ages, the validity of the underlying cause of death may be questioned 
owing to the presence of more than one chronic disease contributing to death [39,40]. 
Because changes over time in the quality of reporting underlying causes of death are likely 
to be gradual rather than abrupt, this may have resulted in only a modest overestimation 
of period effects. The non-linear cohort patterns in cause-specific mortality trends are likely 
to be unaffected. 
 
We made considerable effort to control for the abrupt coding changes between and within 
revisions of the International Classification of Diseases (ICD), which otherwise could have 
biased the analyses of long-term trends in causes of death, and could overestimate period 
effects in APC analyses. We expect that any residual bias of coding problems is removed 
from our analyses by including period as a control variable in all our analyses of cohort 
patterns of mortality.  
 
The identification problem inherent to APC analyses was dealt with by dividing mortality 
into a linear component (drift) and non-linear components. This enabled us to identify non-
linear cohort effects and to quantify their importance. A focus on non-linear cohort effects 
leads to underestimation of the importance of all cohort effects to an unknown degree, 
because linear cohort effects are, together with linear period effects, included in the drift 
term. There can be substantial linear cohort effects when there is a large effect of drift, i.e. 
when mortality trends are largely linear. When we observed small non-linear cohort effects, 
they occurred in general together with large drift effects. The only exception concerned 
trends in IHD in Danish, Dutch, and Norwegian men. Only in these cases, it is certain that 
mortality trends are not strongly determined by cohort effects (see Appendix I). Our 
method thus yields a conservative but informative estimate of the contribution of cohort 
effects.  
 
Explanation of observed cohort patterns 
 
Where the decline in all-cause mortality stagnated among subsequent cohorts, cohort-
specific trends in mortality from lung cancer, COPD, and to a lesser extent IHD, were 
generally unfavourable as well. This parallel development indicates that changed smoking 
behaviour among adults, as reflected by the cohort patterns in lung cancer mortality [41], 
largely influenced the trends in COPD and IHD and also influenced the temporal stagnation 
of male all-cause mortality in The Netherlands, Denmark and Norway among birth cohorts 
1895-1920, and the stagnation of all-cause mortality decline for women born from 1920 
onwards. Available data on smoking prevalence strengthen this conclusion. Dutch men 
born between 1897 and 1917 had a higher life-time exposure to smoking as compared with 
other generations of men [42]. Among Danish adult men in 1954, 86 % were present or 
former smokers, with a higher percentage for those aged 35-54 (cohorts 1900-19) as 
compared with older men (cohorts before 1900) [43]. For Norwegian men, the proportion 
of ever smokers increased for the birth cohorts 1890-1914, after which it stayed at the 
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same level up to cohort 1930-34 (83 %) [44]. Among men in the other countries, lung 
cancer also increased among the earlier birth cohorts, as observed in previous studies (e.g. 
[37]). However, this increase seemed not strong enough in absolute terms to substantially 
influence the trends for all-cause mortality. For women, the large increase in lung cancer 
mortality for the cohorts born from 1920 onwards also parallels increasing smoking rates 
among subsequent generations [44,45]. The low contribution of non-linear cohort effects 
to trends in lung cancer mortality among older women might be due to the recent timing 
and the generalized nature (among all birth cohorts) of the spread of smoking among 
women. 
 
The onset of the mortality decline in infectious diseases, cerebrovascular diseases and 
stomach cancer for cohorts born at the end of the 19th century, which occurred in all 
countries, seems to indicate a contribution of the improvements in living conditions in early 
life. Earlier, a poor environment during infancy and childhood, and especially a high load of 
respiratory or gastrointestinal infections, has been proposed as a determinant of mortality 
from stomach cancer, tuberculosis and cerebrovascular diseases at older ages [46]. 
Mortality from infectious diseases at older ages is related to the disease load experienced 
during the first year of life, especially exposure to airborne infectious diseases [47]. Infant 
mortality - often used as a proxy of living conditions in infancy [48] and of the disease load 
during the birth year [47] – was still high in the late 19th century in most European 
countries, and began to fall at the turn of the century [49]. The fact that infant mortality 
started to decline for about the same cohorts as adult mortality from the abovementioned 
causes of death suggests that improvements in living conditions have left an imprint on the 
mortality experience of cohorts up to old age. It is important to note, however, that this 
possible impact is visible only in mortality trends from some specific causes of death, while 
it is not reflected in all-cause mortality trends.  
 
The strong non-linear cohort patterns in IHD mortality trends in France, Finland, and to a 
lesser extent Norway may reflect another cohort-specific determinant of old-age mortality 
trends. As these cohort patterns (strong increases among the birth cohorts born before 
1900 or 1910, followed by substantial decreases afterwards) were observed for both men 
and women, changed smoking behaviour among adults could not be the determining factor 
in these countries, given the fact that men and women differed in their smoking history 
[16]. Late effects of circumstances in early life have been suggested in relation to IHD 
[48,50,51], but the effects have been debated and seem to be less pronounced than for 
stroke and COPD [46,52]. Moreover, during the late 19th and early 20th century, trends in 
infant mortality and Gross Domestic Product (an indicator of general socio-economic 
development [53]) were not markedly different in France, Finland, and Norway as 
compared with the other countries (data not shown). Another possibility is that the initial 
rise in IHD mortality risk in France, Finland and Norway is related to national patterns of 
behavioural change that are similar for both men and women, such as diet, alcohol use, or 
physical inactivity [54,55]. This hypothesis, which was generated by observing variations 
between countries in cohort patterns for IHD, needs further testing by in-depth analyses 
within specific countries using data on trends in these possible determinants. 
 
Implications 
 
Cohort effects appear to be important in determining secular trends in all-cause and cause-
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specific mortality among the elderly in seven European countries. Our results indicate that 
factors occurring in adulthood (predominantly due to smoking) and in infancy or childhood 
(such as poor living conditions) have left an imprint on the mortality experience of birth 
cohorts up to old age. Therefore, in order to understand the recent trends in old-age 
mortality and to make projections of possible future developments, one should take into 
account determinants that are located earlier in the life course of subsequent cohorts. 
 
KEY POINTS 
 
● Cohort patterns were identified in old-age mortality trends in all seven European 
countries, for both the sexes and virtually all causes of death. 
● Parallel unfavourable cohort trends were observed for all-cause mortality and mortality 
from lung cancer, COPD, and to a lesser extent IHD, among Danish, Dutch and 
Norwegian men born between 1890 and 1915. 
● For infectious diseases, stomach cancer, and cerebrovascular diseases, mortality 
increased among cohorts born before 1890, and decreased strongly thereafter. 
● Both living conditions in childhood and smoking in adulthood seem to have left an 
imprint on the mortality experience of birth cohorts up to high ages. 
 
REFERENCES 
 
[1] Preston SH, Himes C, Eggers M. Demographic conditions responsible for population aging. 
Demography 1989;26(4):691-704. 
[2] Kannisto V, Lauritsen J, Thatcher AR, Vaupel JW. Reductions in mortality at advanced ages: 
several decades of evidence from 27 countries. Popul Dev Rev 1994;20(4):793-810. 
[3] Kannisto V. Development of oldest-old mortality, 1950-1990: evidence from 28 developed 
countries. Odense, Denmark: Odense University Press; 1994. 
[4] Thatcher AR. Trends in numbers and mortality at high ages in England and Wales. Popul Stud 
1992;46:411-426. 
[5] Vaupel JW. The average French baby may live 95 to 100 years. In: Robine J-M, Vaupel J, Jeune 
B, Allard M, editors. Longevity: to the limits and beyond. Berlin Heidelberg: Springer-Verlag; 
1997:11-27. 
[6] Janssen F, Mackenbach JP, Kunst AE. Trends in old-age mortality in seven European countries, 
1950-1999. J Clin Epidemiol 2004;57(2):203-16. 
[7] Kermack WO, McKendrick AG, McKinlay PL. Death-rates in Great Britain and Sweden. Some 
general regularities and their significance. Lancet 1934;226:698-703. 
[8] Case RA. Cohort analysis of mortality rates as an historical or narrative technique. Br J Prev Soc 
Med 1956;10(4):159-71. 
[9] MacMahon B, Terry WD. Application of cohort analysis to the study of time trends in neoplastic 
disease. J Chronic Dis 1958;7(1):24-35. 
[10] Kuh D, Ben-Shlomo Y. A life course approach to chronic disease epidemiology. Oxford: Oxford 
University Press; 1997. 
[11] Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual 
models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 2002;31(2):285-
93. 
[12] Caselli G, Vallin J, Vaupel JW, Yashin A. Age-specific mortality trends in France and Italy since 
1900: period and cohort effects. Eur J Popul 1987;3(1):33-60. 
[13] Horiuchi S. The long-term impact of war on mortality: old-age mortality of the First World War 
survivors in the Federal Republic of Germany. Popul Bull UN 1983;15:80-92. 
[14] Wilmoth J, Vallin J, Caselli G. Differences between observed and expected cohort mortality. 
Population 1989;44(2):335-376. 
[15] Caselli G. The influence of cohort effects on differentials and trends in mortality. In: Vallin J, 
D'souza S, Palloni A, editors. Measurement and analysis of mortality; New approaches. New York 
/ England: Oxford University Press; 1990:229-49. 
CHAPTER 5 
 82 
[16] Lopez AD, Collishaw NE, Piha T. A descriptive model of the cigarette epidemic in developed 
countries. Tob Control 1994;3(3):242-247. 
[17] Vallin J, Meslé F. Les causes de décès en France depuis 1925. [Causes of death in France since 
1925]. Available from:http://matisse.ined.fr/%7Etania/ causfra/data/. 
[18] Janssen F, Kunst AE. ICD coding changes and discontinuities in trends in cause-specific mortality 
in six European countries, 1950-99. Bull World Health Organ 2004;82(12):904-13. 
[19] Hobcraft J, Gilles W. Age, period and cohort analysis in mortality studies. In: Vallin J, Pollard JH, 
Heligman L, editors. Methodologies for the collection and analysis of mortality data. Proceedings 
of a seminar at Dakar, Senegal, July 7-10, 1981. Liege: Ordina Editions; 1984. 
[20] Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: Age-period and age- 
cohort models. Stat Med 1987;6(4):449-67. 
[21] Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort 
models. Stat Med 1987;6(4):469-81. 
[22] Jacobsen R, Keiding N, Lynge E. Long term mortality trends behind low life expectancy of Danish 
women. J Epidemiol Community Health 2002;56(3):205-8. 
[23] Janssen F, Nusselder WJ, Looman CWN, Mackenbach JP, Kunst AE. Stagnation in mortality 
decline among elders in The Netherlands. Gerontologist 2003;43:722-734. 
[24] La Vecchia C, Negri E, Levi F, Decarli A, Boyle P. Cancer mortality in Europe: effects of age, 
cohort of birth and period of death. Eur J Cancer 1998;34(1):118-41. 
[25] Peltonen M, Asplund K. Age-period-cohort effects on ischaemic heart disease mortality in 
Sweden from 1969 to 1993, and forecasts up to 2003. Eur Heart J 1997;18(8):1307-12. 
[26] Peltonen M, Asplund K. Age-period-cohort effects on stroke mortality in Sweden 1969-1993 and 
forecasts up to the year 2003. Stroke 1996;27(11):1981-5. 
[27] Sverre JM. Secular trends in coronary heart disease mortality in Norway, 1966-1986. Am J 
Epidemiol 1993;137(3):301-10. 
[28] Osmond C. Coronary heart disease mortality trends in England and Wales, 1952-1991. J Public 
Health Med 1995;17(4):404-10. 
[29] Aragones N, Pollan M, Rodero I, Lopez-Abente G. Gastric cancer in the European Union (1968-
1992): mortality trends and cohort effect. Ann Epidemiol 1997;7(4):294-303. 
[30] Wolfe CD, Burney PG. Is stroke mortality on the decline in England? Am J Epidemiol 
1992;136(5):558-65. 
[31] Tarone RE, Chu KC. Implications of birth cohort patterns in interpreting trends in breast cancer 
rates. J Natl Cancer Inst 1992;84(18):1402-10. 
[32] Bornefalk A, Persson I, Bergstrom R. Trends in breast cancer mortality among Swedish women 
1953-92: analyses by age, period and birth cohort. Br J Cancer 1995;72(2):493-7. 
[33] Hermon C, Beral V. Breast cancer mortality rates are levelling off or beginning to decline in many 
western countries: analysis of time trends, age-cohort and age-period models of breast cancer 
mortality in 20 countries. Br J Cancer 1996;73(7):955-60. 
[34] Post PN, Straatman H, Kiemeney LA, Coebergh JW. Increased risk of fatal prostate cancer may 
explain the rise in mortality in The Netherlands. Int J Epidemiol 1999;28(3):403-8. 
[35] van der Gulden JW, Kiemeney LA, Verbeek AL, Straatman H. Mortality trend from prostate 
cancer in The Netherlands (1950-1989). Prostate 1994;24(1):33-8. 
[36] Caselli G. Future longevity among the elderly. In: Caselli G, Lopez A, editors. Health and 
mortality among elderly populations. Oxford: Clarendon Press; 1996:235-265. 
[37] Osmond C, Gardner MJ, Acheson ED. Analysis of trends in cancer mortality in England and Wales 
during 1951-80 separating changes associated with period of birth and period of death. BMJ 
(Clinical research ed) 1982;284(6321):1005-8. 
[38] Condran AG, Himes CL, Preston SH. Old-age mortality patterns in low-mortality countries: An 
evaluation of population and death data at advanced ages, 1950 to the present. Popul Bull UN 
1991;30:23-60. 
[39] Mackenbach JP, Kunst AE, Lautenbach H, Bijlsma F, Oei YB. Competing causes of death: an 
analysis using multiple-cause-of-death data from The Netherlands. Am J Epidemiol 
1995;141(5):466-75. 
[40] Manton KG. Cause specific mortality patterns among the oldest old: multiple cause of death 
trends 1968 to 1980. J Gerontol 1986;41(2):282-9. 
[41] Peto R, Lopez AD, Boreham J, Thun M, Heath C, Jr. Mortality from tobacco in developed 
countries: indirect estimation from national vital statistics. Lancet 1992;339(8804):1268-78. 
IDENTIFICATION OF COHORT PATTERNS IN OLD-AGE MORTALITY TRENDS 
 83
[42] Gunning-Schepers LJ. The Health Benefits of Prevention. A Simulation Approach. Rotterdam: 
Erasmus University Rotterdam; 1988. 
[43] Hamtoft H, Lindhardt M. Tobacco consumption in Denmark. II. The Danish National Morbidity 
Survey of 1950. Communication no 12. Dan Med Bull 1956;3:188-96. 
[44] Ronneberg A, Lund KE, Hafstad A. Lifetime smoking habits among Norwegian men and women 
born between 1890 and 1974. Int J Epidemiol 1994;23(2):267-76. 
[45] Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Changed trends of cancer mortality in the 
elderly. Ann Oncol 2001;12(10):1467-77. 
[46] Leon DA, Davey Smith G. Infant mortality, stomach cancer, stroke, and coronary heart disease: 
ecological analysis. BMJ 2000;320(7251):1705-6. 
[47] Bengtsson T, Lindstrom M. Airborne infectious diseases during infancy and mortality in later life 
in southern Sweden, 1766-1894. Int J Epidemiol 2003;32(2):286-94. 
[48] Forsdahl A. Are poor living conditions in childhood and adolescence an important risk factor for 
arteriosclerotic heart disease? Br J Prev Soc Med 1977;31(2):91-5. 
[49] Corsini CA, Viazzo PP, editors. The decline of infant and child mortality. The European 
experience: 1750-1990. The Hague: Martinus Nijhoff Publishers; 1997. 
[50] Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in 
England and Wales. Lancet 1986;1(8489):1077-81. 
[51] Williams DR, Roberts SJ, Davies TW. Deaths from ischaemic heart disease and infant mortality in 
England and Wales. J Epidemiol Community Health 1979;33(3):199-202. 
[52] Ben-Shlomo Y, Davey Smith G. Deprivation in infancy or in adult life: which is more important for 
mortality risk? Lancet 1991;337(8740):530-4. 
[53] Smits JP, Horlings E, Luiten van Zanden J. Dutch GNP and its components, 1800-1913. 
Groningen: Groningen Growth and Development Centre (Groningen University); 2000. 
[54] Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimation of 
contribution of changes in classic risk factors to trends in coronary-event rates across the WHO 
MONICA Project populations. Lancet 2000;355(9205):675-87. 
[55] Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, et al. Trends and 
disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United 
States: findings of the national conference on cardiovascular disease prevention. Circulation 
2000;102(25):3137-47. 
 
CHAPTER 5 
 84 
Appendix I. The contribution of drift to all-cause and cause-specific mortality trends, by sex and 
country 
 
 Share of scaled deviancea explained by adding drift to the 
model including only age 
 DK E&W FIN F NL NO S 
Men   
   
All-cause mortality 39.3 86.8 87.3 93.2 26.9 23.1 80.8 
   
Cancer of lung 63.1 4.3 0.8 78.6 42.7 85.4 47.4 
COPD 75.4 58.0 10.6 0.8 50.5 81.1 64.2 
Ischaemic heart disease 4.3 18.4 3.2 8.1 2.1 0.4 18.7 
Infectious diseases 65.8 75.7 86.3 52.3 36.7 50.1 50.6 
Cancer of stomach 98.2 88.4 95.8 92.9 98.7 97.6 97.7 
Cancer of prostate 75.7 68.9 69.9 45.8 81.3 79.9 85.7 
Cerebrovascular diseases 95.2 90.0 91.3 82.3 94.4 80.4 92.0 
   
Women   
   
All-cause mortality 81.9 98.5 93.1 93.8 91.7 93.3 95.4 
   
Cancer of lung 95.9 92.3 83.4 90.2 85.7 94.5 90.1 
COPD 83.2 24.2 (0.1) 0.5 15.3 42.9 67.1 
Ischaemic heart disease 44.0 56.6 4.8 5.7 55.1 22.1 69.0 
Infectious diseases 49.6 37.1 75.1 16.2 33.4 26.1 20.4 
Cancer of stomach 98.7 96.7 96.5 92.3 98.9 99.4 98.7 
Cancer of breast 27.5 50.4 68.7 88.6 45.4 50.2 25.3 
Cerebrovascular diseases 88.2 87.7 90.4 74.7 92.2 83.7 81.7 
a The scaled deviance that is explained by the full age-period-cohort model as compared with the 
model including only age.  
DK = Denmark; E&W = England and Wales; FIN = Finland; F = France; NL = The Netherlands; NO = 
Norway; S = Sweden. 
( ) No statistically significant reduction in the scaled deviance ( p < 0.05 one sided). 
COPD = chronic obstructive pulmonary diseases. 
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RELATION BETWEEN TRENDS IN LATE MIDDLE-AGE MORTALITY AND 
TRENDS IN OLD-AGE MORTALITY – IS THERE EVIDENCE FOR 
MORTALITY SELECTION? 
 
 
Objective To test whether mortality selection was a dominant factor in determining trends 
in old-age mortality, by empirically studying the existence of a negative correlation 
between trends in late middle-age mortality and trends in old-age mortality among the 
same cohorts. Methods A cohort approach was applied to period data on total and cause-
specific mortality for Denmark, England and Wales, Finland, France, the Netherlands, 
Norway, and Sweden, in 1950-1999. The study described and correlated mortality trends 
for five-year centralised cohorts from 1895 to 1910 at ages 55-69, with the trends for the 
same cohorts at ages 80-89. The research distinguished between circulatory diseases, 
cancers, and diseases specifically related to old age. Results All-cause mortality changes 
at ages 80-89 were strongly positively correlated with all-cause mortality changes at ages 
55-69, especially among men, and in all countries. Virtually the same correlations were 
seen between all-cause mortality changes at ages 80-89 and changes in circulatory disease 
mortality at ages 55-69. Trends in mortality at ages 80-89 from infectious diseases, 
pneumonia, diabetes mellitus, symptoms or external causes showed no clear negative 
correlations with all-cause mortality trends at ages 55-69. Conclusion The consistently 
positive correlations seen in this study suggest that trends in old-age mortality in north 
western Europe in the late 20th century were determined predominantly by the prolonged 
effects of exposures carried throughout life, and not by mortality selection. 
 
BACKGROUND 
 
The ageing of populations has important consequences for future demands of health care 
services and old-age benefit systems. The degree of ageing of populations is strongly 
influenced by future patterns of old-age mortality [1,2]. Therefore, projections of future 
mortality trends are highly important for public health. To make informed projections of 
future mortality trends it is important to accurately describe past trends in old-age mortality 
and to analyse its determinants. 
 
Past trends in old-age mortality have been studied in many countries. Among low-mortality 
countries, a general decline in mortality among those aged 80 and over since the 1950s 
has been found [3-6]. However, when this period of mortality decline is examined more 
closely, important cross-national differences in the pace of decline in old-age mortality 
appear. From the 1980s onwards, mortality decline stagnated in Denmark, the Netherlands, 
and among Norwegian men, while in other countries the mortality decline continued [7-9].  
 
The mechanisms behind these trends are still largely unknown. Next to effects of life-style 
or events occurring in late life itself, studies have focused on the effects of events or life-
style earlier in life, in accordance with the life course perspective. One mechanism 
mentioned in literature as a possible determinant of old-age mortality trends, and one that 
is related to the life-course perspective, is mortality selection [1,7,10,11]. 
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Mortality selection indicates that when mortality at younger ages is high, it tends to affect 
the frail individuals first, leaving a more selected and more robust population that survive 
up to high ages [12]. With decreasing mortality at younger ages, the increasing proportion 
of the elderly population might be expected to be less healthy when compared with their 
more selected predecessors [1], and subsequently could experience comparatively higher 
morbidity and mortality at older ages.  
 
Mortality selection effects have been posited in studies that use mathematical models to 
study cohort mortality (e.g. [12-18]), for example to explain the deceleration of the age 
pattern of mortality at older ages (e.g. [16]), or the Black-White mortality crossover (e.g. 
[12]). In addition, there is a long history of empirical cohort analyses of mortality. These 
studies focussed mainly on the association between debilitating events or mortality in early 
life and mortality in adult ages (e.g. [19-25]). They showed predominantly positive 
associations, indicating no mortality selection. However, one study reported negative 
associations [26], and another reported no associations [27]. Three other empirical studies, 
focussing more explicitly on old-age mortality, did not find any empirical evidence for 
mortality selection [28-30]. 
 
Thus, the evidence on mortality selection effects is rather mixed. Moreover, as most of 
these studies studied the mortality experience of single cohorts, little is known on the role 
of mortality selection in long-term mortality trends. Furthermore, because previous studies 
often focused on the effects of mortality at very early ages on adult mortality, the effects of 
adult mortality on old-age mortality are largely unknown.  
 
The objective of this paper is to empirically study whether, and in what way, trends in late 
middle-age mortality are correlated with old-age mortality trends among the same cohorts. 
We hypothesise that mortality selection is a driving factor in old-age mortality trends in 
seven north western European countries from 1950 to 1999. Consequently, we expect 
inverse correlations. 
 
To test this hypothesis, we use data on all-cause mortality and mortality data for causes of 
death that are especially susceptible to mortality selection – that is circulatory diseases at 
late middle age and diseases specifically related to old age. Mortality declines in circulatory 
diseases (predominantly ischaemic heart diseases) have been shown to lead to increased 
prevalence of chronic heart diseases at older ages [31], with subsequently higher mortality 
risks of related diseases [32]. With respect to diseases specifically related to old age, 
recent mortality increases were observed [9]. These increases could possibly result from an 
increasing proportion of frailer people at higher ages, due to decreased selection, because 
of mortality declines at younger ages.  
 
In this study, we assess whether trends in old-age mortality (ages 80-89) among 
subsequent birth cohorts are inversely correlated with mortality trends at late middle age 
(ages 55-69) for the same cohorts, and whether different correlations are observed for (a) 
trends in circulatory diseases mortality at late middle age, and (b) mortality trends from 
diseases specifically related to old age.   
 
DATA AND METHODS 
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For this analysis, data on all-cause mortality, cause-specific mortality and population 
numbers, by five-year age groups and sex, were obtained from national statistical offices 
and related institutes, for Denmark, England and Wales, Finland, France, the Netherlands, 
Norway, and Sweden, for the years 1950 to 1999.  
 
In addition to all-cause mortality, we included three main groups of causes of death in our 
analysis: all circulatory diseases, all cancers, and the remaining causes of death. Within all 
circulatory diseases we distinguished between ischaemic heart diseases and cerebro-
vascular diseases. Within the remaining causes of death, we focused on diseases 
specifically related to old age – that is infectious diseases, pneumonia, diabetes mellitus, 
dementia, and symptoms. See Janssen et al. (2004) for the three-digit codes used for 
these causes of death in the different revisions of the International Classification of 
Diseases (ICD) from the World Health Organisation [33]. For ischaemic heart diseases we 
included the numbers of deaths for code 422.1 under ICD-6/7.  
 
The use of three-digit codes can still generate mortality discontinuities due to ICD revisions 
or due to incidental coding changes, such as the ones in England and Wales between 1984 
and 1992, and in Sweden after 1980 [33]. We identified and adjusted for these coding-
related mortality discontinuities in our analysis. Adjustment involved the recalculation of the 
number of cause-specific deaths by means of sex- and cause-specific transition coefficients. 
These transition coefficients are the parameter estimates of variables associated with a 
coding change (e.g. ICD-8toICD-9), and obtained through sex-specific regression models. 
In these regression models, cause-specific mortality was the dependent variable and age, 
year of death, and variables associated with a coding change were independent variables. 
To obtain the sex- and cause-specific transition coefficients to recalculate cause-specific 
deaths for those aged 55-69 and those aged 80-89, the regression model was applied to 
cause-specific mortality among those aged 60 and over, and those aged 80 and over, 
respectively. For those aged 55-69, recalculation was applied to ischaemic heart diseases in 
the Netherlands and Sweden, and cerebrovascular diseases in Finland. For those aged 80-
89, deaths from all selected causes, except all circulatory diseases and infectious diseases, 
were adjusted for coding changes.  
 
We aggregated the mortality and population data into five-year periods, and calculated 
five-year age-specific mortality rates by dividing the mortality data by the mid-year 
population estimates. To these period data, we applied a "mixed cohort approach", by 
using as the unit of observation centralised birth cohorts. In this approach, the data are 
combined by five-year period and five-year age group, and centred around the cohort 
calculated by subtracting the age group from the period (see figure 1). We were able to 
study four different centralised birth cohorts (those born around 1895, 1900, 1905, and 
1910) to fulfil our aim of correlating mortality among those aged 55-69, with mortality 
among those aged 80-89 using the available data (1950-1999).  
 
Cohort mortality rates for ages 55-69 and ages 80-89 were obtained by taking for each 
separate centralised cohort the unweighted average of the age-specific rates over the three 
or two five-year age groups, respectively. Relative changes in these cohort mortality rates 
were calculated by relating the mortality rate of a given centralised cohort to the mortality 
rate of the preceding centralised cohort. 
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Figure 1. The mixed cohort approach applied to period data from 1950 to 1999, for the ages 50 to 
100 
 
As a first exploration of the mortality selection mechanism, we correlated all-cause 
mortality levels between those aged 55-69 and those aged 80-89. Our main analysis, 
however, consisted of the correlation of relative cohort mortality changes between the late 
middle aged and the elderly population. For all-cause mortality, we correlated absolute 
cohort mortality changes as well. Whereas absolute mortality changes more accurately 
express the importance of the mortality changes at younger ages, and the effect that they 
can have on trends in mortality at older ages, relative mortality changes can be more 
readily compared between countries.  
 
The correlations were calculated across the seven countries, two sexes, and (changes in 
the) four centralised cohorts. In addition, correlations were calculated separately for men 
and women, each (change in) centralised cohort, and each country. The correlations of the 
mortality levels were stratified by sex.  
 
In an additional analysis, we correlated the relative changes in all-cause mortality trends – 
that is the deceleration or acceleration of mortality trends in both late middle age and old 
age. We did so to find out if mortality at late middle age and old age is not only related in 
terms of the direction of mortality changes (is an increase in the one associated with a 
decrease in the other?) but also in terms of the pace of the mortality change (is an 
acceleration of the one associated with a deceleration in the other?). This additional 
analysis was conducted as an attempt to explain the deceleration of old-age mortality 
decline that was seen in Denmark, the Netherlands, and among Norwegian men [9].  
 
To check the robustness of our results, different age groups were used when correlating 
all-cause mortality trends – that is ages 70-79 instead of 55-69 and ages 80-94 instead of 
80-89. For the latter analysis only three instead of four centralised cohorts could be 
analysed. 
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RESULTS 
 
Among those aged 55-69, mortality levels were highest in Finland, England and Wales, and 
France (men), and lowest in Norway, Sweden, and the Netherlands (women)(table 1). 
Among those aged 80-89, Finland had by far the highest mortality level, and France the 
lowest level, especially among the more recent cohorts. Correlation between all-cause 
mortality levels of those aged 55-69 and those aged 80-89, showed highly positive and 
significant correlations, among both men and women, although less so for the more recent 
cohorts (table 2). 
 
All-cause mortality generally declined over the five-year centralised birth cohorts from 1895 
to 1910 both among men and women aged 55-69 and among men and women aged 80-89 
(table 1). The trends for men in Denmark, the Netherlands, and Norway were less 
favourable. Correlations between both relative and absolute changes in all-cause mortality 
at ages 55-69 with those at ages 80-89 were significant and positive (0.61 and 0.58, 
respectively) (table 3, figure 2). Among men, the correlation coefficients were especially 
high (0.7). Among women, the correlations were lower (0.3) and not statistically 
significant. The correlations were strongest for the Netherlands, Norway, and Sweden (men 
only). 
 
Circulatory disease mortality among those aged 55-69 generally declined over subsequent 
centralised birth cohorts (data not shown). For men, this decline started only among later 
cohorts. For Dutch men, circulatory disease mortality increased. Relative changes in 
circulatory disease mortality at ages 55-69 correlated significantly and positively with all-
cause mortality changes at ages 80-89 (0.61) (table 4).  
 
Table 1a. All-cause mortality levels and trends, men aged 55-69 and 80-89, centralised birth cohorts 
1895-1910, by country  
 
Country Mortality rate (x 10000) by centralised  
birth cohort 
Relative change in mortality rate 
between subsequent centralised 
birth cohorts (%) 
 1895 1900 1905 1910 1895-1900 1900-1905 1905-1910 
Aged 55-69    
    
Denmark 212.46 225.84 229.71 224.01 6.29 1.71 -2.48 
England&Wales 298.60 297.38 285.20 267.64 -0.41 -4.10 -6.16 
Finland 345.14 342.36 335.37 320.07 -0.80 -2.04 -4.56 
France 279.41 282.70 270.58 250.08 1.18 -4.29 -7.58 
Netherlands 203.58 217.06 229.24 229.41 6.62 5.61 0.07 
Norway 192.22 207.20 208.91 204.28 7.79 0.82 -2.21 
Sweden 198.89 198.23 195.77 192.72 -0.33 -1.24 -1.56 
    
Aged 80-89    
    
Denmark 1508.78 1485.48 1497.17 1476.78 -1.54 0.79 -1.36 
England&Wales 1725.58 1622.06 1511.90 1427.60 -6.00 -6.79 -5.58 
Finland 1670.92 1638.10 1582.05 1508.16 -1.96 -3.42 -4.67 
France 1595.21 1498.76 1356.52 1258.63 -6.05 -9.49 -7.22 
Netherlands 1497.12 1494.98 1520.32 1498.09 -0.14 1.70 -1.46 
Norway 1479.93 1473.07 1477.12 1446.20 -0.46 0.28 -2.09 
Sweden 1556.02 1506.78 1442.75 1375.34 -3.16 -4.25 -4.67 
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Table 1b. All-cause mortality levels and trends, women aged 55-69 and 80-89, centralised birth 
cohorts 1895-1910, by country 
 
Country Mortality rate (x 10000) by centralised  
birth cohort 
Relative change in mortality rate 
between subsequent centralised 
birth cohorts (%) 
 1895 1900 1905 1910 1895-1900 1900-1905 1905-1910 
Aged 55-69    
    
Denmark 143.52 134.82 124.80 118.72 -6.06 -7.43 -4.88 
England&Wales 152.94 144.10 136.86 132.50 -5.78 -5.02 -3.19 
Finland 175.06 166.49 146.57 128.21 -4.90 -11.96 -12.53 
France 144.73 131.19 119.31 106.29 -9.35 -9.05 -10.91 
Netherlands 129.23 118.69 111.83 102.14 -8.16 -5.78 -8.67 
Norway 121.47 114.11 106.87 98.75 -6.06 -6.35 -7.60 
Sweden 134.22 120.12 109.01 100.25 -10.50 -9.25 -8.03 
    
Aged 80-89    
    
Denmark 1098.45 1064.71 1037.78 1003.58 -3.07 -2.53 -3.30 
England&Wales 1218.97 1104.13 1010.94 981.43 -9.42 -8.44 -2.92 
Finland 1263.72 1213.57 1183.91 1095.07 -3.97 -2.44 -7.50 
France 1146.66 1039.61 919.98 837.24 -9.34 -11.51 -8.99 
Netherlands 1076.92 1017.34 1003.29 982.93 -5.53 -1.38 -2.03 
Norway 1119.08 1065.37 1033.13 982.27 -4.80 -3.03 -4.92 
Sweden 1131.19 1059.75 982.29 931.49 -6.32 -7.31 -5.17 
 
For women, the positive correlation was not significant. Correlations of all-cause mortality 
changes at ages 80-89 with trends in mortality from ischaemic heart diseases and 
cerebrovascular diseases at ages 55-69 were also significant and positive, but less strong 
(0.40 and 0.42, respectively). 
 
Table 2. Correlation of all-cause mortality levels at ages 55-69 with all-cause mortality levels at ages 
80-89, for men and women born to the centralised birth cohorts 1895-1910 among seven European 
countries, stratified by sex 
 
 Correlation of mortality levels 
Stratified by: Total (N) Men (N) Women (N) 
     
All 0.90** (56) 0.52** (28) 0.83** (28) 
     
Centralised birth cohort 1895 0.91** (14) 0.88** (7) 0.87* (7) 
Centralised birth cohort 1900 0.93** (14) 0.85* (7) 0.89** (7) 
Centralised birth cohort 1905 0.90** (14) 0.40 (7) 0.65 (7) 
Centralised birth cohort 1910 0.90** (14) 0.22 (7) 0.52 (7) 
     
Denmark 0.99** (8) # (4) # (4) 
England and Wales 0.96** (8) # (4) # (4) 
Finland 0.99** (8) # (4) # (4) 
France 0.94** (8) # (4) # (4) 
Netherlands 0.99** (8) # (4) # (4) 
Norway 0.99** (8) # (4) # (4) 
Sweden 0.99** (8) # (4) # (4) 
* Correlation is significant at the 0.05 level (two-tailed). 
** Correlation is significant at the 0.01 level (two-tailed). 
# Too few observations. 
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All-cause mortality change at ages 55-69
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Table 3. Correlation of relative and absolute cohort changes in all-cause mortality at ages 55-69 with 
relative and absolute cohort changes in all-cause mortality at ages 80-89, for men and women born to 
the centralised birth cohorts 1895-1910 among seven European countries 
 
      Correlation of mortality changes  
Stratified by:                  Relative     Absolute  N 
       
All  0.61**  0.58**  42 
       
Men  0.71**  0.70**  21 
Women  0.33  0.32  21 
       
Cohort changea 1895 to 1900  0.74**  0.61*  14 
Cohort changea 1900 to 1905  0.56*  0.64*  14 
Cohort changea 1905 to 1910  0.74**  0.82**  14 
       
Denmark  0.63  0.44  6 
England and Wales  0.41  0.20  6 
Finland  0.52  0.37  6 
France  0.64  0.08  6 
Netherlands  0.78  0.79  6 
Norway  0.84*  0.76  6 
Sweden  0.88*  0.54  6 
a Relative change in mortality rates between the two subsequent centralised birth cohorts.  
* Correlation is significant at the 0.05 level (two-tailed). 
** Correlation is significant at the 0.01 level (two-tailed). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Scatter plot of the correlation of relative changes in all-cause mortality at ages 55-69 and at 
ages 80-89, for men and women born to the centralised cohorts 1895-1910 among seven European 
countries 
 
DK = Denmark, EW = England and Wales, FN = Finland, F = France, NL = the Netherlands, NO = 
Norway, S = Sweden; Cohort change: 1 = cohort change 1895-1900, 2 = cohort change 1900-1905, 3 
= cohort change 1905-1910. 
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Table 4. Correlation of relative changes in circulatory disease mortality at ages 55-69 with relative 
changes in all-cause mortality at ages 80-89, for men and women born to the centralised birth cohorts 
1895-1910 among seven European countries 
 
 
 
 
Causes of death at ages 55-69 
     All 
(N=42)
    Men 
(N=21)
Women
(N=21)
Cohort
changea
1895-1900
(N=14)
Cohort 
changea 
1900-1905 
(N=14) 
Cohort 
changea 
1905-1910 
(N=14) 
All circulatory diseases    0.61**   0.70**  0.40  0.77**  0.56*  0.60* 
Ischaemic heart diseases   0.40**   0.40  0.12  0.84**  0.47  0.39  
Cerebrovascular diseases    0.42**   0.41  0.09  0.39  0.50  0.47  
a Relative change in mortality rates between the two subsequent centralised birth cohorts.  
* Correlation is significant at the 0.05 level (two-tailed). 
** Correlation is significant at the 0.01 level (two-tailed). 
 
All-cause mortality trends at ages 55-69 correlated significantly and positively with 
mortality trends in circulatory diseases and cancer at ages 80-89 (0.58 and 0.69, 
respectively)(table 5). The positive correlation for cancer mortality was observed for both 
men and women, whereas for circulatory disease mortality only for men. All-cause mortality 
trends at ages 55-69 did not clearly correlate with mortality trends at ages 80-89 from 
diseases other than circulatory diseases and cancer, nor with diseases specifically related to 
old age, such as infectious diseases, pneumonia, diabetes mellitus, dementia, symptoms, 
and external causes of death. A significant positive correlation was found only for diabetes 
mellitus and symptoms (among women). While a few inverse correlations were seen, 
especially for pneumonia, these correlations were weak, inconsistent, and non-significant.  
 
Table 5. Correlation of relative changes in all-cause mortality at ages 55-69 with relative mortality 
changes in specific causes of death at ages 80-89, for men and women born to the centralised birth 
cohorts 1895-1910 among seven European countries 
 
 
 
 
Causes of death at ages 80-89 
   All 
(N=42)
    Men 
    (N=21)
   Women
   (N=21)
Cohort
changea
1895-1900
(N=14)
Cohort 
changea 
1900-1905 
(N=14) 
Cohort 
changea 
1905-1910 
(N=14) 
       
All circulatory diseases    0.58**    0.66**   0.14     0.63*     0.54*  0.51 
All cancers    0.69**    0.54*   0.49*     0.64*     0.79**  0.50 
All other causes    0.17     0.40   0.19     0.26     0.14  0.42 
       
Diseases specifically related to old-age within "all other causes": 
Infectious diseases     0.01    0.15   0.26   –0.15     0.14  0.43 
Pneumonia  –0.03  –0.14 –0.23   –0.15     0.14  0.25 
Diabetes mellitus    0.44**    0.11   0.42     0.44     0.33  0.55* 
Dementia    0.18    0.25   0.21   –0.23     0.37  0.44 
All symptoms and ill-defined 
   conditions 
   0.07   –0.12   0.62**   –0.25     0.13  0.35 
All other diseasesb    0.22    0.67**   0.13     0.45   –0.03  0.17 
All external causes of death    0.39*    0.33 –0.09     0.42     0.36  0.18 
a Relative change in mortality rates between the two subsequent centralised birth cohorts.  
b This refers to all diseases not included in this table – that is all-cause mortality minus all circulatory 
diseases, all cancers, infectious diseases, pneumonia, diabetes mellitus, dementia, "all symptoms and 
ill-defined conditions", and all external causes of death. 
* Correlation is significant at the 0.05 level (two-tailed). 
** Correlation is significant at the 0.01 level (two-tailed). 
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Acceleration or deceleration of mortality trends among those aged 80-89 was positively 
correlated with the pace of mortality change among those aged 55-69, although 
correlations were weak (0.27) and non-significant.  
 
Trends in all-cause mortality at ages 70-79 (instead of 55-69) correlated significantly and 
highly positive with trends in all-cause mortality at ages 80-89 (0.69). The correlation of 
all-cause mortality changes at ages 55-69 with those at ages 80-94 (instead of 80-89) was 
significant and positive (0.59) as well. 
 
DISCUSSION 
 
In this paper, we explored the relation between mortality trends in late middle age (55-69) 
and mortality trends in old age (80-89) for male and female cohorts born around 1895, 
1900, 1905 and 1910 in seven European low-mortality countries. All-cause mortality 
changes at ages 80-89 are strongly positively correlated with all-cause mortality changes at 
ages 55-69, especially among men, and in all countries. Virtually the same correlations 
were seen between all-cause mortality changes at ages 80-89 and changes in circulatory 
disease mortality at ages 55-69. Mortality trends at ages 80-89 from diseases specifically 
related to old age – that is infectious diseases, pneumonia, diabetes mellitus, symptoms 
and external causes, showed no clear negative correlations with all-cause mortality trends 
at ages 55-69. 
 
This evidence suggests that mortality selection has not been a driving factor behind old-
age mortality trends in the countries under study. Our results were found robust against 
the selection of different age groups (70-79 instead of 55-69 and 80-94 instead of 80-89). 
Furthermore, we found no indications that the recent deceleration of the mortality decline 
among the elderly in Denmark, the Netherlands, and Norway was related to accelerated 
declines in mortality at earlier ages of the same cohorts.  
 
This study is unique in its attempt to link, in a cohort-wise manner, trends in middle-age 
mortality with trends in old-age mortality. Perhaps closest to our study is a study by 
Manton on the effects of increases in life expectancy at advanced ages on mortality from 
conditions associated with a debilitation at those ages. He also found no evidence for 
decreased selectivity [29]. Persons who survive up to age 85 were on average healthier 
than their predecessors, in contrast with what would be expected according to the 
mortality selection theory when mortality is improving.  
 
Evaluation of data and methods 
 
The mortality and population data used in this study stem from countries considered to 
have good or excellent population and vital registries [4,5]. Reported survivorship counts 
are highly accurate [5,34]. Comparison of our mortality data to the mortality data among 
those aged 80 and over from the Kannisto-Thatcher Database [5] - in which the data were 
checked for age-heaping and were subjected to a number of checks for plausibility - 
showed only small discrepancies. 
 
In our analysis, we applied a mixed cohort approach – that is a cohort approach applied to 
period data. A pure cohort approach was difficult to conduct with the available data, and 
CHAPTER 6 
 96 
would have led to the inclusion of only three subsequent five-year cohorts, which we 
considered too few for correlation analyses. A disadvantage of the mixed cohort approach 
is that it cannot clearly separate subsequent cohorts. Consequently, the identified cohorts 
overlap, which could lead to an underestimation of mortality trends and possibly to a 
dilution of the strength of the correlations between trend estimates. However, some 
dilution of effect could not explain the observed positive instead of inverse relation 
between mortality trends at late middle age and old age. 
 
We made an extraordinary effort to deal with ICD and other coding related changes that 
can affect cause-specific mortality trends, and that are often neglected in other studies. 
Even though some residual effects of coding problems could not be excluded, we expect 
that these problems did not affect the results to any substantial extent [8,9,33].  
 
We do not expect that the potentially inferior quality of cause of death coding among the 
very elderly as compared with the late middle age would substantially affect our results. 
The quality of coding can only bias the correlation of trends if clear changes in the quality 
of coding over time occurred, which is unlikely.   
 
Explanations of the absence of hypothesised inverse correlations 
 
One possible explanation of the lack of negative correlations is that our study lacked 
potential to empirically observe an effect of mortality selection, because of comparatively 
little variation in mortality at younger ages between subsequent cohorts. Larger variations 
were, however, seen between the selected countries. Moreover, life-table calculations for 
the Netherlands in 1950 showed that the mortality declines among those aged 55-69 within 
most individual countries were large enough to influence mortality trends among those 
aged 80-89. Considering the extreme situation in which all people saved from dying in the 
younger group will eventually die in the older group, a 10% mortality reduction among 
those aged 55-69 would lead to a mortality increase at age 80-89 years of 14% among 
men, and of 11% among women.   
 
The lack of empirical support to the mortality selection hypothesis could also possibly be 
explained by not considering the greatest advances in medical care and resulting mortality 
declines since the 1970s among those aged 55-69 [35]. Improvements in medical care and 
new treatments lead to higher prevalences in chronic disease for those who survive [29], 
which could result in higher mortality at higher ages from these diseases. Although we 
cannot exclude that more recent declines in mortality at ages 55-69 might influence trends 
in old-age mortality for more recent cohorts and future periods differently, our finding that 
positive correlations were also observed among the more recent cohorts studied, which 
were also characterized by important declines in mortality at middle age, casts doubt about 
the potential of mortality selection to determine future old-age mortality trends. 
   
Explanations of the positive correlations observed 
 
The consistently positive correlations seen in our analysis suggest the existence of parallel 
trends in late middle-age mortality and old-age mortality. This points to common 
mechanisms that develop in a cohort-wise fashion.  
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It has frequently been mentioned in literature that risks established early in life influence 
health conditions at adult ages. Examples of relevant exposures include nutrition in utero, 
exposure to infectious diseases and/or socio-economic circumstances in infancy or 
childhood [19-23,36]. Less clear is whether the effects of early life events last until old age 
[17,26,27]. Our results could indicate that effects of early life events or conditions, that 
have been shown to influence mortality risk at late middle age, have the potential to exert 
their influence until old age. 
 
Prolonged exposure to, or longlasting effects of, risks emerging during adult age might be 
another factor contributing to the observed positive correlations. Additional analyses 
showed that changes in circulatory disease mortality at ages 55-69 correlated most strongly 
with changes in mortality at ages 80-89 from circulatory diseases (0.61) and cancers 
(0.54), and hardly with old-age mortality changes in remaining causes of death (0.15) and 
infectious diseases (-0.10). This indeed suggests that risk factors for circulatory diseases, 
like physical activity, hypertension, diet, smoking, and utilisation of medical care [37-39] 
emerging during adult age, are common determinants of mortality at both adult and old 
age among the same cohorts. With respect to smoking among men, changes in all-cause 
mortality at ages 55-69 were indeed strongly correlated to changes in mortality from lung 
cancer at ages 80-89 (0.71).  
 
Implications 
 
The consistently positive correlations between mortality changes at late middle age and 
mortality changes among the elderly population suggest that old-age mortality trends in 
north western Europe in the late 20th century are determined predominantly by the effects 
of early life circumstances carried throughout life and prolonged exposure to, or long-
lasting effects of, risk factors emerging in adult life. Mortality selection has no discernible 
effect on secular trends in mortality. Our results, thus, do not support the concern that 
strong declines in middle-age mortality will ultimately lead to increases in old-age mortality 
for the same cohorts. In fact, the positive associations seen in our study suggest that 
recent trends in all-cause mortality among the middle aged may be used to inform 
projections of future trends in all-cause mortality among the elderly population.  
 
Key points 
 
● The evidence on mortality selection effects is rather mixed, and studied predominantly 
by relating mortality at very early ages with adult mortality among single cohorts. 
Consequently, little is known on mortality selection effects of mortality trends at adult 
ages on old-age mortality trends. 
● In all countries under study, trends in mortality at late middle age correlate positively 
with trends in old-age mortality of the same birth cohorts. 
● Positive correlations are also seen with trends in mortality from cardiovascular diseases 
at late middle age. Weak, but not inverse correlations are seen with trends in mortality 
from diseases specifically related to old age. 
● The observed positive correlations point to effects of early life circumstances carried 
throughout life and prolonged exposure to, or long-lasting effect of, risk factors 
emerging in adult life. Effects of mortality selection seem to be of lesser importance in 
determining old-age mortality trends. 
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● Our results do not support the concern that strong declines in middle-age mortality will 
lead to an increase in old-age mortality for the same cohorts. 
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7 
 
ASSOCIATION BETWEEN GROSS DOMESTIC PRODUCT THROUGHOUT 
THE LIFE-COURSE AND OLD-AGE MORTALITY ACROSS BIRTH COHORTS. 
PARALLEL ANALYSES OF SEVEN EUROPEAN COUNTRIES, 1950-1999 
 
 
Objective Mortality levels of national populations have often been studied in relation to 
levels of Gross Domestic Product (GDP) at time of death. Following the life-course 
perspective, we assessed whether old-age mortality levels for subsequent cohorts are 
differentially associated with GDP levels prevailing at different ages of the cohorts. 
Methods We used all-cause and cause-specific mortality data by sex, age at death (65-
99), year at death (1950 to 1999), and year of birth (1865 to 1924) for Denmark, England 
and Wales, Finland, France, the Netherlands, Norway, and Sweden. Trends in national GDP 
per capita between 1865 and 1999 were reconstructed from historical national accounts 
data. Through Poisson regression analyses, we determined for each country both univariate 
and multivariate associations across five-year birth cohorts between mortality and GDP 
levels prevailing at time of death, and at earlier ages of the cohorts (i.e. 0-5, 6-19, 20-49, 
and 50-64). Results For the subsequent cohorts, levels of GDP at time of death were 
strongly inversely associated with all-cause mortality, especially among women, and among 
men in England and Wales, Finland, and France. In most countries, stronger associations 
were observed with GDP levels prevailing at earlier ages of the cohorts. After control for 
GDP at time of death, these associations remained. An independent association of GDP at 
earlier ages of the cohort was also observed for cause-specific mortality. The associations 
were negative for ischaemic heart diseases, cerebrovascular diseases, and stomach cancer. 
They were positive for prostate cancer, breast cancer, COPD (women), and lung cancer 
(women). GDP prevailing at ages 20-49 (men) and ages 50-64 (women) had the largest 
associations with old-age mortality. Conclusion These findings suggest an independent, 
mostly negative effect of GDP prevailing at earlier ages of subsequent cohorts on old-age 
mortality. Socio-economic circumstances during adulthood and middle age seem more 
important in determining old-age mortality trends than those during infancy or childhood.  
 
BACKGROUND 
 
The ageing of populations is a major challenge for individuals, society, policy makers and 
public health professionals. An increasing share of the elderly in national populations is 
expected to lead to increasing future demands of health care services and old-age benefit 
systems. The degree of ageing in European populations is determined substantially by 
current and future mortality trends among the elderly [1-3]. In order to make inferences on 
possible future old-age mortality trends, it is important to carefully describe past and 
current mortality trends among the elderly, and to study its determinants. 
 
One key factor in influencing mortality levels and trends may be economic growth (e.g. 
[4]). During the 20th century, all European countries, and particularly those in the west and 
north, experienced dramatic increases in both economic prosperity and life expectancy. 
Economic growth is assumed to affect life expectancy in various ways: directly, through the 
improvement of material living conditions of European populations; and indirectly, by 
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facilitating advances in medical technology, and through rising educational levels, and the 
development of social welfare systems [5-7].  
 
Usually, mortality trends are correlated with contemporaneous economic developments, 
e.g. with Gross Domestic Product (GDP) measured around the year of death [8,9]. 
Similarly, cross-national studies on the correlation between national mortality levels and 
national GDP levels have often assumed no or only a short lag time between GDP and 
mortality [10,11]. However, the influential paper by Kermack, McKendrick, and McKinlay in 
1934, emphasizing the importance of environmental conditions during childhood [12], and 
recent insights from life-course epidemiology [13,14] stress the need to take into account 
determinants occurring in earlier phases of the lifetime of the respective birth cohorts. 
Longitudinal studies at the individual level have identified a series of factors related to early 
life that have long-lasting effects on the health and risk factor profile of people in later life 
(e.g. [15-17]). Socio-economic conditions in early life have also been found to be related to 
mortality in later life, both in ecological and individual level studies (e.g. [18-27]).  
 
The abovementioned studies mainly focused on the relation between socio-economic 
conditions in very early life (infancy or childhood) and mortality at adult ages, rather than 
explicitly with mortality at old ages. Furthermore few studies that explicitly adopted a life-
course perspective have described in detail the association between economic 
developments and secular trends in mortality. Therefore, it remains unknown whether the 
effect of socio-economic conditions related to earlier phases of life is strong enough to 
determine secular trends in old-age mortality of national populations.  
 
In accordance with the life-course perspective, we assessed in this paper whether old-age 
mortality levels for subsequent cohorts in different countries are differentially associated 
with GDP levels prevailing at different ages of the cohorts. We addressed this question for 
men and women from seven European countries, thereby aiming to identify patterns that 
are common to most or all countries. Data were analysed from a cohort perspective. We 
focused on mortality levels of 12 subsequent five-year cohorts aged 65 to 99 between 1950 
and 1999. Mortality levels of these different cohorts, born between 1865 and 1924, were 
related to national GDP levels prevailing at time of death, at ages 0-5, and at intermediate 
ages (i.e. 6-19, 20-49, and 50-64) for each birth cohort. In addition to all-cause mortality, 
we focused on a number of specific causes of death. 
 
We hypothesized that GDP levels both at time of death and at earlier ages of the cohort are 
negatively associated with old-age mortality, both with and without control for GDP at time 
of death. With respect to cause-specific mortality, we expect an independent negative 
association of old-age mortality with GDP prevailing at ages 0-5 years for causes of death 
for which individual-level studies observed relationships with living conditions in childhood, 
i.e. cerebrovascular diseases, stomach cancer and ischaemic heart diseases [27]. For 
mortality from the remaining selected causes of death, i.e. prostate cancer, breast cancer, 
lung cancer, and chronic obstructive pulmonary diseases, we expect no, or perhaps 
positive, independent associations with GDP at early ages.   
 
DATA AND METHODS 
 
Data 
GDP THROUGHOUT THE LIFE-COURSE AND OLD-AGE MORTALITY 
 103 
From the Human Mortality Database (HMD), we obtained all-cause death counts by Lexis 
triangle (i.e. by both year of death and year of birth), sex, and single year of age (65 to 99 
years) for Denmark, England and Wales, Finland, France, the Netherlands, Norway and 
Sweden, in the period 1950-1999 (http://www.mortality.org/). Cause-specific mortality 
data by five-year age group and sex were acquired from national statistical offices and 
related institutes. Cause-specific mortality data were available from 1951 onwards in 
Denmark, Finland, and Norway, and from 1952 onwards for Sweden. Data were available 
until 1997 for France and until 1998 for Denmark and England and Wales.  
 
For the causes of death we selected ischaemic heart diseases (ICD-9 410-414), 
cerebrovascular diseases (ICD-9 430-434, 436-438), stomach cancer (ICD-9 151), prostate 
cancer (ICD-9 185), breast cancer (ICD-9 174-175), lung cancer (ICD-9 162), and chronic 
obstructive pulmonary diseases (ICD-9 490-494, 496). These are all causes of death 
frequently occurring among the elderly.  
 
When analyzing long-term mortality trends in causes of death, coding changes, like the 
numerous revisions of the International Classification of Diseases (ICD), have to be taken 
into account. In our analysis of cause-specific mortality trends over the period 1950 to 
1999, we had to bridge five different ICD revisions (ICD-6 to ICD-10). For this purpose, we 
constructed a general concordance table, i.e. a table linking the codes for specific causes of 
death through each successive ICD revision, based on three-digit ICD codes (see Janssen & 
Kunst, 2004)[28]. In addition, we identified and adjusted for other mortality discontinuities, 
such as those caused by our reliance on three-digit ICD codes instead of four-digit ICD 
codes and by incidental changes in coding rules unrelated to new ICD revisions. This 
adjustment involved multiplying cause-specific death numbers with cause-specific transition 
coefficients. These transition coefficients were obtained through cause-specific regression 
models. In these models, cause-specific mortality was the dependent variable and age, 
year of death, and variables associated with a transition, i.e. a coding change, were 
independent variables (see Janssen & Kunst, 2004 for a full description)[28]. For the 
current analyses, we used the transition coefficients from cause-specific regression models 
applied to mortality among those aged 60 and over.  
 
In accordance with the life-course perspective, we distinguished twelve five-year cohort 
groups, born between 1865-69 and 1920-24. The all-cause mortality data have carefully 
been reconstructed into mortality rates by single year of age and single year of birth based 
on the available all-cause death counts by Lexis triangle, and the population data at 
January 1. To convert the cause-specific mortality data into cohort data, the country-
specific and sex specific cohort weights from all-cause mortality were used. 
 
For each country, for the period 1865 to 1999, trends in national real Gross Domestic 
Product per capita at constant 1995 prices in millions of national currency were 
reconstructed from historical national accounts data [29-31]. See Appendix I for our 
reconstruction method. Subsequently, these national GDP values were transformed into 
internationally comparable values using the purchasing power parities (PPP) of 1995, which 
take into account international differences in currencies and price levels, and are expressed 
in US Dollars.  
 
Methods 
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Cohort- and country-specific levels of old-age mortality were estimated indirectly through 
sex-specific Poisson regression models. In these models, we included the number of deaths 
as dependent variable, and single year of age (categorical variable) and the interaction 
between country and five-year cohort group (discrete variable) as independent variables. 
The offset variable was the number of persons at risk. The parameter estimates for the 
interaction term were converted into relative mortality risks by taking exponents. The 
baseline cohort group was 1890-94, which is one of the cohorts for which information is 
available over the entire age range from 65 to 99 years during 1950-1999. The baseline 
country was England and Wales, i.e. one of the largest populations.  
 
Through Poisson regression modelling, we determined, for each country separately, 
associations across birth cohorts between old-age mortality and GDP levels prevailing at 
time of death, during infancy and early childhood (0-5), at school ages and during 
adolescence (6-19), at main working ages (20-49), and at retirement ages (50-64). In the 
regression models, we included the number of deaths as dependent variable, and single 
year of age (categorical variable) and the GDP variables, separately, as independent 
variables. The offset variable was the number of persons at risk. All GDP variables were 
logarithmically transformed, throughout the analyses, in order to look at relative change. 
 
To assess the strength and the direction of the effect of GDP at time of death on old-age 
mortality, we measured the income elasticity of cohort mortality. Income elasticity denotes 
the percentage mortality increase per percentage increase in GDP (on a logarithmic scale). 
It was calculated by transforming the parameter estimates of the GDP variable in the 
regression model by 100 * [exp(parameter estimate)-1].  
 
To assess and compare the strength of the association between GDP at different ages and 
old-age mortality, we measured the reduction in scaled deviances (a measure of 
unexplained variance) when, in separate models, the different GDP variables are added to 
the regression model including only age. The higher the reduction in scaled deviances, the 
better the fit of the model has improved. The independent effect of GDP prevailing at 
earlier ages of the cohort on old-age mortality was assessed by comparing the reduction in 
scaled deviances of the regression model including GDP at time of death with the reduction 
in scaled deviances of the model including as well GDP at an earlier age of the cohort. To 
enable comparison, these reductions in scaled deviances were expressed as percentages of 
the reduction observed for a full age-period-cohort model. The statistical significance of the 
difference in scaled deviances between the different models was assessed by a log-
likelihood ratio test.  
 
All analyses were stratified by sex and by county. For the regression analyses we used SAS 
package 8.0.  
 
RESULTS 
 
For men and women alike, cohort- and country-specific mortality levels among those aged 
65-99 in 1950-1999 generally declined over the successive five-year birth cohorts. 
However, for Danish, Dutch and Norwegian men born between 1890 and 1909, and for 
Danish and English & Welsh women born between 1910 and 1924, mortality was higher 
than mortality in surrounding cohorts. (Figure 1) 
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Figure 1. Cohort- and country-specific mortality levels for those aged 65-99, by sex 
 
DK = Denmark; UK = England and Wales; FIN = Finland; FR = France; NL = the Netherlands; NO = 
Norway; S = Sweden. 
 
GDP per capita increased approximately exponentially from 1865 to 1999, with a stronger 
increase after the Second World War. In the earlier decades, levels of GDP fluctuated and 
were very different between the countries. In later years, most countries occasionally 
experienced a temporal stagnation in the increase of GDP, but the general pattern was a 
fairly smooth increase with a gradual convergence of GDP levels between countries. (Figure 
2) 
 
For all-cause mortality among men, mortality decreased by 5 to 36 per cent per percentage 
increase in GDP at time of death (Table 1). Highest negative income elasticity was 
observed for England and Wales, France and Finland, whereas among Dutch, Norwegian, 
and Danish men, the income elasticity was only modest.  
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Figure 2. Time trends of real Gross Domestic Product per capita at 1995 US Dollars (PPP adjusted), 
1865-1999, by country 
 
DK = Denmark; FIN = Finland; FR = France; NL = the Netherlands; NO = Norway; S = Sweden; UK = 
United Kingdom. 
 
For women, the decrease in old-age mortality accompanying an increase in national income 
at time of death was approximately similar for the different countries, with an average of 
44 per cent. 
 
The effect of GDP at time of death on old-age mortality can be determined by means of the 
reduction in scaled deviances presented in Figure 3. For all-cause mortality, adding GDP at 
time of death as an explanatory variable in the regression model including only age led to a 
statistically significant but modest reduction in scaled deviances among Dutch, Norwegian 
and Danish men (9%, 19%, and 31%, respectively), indicating a modest improvement of 
the fit of the model. 
 
Table 1. Income elasticitya of GDPb at time of death on all-cause mortality for those aged 65-99, by 
country and sex 
 
Country Income elasticity of GDP at time of death 
 Men CI Women CI 
Denmark -8.8 (-9.4;-8.1) -42.4 (-42.8;-42.0) 
England and Wales -35.8 (-36.0;-35.7) -43.9 (-44.1;-43.8) 
Finland -29.7 (-30.2;-29.2) -47.0 (-47.4;-46.7) 
France -32.9 (-33.0;-32.8) -45.3 (-45.4;-45.2) 
Netherlands -4.9 (-5.4;-4.5) -45.2 (-45.4;-44.9) 
Norway -5.3 (-5.9;-4.7) -31.0 (-31.4;-30.6) 
Sweden -23.6 (-24.0;-23.1) -51.7 (-52.0;-51.4) 
a Income elasticity is measured by 100*(exp(parameter estimate)-1), and denotes the percentage 
mortality increase per percentage increase in national income (LN(GDP/c)). 
b With log transformation of the GDP variable. 
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Figure 3. Comparison of the association of GDPa measured at different ages of subsequent cohorts 
born between 1865 and 1924 with all-cause mortality among those aged 65-99, by country and sex 
 
a With log transformation of the GDP variables. 
Reduction in scaled deviance (a measure of unexplained variance) compared to the model with age 
only. This reduction is expressed as percentage of the total reduction in scaled deviances between the 
model with age only and the model with age, period, and cohort terms. The higher the reduction in 
scaled deviances, the better the fit of the model has improved on including an additional variable. All 
reductions in scaled deviances are statistically significant (p = 0.05). 
DK = Denmark; E&W = England and Wales; FIN = Finland; FR = France; NL = the Netherlands; NO = 
Norway; S = Sweden; Current GDP = GDP at time of death. 
 
Among men in England and Wales, Finland, and France, the reduction in scaled deviances 
was around 80 per cent. Among women in all countries, this reduction was even higher. 
Women
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
DK E&W FI FR NL NO S
R
ed
uc
tio
n 
in
 s
ca
le
d 
de
vi
an
ce
s 
(%
) b
GDP0-5
GDP6-19
GDP20-49
GDP50-64
Current GDP
 Men
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
DK E&W FI FR NL NO S
R
ed
uc
tio
n 
in
 s
ca
le
d 
de
vi
an
ce
s 
(%
) b
GDP0-5
GDP6-19
GDP20-49
GDP50-64
Current GDP
CHAPTER 7 
 108 
Regression models that included GDP levels prevailing at earlier ages of the cohorts, 
instead of GDP at time of death, produced larger reductions in scaled deviances. Only 
among Danish and Dutch women, GDP at time of death explained more of the mortality 
variation than GDP at earlier ages (Figure 3).  
 
When variables indicating GDP levels prevailing at different earlier ages of the cohorts are 
added to the model including age and GDP at time of death, the reductions in scaled 
deviances increased significantly (p = 0.05), indicating a significant improvement of the fit 
of the model (Table 2). Thus GDP levels prevailing at earlier ages of the subsequent 
cohorts were related to old-age mortality independently of GDP levels at time of death. 
This independent association is observed for men and women in all countries. 
 
Table 2. Comparison of the independent association of GDPa measured at different ages of 
subsequent cohorts born between 1865 and 1924 with all-cause mortality among those aged 65-99, by 
country and sex 
 
Model: Age and …  Reduction in scaled deviances (%)b 
 DK E&W FIN FR NL NO S
MEN  
  
Current GDP 31(–) 83(–) 81(–) 78(–) 9(–) 19(–) 65(–)
  
Current GDP and GDP at ages 0-5 35(–) 84(+) 82(–) 79(–) 66(–) 33(–) 81(–)
Current GDP and GDP at ages 6-19 60(–) 90(+) 93(–) 96(–) 16(–) 34(–) 94(–)
Current GDP and GDP at ages 20-49 49(–) 95(–) 95(–) 97(–) 40(–) 32(–) 96(–)
Current GDP and GDP at ages 50-64 33(–) 95(–) 95(–) 95(–) 12(–) 40(–) 87(–)
  
Current GDP and cohort GDP 72(–) 97(–) 96(–) 99(–) 67(–) 44(–) 98(–)
  
WOMEN  
  
Current GDP 95(–) 97(–) 91(–) 88(–) 92(–) 93(–) 93(–)
  
Current GDP and GDP at ages 0-5 95(–) 97(–) 91(–) 88(–) 92(–) 96(–) 96(–)
Current GDP and GDP at ages 6-19 95(–) 97(+) 93(–) 94(–) 94(–) 96(–) 96(–)
Current GDP and GDP at ages 20-49 95(+) 97(–) 96(–) 98(–) 94(–) 95(–) 97(–)
Current GDP and GDP at ages 50-64 95(–) 98(–) 95(–) 99(–) 95(–) 95(–) 97(–)
  
Current GDP and cohort GDP  97(–) 99(–) 96(–) 99(–) 95(–) 98(–) 98(–)
a With log transformation of the GDP variables. 
b Reduction in scaled deviance (a measure of unexplained variance) for the stepwise inclusion of GDP 
at time of death, GDP at ages 0-5, 6-19, 20-49, and 50-64 in the model, compared to the model with 
age only. This reduction is expressed as percentage of the total reduction in scaled deviances between 
the model with age only and the model with age, period, and cohort terms. The higher the reduction 
in scaled deviances, the better the fit of the model has improved on including an additional variable. All 
reductions in scaled deviances are statistically significant (p = 0.05). 
( ) = either positive (+) or negative (-) independent association of GDP prevailing at the specific ages 
(i.e. positive or negative income elasticity, respectively). 
Underlined = highest reduction in scaled deviances for GDP prevailing at the specific ages in 
comparison to GDP prevailing at different ages of the cohorts. 
DK = Denmark; E&W = England and Wales; FIN = Finland; FR = France; NL = the Netherlands; NO = 
Norway; S = Sweden. Current GDP = GDP at time of death. Cohort GDP = GDP0005 GDP0619 
GDP2049 GDP5064. 
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The extent to which GDP in earlier life explains time trends in old-age mortality can be 
assessed by comparison of the reduction in scaled deviances for the model including age 
and GDP at time of death (first rows of Table 2) with the reduction in scaled deviances for 
the model including GDP at earlier ages of the cohort as well (last rows of Table 2). 
According to Table 2, earlier-life GDP explained a substantial part of the time trends among 
Dutch men (change in reduction in scaled deviances from 9% to 67%), and also among 
Danish, Swedish and Norwegian men. The percentage explained is somewhat less among 
men in the other countries, and limited among women in all countries.  
 
Turning to the causes of death, significant independent effects of GDP levels prevailing at 
earlier ages of the cohort were observed for all causes of death, except in a number of 
countries for prostate cancer and breast cancer (Table 3)(See Appendix II for more 
details).  
 
Table 3. The age groups of the subsequent cohorts born between 1865 and 1924 for which GDP 
showed the largest associations with mortality for those aged 65-99, by cause of death, sex and 
country 
 
Cause of death The age groups for which GDP showed the largest reduction in scaled 
deviances when added to the model including age and GDP at time of death 
 DK E&W FIN FR NL NO S 
MEN  
  
All-cause mortality 6–19(–) 20–64(–) 20–64(–) 20–49(–) 0–5(–) 50–64(–) 20–49(–) 
  
Ischaemic heart diseases 20–49(–) 20–64(–) 6–19(–) 20–64(–) 20–49(–) 6–19(–) 20–49(–) 
Cerebrovascular diseases 6–19(–) 20–49(–) 20–49(–) 50–64(–) 20–49(–) 6–19(–) 0–64(–) 
Stomach cancer 6–64(–) 20–49(–) 20–64(–) 50–64(–) 20–49(–) 6–19(–) 20–64(–) 
Prostate cancer 0–19(+) 50–64(+) NS 50–64(–) NS 0–19(–) 6–49(+) 
Lung cancer 20–49(–) 20–49(–) 20–49(–) 6–64(–) 0–5(–)
20–49(–)
50–64(–) 20–49(–) 
COPD 6–49(–) 20–49(–) 20–49(–) 6–19(–)
50–64(–)
0–5(–) 50–64(–) 20–49(–) 
  
WOMEN  
  
All-cause mortality 0–64(–) 50–64(–) 20–49(–) 50–64(–) 50–64(–) 0–19(–) 20–64(–) 
  
Ischaemic heart diseases 50–64(–) 50–64(–) 6–19(–) 50–64(+) 20–49(–) 6–19(–) 20–64(–) 
Cerebrovascular diseases 50–64(–) 20–49(–) 20–49(–) 50–64(–) 50–64(–) 6–19(–) 0–64(–) 
Stomach cancer 0–49(–) 20–49(–) 20–64(–) 50–64(–) 50–64(–) 0–64(–) 0–5(–) 
20–64(–) 
Breast cancer 20–49(+) 0–5(+) 20–64(+) 50–64(+) 0–5(+) NS 20–64(–) 
Lung cancer 20–49(+) 0–19(+)
50–64(+)
6–19(+) 20–49(+) 20–49(+) 6–19(+)
50–64(+)
6–19(+) 
COPD 20–49(+) 20–49(–) 0–5(–) 0–5(–) 20–49(+) 6–19(+) 20–49(+) 
( ) = either positive (+) or negative (-) independent association of GDP prevailing at the specific ages 
(i.e. positive or negative income elasticity, respectively). 
NS = Non-significant (p = 0.05) reduction in scaled deviances when the GDP variables at different 
ages are included in the regression model with age and GDP at time of death as independent 
variables. 
DK = Denmark; E&W = England and Wales; FIN = Finland; FR = France; NL = the Netherlands; NO = 
Norway; S = Sweden; COPD = chronic obstructive pulmonary diseases. 
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Among men, the largest reduction in scaled deviances – after control for GDP at time of 
death - is observed for GDP prevailing at ages 20-49, both for all-cause mortality, and for 
the majority of causes of death. However, larger reductions in scaled deviances were 
observed for GDP prevailing at ages 6-19 and 50-64 in Norway, GDP prevailing at ages 50-
64 in France, and GDP prevailing at ages 6-19 in Denmark. For prostate cancer, the 
reductions in scaled deviances were highest for GDP prevailing at ages 6-19. Among 
women, the largest reduction in scaled deviances is observed for GDP prevailing at ages 
50-64, both for all-cause mortality, and for the majority of causes of death. GDP prevailing 
at ages 20-49 seems equally important as GDP at ages 50-64 for stomach cancer and 
breast cancer, and more important for chronic obstructive pulmonary diseases (COPD). For 
lung cancer, the reductions in scaled deviances were highest for GDP prevailing at ages 6-
19. For Norway, GDP prevailing at ages 6-19 showed the largest reduction in scaled 
deviances. The above-mentioned associations were mainly negative, except for prostate 
cancer, breast cancer, and lung cancer and COPD among women.  
 
DISCUSSION 
 
In this paper, we assessed whether old-age mortality levels for subsequent cohorts are 
associated differentially with GDP levels prevailing at different ages of the cohorts. We did 
so separately for seven low-mortality European countries, for men and women, and for all-
cause mortality and seven specific causes of death.  
 
For the subsequent cohorts, levels of GDP at time of death were strongly and inversely 
associated with all-cause mortality, especially among women, and among men in England 
and Wales, Finland, and France. In most countries, stronger associations were observed 
with GDP levels prevailing at earlier ages of the cohorts. These associations remained after 
control for GDP at time of death. An independent association of GDP at earlier ages of the 
cohort was also observed for specific causes of death. The associations were negative for 
ischaemic heart diseases, cerebrovascular diseases, stomach cancer, and positive for 
prostate cancer, breast cancer, COPD (women), and lung cancer (women). Of all ages, 
GDP prevailing at ages 20-49 (men) and ages 50-64 (women) were most strongly related 
to cohort differences in old-age mortality. 
 
These results are in agreement with one of the key paradigms in public health, which 
states that economic progress is of fundamental importance to the improvement of 
population health (e.g. [4]), and with recent epidemiological individual-level studies that 
observed relations between socio-economic conditions in early life and (cause-specific) 
mortality in later life (e.g. [21,24-26])(see Galobardes et al., 2004 for a review)[27].  
 
Evaluation of data and methods 
 
The mortality and population data used in this study are obtained from countries 
considered having good or excellent population registries and vital registries [32]. In these 
countries, reported survivorship counts are highly accurate [32,33]. Moreover, all-cause 
mortality data and population data stem from the Human Mortality Database, in which the 
data has been corrected for errors (http://www.mortality.org/).  
 
On the basis of historical national accounts data from different sources, we constructed 
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time series of GDP for seven countries covering the period 1865 to 1999 [29-31] (see 
Appendix I). In general, the measurement of GDP levels and trends is probably less 
accurate for the 19th century than for the 20th century [29]. If so, this may have 
contributed to our finding that mortality levels were less strongly related to the older 
measures of GDP related to early ages of our birth cohorts, as compared to the more 
recent measures of GDP related to adulthood and middle age. 
 
In our analyses, we assumed that the socio-economic conditions prevailing at specific ages 
of the cohorts, and thus during a certain time period, could be measured by the national 
level of GDP prevailing during that period in time. However, this assumption may not fully 
apply. The alternative approach would be to use measures that are more applicable to 
specific age groups. For example, the infant mortality rate (IMR) might be used as a proxy 
of the living conditions at the time of birth of a cohort [18,23]. In additional analyses, the 
use of the IMR (data obtained from Mitchell (1992) and Turpeinen (1979))[29,34] yielded 
about the same results as we obtained with the use of GDP at the time of birth (Table 4). 
Similarly, specific indicators might need to be used to measure the material living 
conditions as experienced by a birth cohort during their old age, such as the level of old 
benefits and pensions. Unfortunately, in most countries, data on pensions or old-age 
benefits were not available in a comparable way for a prolonged period on a yearly basis 
[35-37]. If such data had been available, they might have shown an even higher predictive 
power of economic measures related to later life or time of death, as compared to 
measures related to infancy or childhood and adolescence.  
 
Our analyses focused on associations across birth cohorts between their level of old-age 
mortality and the national level of GDP prevailing at different ages of these cohorts. 
Another approach would have been to analyse associations across countries instead of 
across birth cohorts. Additional cross-country analyses for all-cause mortality resulted in 
mainly negative associations with GDP at time of death, but mainly positive associations 
with GDP at earlier ages of the cohorts (results not shown). These counterintuitive results 
might be due to the small number of observations in these cross-country analyses, 
combined with the large potential for confounding in cross-national comparisons.  
 
 
Table 4. Correlations of GDP and infant mortality (IMR) prevailing at birtha for subsequent cohorts 
born between 1865 and 1924 with all-cause mortality among those aged 65-99, by country and sex 
 
  DK E&W FIN FR NL NO S 
   
MEN   
   
GDP at birth -0.84 -0.90 -0.94 -0.90 -0.92 -0.85 -0.96 
IMR at birth 0.62 0.89 0.93 0.94 0.73 0.88 0.98 
   
WOMEN   
   
GDP at birth -0.96 -0.94 -0.96 -0.91 -0.90 -0.99 -0.99 
IMR at birth 0.74 0.78 0.91 0.94 0.95 0.96 0.99 
a With log transformation of the values. 
All correlations are significant at the 0.05 level (2-tailed). 
DK = Denmark; E&W = England and Wales; FIN = Finland; FR = France; NL = the Netherlands; NO = 
Norway; S = Sweden. 
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For international comparative research, more countries need to be included to obtain valid 
results. We furthermore recommend that in such cross-country analyses separate cohorts 
are distinguished in order to study changes over time in the influence of early life social 
circumstance on late life mortality [38,39]. 
 
Another complementary approach would have been to focus on the long-lasting effects of 
exceptional economic circumstances earlier in life, e.g. by focusing on old-age mortality of 
generations having experienced World War I and/or the Spanish influenza epidemic in their 
earlier years. Due to our focus on the effect of GDP at different age groups of the cohorts, 
the deviating patterns for GDP during World War I and/or the Spanish influenza epidemic 
are only clearly visible for GDP at the youngest ages. With respect to the cohort trends for 
GDP at later and larger age groups, this peak is dispersed over many cohorts. Scatter plots 
of cohort trends in GDP at age 0-5 and the mortality progress over the successive cohorts 
suggested that the deviating patterns for the cohort groups 1910-14 and 1915-19 were not 
reflected in irregularities in trends in all-cause mortality at old age (see Appendix III). It 
can be concluded that this approach does not generate compelling evidence for an effect of 
socio-economic circumstances at the youngest ages on mortality up to old ages, either.  
 
Cohort trends in all-cause mortality among women were approximately linear over time. 
Similarly, cohort trends in mortality from cerebrovascular diseases and stomach cancer did 
not show strong irregularities [40]. In these cases, associations with factors that gradually 
change over time, such as the logarithmically transformed GDP, are likely to be strong (see 
also Appendix II). These strong associations therefore cannot be taken as hard evidence 
for a causal association. A harder test for the existence of a causal association could be 
provided by the study of correlates of stronger irregularities in all-cause mortality trends 
among men and in mortality trends from lung cancer, ischaemic heart diseases and chronic 
obstructive pulmonary diseases. The evidence from these cases suggested that the 
association between GDP at different ages and old-age mortality was moderate but clearly 
present (see Table 3 and Appendix II). Therefore we believe that the observed associations 
may be indicative of true causal associations.  
 
Explanations of the observed results in light of the current literature 
 
The observed negative associations between GDP at time of death and old-age mortality 
among different cohorts seem to contradict the weak relationship between GDP and 
mortality that was observed in international studies that compared developed countries at a 
single point of time (e.g. [11,41,42]) For example, comparisons between rich OECD 
countries with respect to GDP and life expectancy typically find correlations lower than 
+0.20 [11]. This lack of association is probably explained by the strong potential for 
confounding in comparisons between countries, related to international differences in 
idiosyncratic determinants such as diet and the progression of the smoking epidemic. 
Studies that circumvent this problem by comparing regions within specific countries, both 
in Europe and in Northern America, generally observed a strong association between socio-
economic levels and male and female life expectancies [42,43]. 
 
The relatively weak associations between GDP at time of death and all-cause mortality 
among Danish, Dutch, and Norwegian men could possibly be explained by the particular 
way in which the smoking epidemic has evolved among men in these countries. Our cause-
specific analyses revealed exceptionally strong positive (instead of negative) associations 
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between GDP at time of death and mortality from chronic obstructive pulmonary diseases 
and lung cancer, i.e. causes of death strongly related to smoking (see Appendix II). 
Furthermore, in additional analyses that excluded all causes of death strongly related to 
smoking (i.e. lung cancer, cancer of the oesophagus, upper respiratory tract, pancreas, 
bladder, and kidney, and chronic obstructive pulmonary diseases) the effect of GDP at time 
of death on old-age mortality among men was found to be more similar for the different 
countries (Table 5). Thus, smoking seems to explain the differences between countries in 
the extent to which GDP at time of death is related to old-age mortality among men. 
Similarly, differences between male and female birth cohorts in their life-time exposure to 
smoking can explain the large differences between men and women in the extent to which 
their mortality trends are related to current levels of GDP. 
 
Table 5. Comparison of the independent association of GDPa measured at different ages of the 
subsequent cohorts born between 1865 and 1924 with mortality from all-cause mortality after 
excluding mortality from strongly smoking-related diseasesb among those aged 65-99, by country and 
sex 
 
Model: Age and …  Reduction in scaled deviances (%)c 
 DK E&W FIN FR NL NO S
MEN  
  
Current GDP 83 91 88 83 74 51 77
  
Current GDP and GDP at ages 0-5 87 91 89 84 86 65 88
Current GDP and GDP at ages 6-19 94 93 95 96 78 66 97
Current GDP and GDP at ages 20-49 92 96 97 98 85 64 97
Current GDP and GDP at ages 50-64 87 96 96 97 78 69 92
  
Current GDP and cohort GDP 94 97 97 100 88 71 99
  
WOMEN  
  
Current GDP 96 96 91 88 91 92 92
  
Current GDP and GDP at ages 0-5 97 96 91 88 91 95 95
Current GDP and GDP at ages 6-19 96 97 93 94 94 96 96
Current GDP and GDP at ages 20-49 96 98 96 98 94 94 96
Current GDP and GDP at ages 50-64 97 98 95 99 96 95 96
  
Current GDP and cohort GDP  98 99 96 99 96 98 97
a With log transformation of the GDP variables. 
b Strongly smoking-related diseases include chronic obstructive pulmonary diseases and cancer of the 
lung, esophagus, upper respiratory tract, pancreas, bladder, and kidney.  
c Reduction in scaled deviance (a measure of unexplained variance) for the stepwise inclusion of GDP 
at time of death, GDP at ages 0-5, 6-19, 20-49, and 50-64 in the model, compared to the model with 
age only. This reduction is expressed as percentage of the total reduction in scaled deviances between 
the model with age only and the model with age, period, and cohort terms. The higher the reduction 
in scaled deviances, the better the fit of the model has improved on including an additional variable. All 
reductions in scaled deviances are statistically significant (p = 0.05). 
Underlined = highest reduction in scaled deviances for GDP prevailing at the specific ages in 
comparison to GDP prevailing at different ages of the cohorts. 
DK = Denmark; E&W = England and Wales; FIN = Finland; FR = France; NL = the Netherlands; NO = 
Norway; S = Sweden. Current GDP = GDP at time of death. Cohort GDP = GDP0005 GDP0619 
GDP2049 GDP5064. 
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Our analyses suggest an independent effect of GDP prevailing at earlier ages of subsequent 
cohorts on all-cause old-age mortality. Previous studies on the link between economic 
circumstances in early life and all-cause mortality focused mainly on the effects that 
dramatic economic events, like war and influenza, occurring at very young ages could have 
on mortality later in life [44-48]. Some studies did observe effects on subsequent mortality, 
but these effects did not always persist with increasing age [47,48]. In our study, an 
association between GDP prevailing at ages 0-5 and old-age mortality was observed in the 
Netherlands. The same result was found in an earlier study on the effects of macro-
economic conditions at ages 1-7 on the individual all-cause mortality rate at ages above 50 
among Dutch cohorts born between 1817 and 1907 [49]. However, our cause-specific 
analyses suggested no association between GDP at very early ages and old-age mortality 
from stomach cancer and cerebrovascular diseases, i.e. causes of death that have been 
found to be related to early life circumstances [21,23]. Also, when looking at the results for 
the other six European countries studied, we found only modest associations between GDP 
prevailing at ages 0-5 and old-age mortality. In general, cohort differences in old-age 
mortality seemed more strongly related to GDP prevailing at ages 20-49 (men) and ages 
50-64 (women). Thus, although some effects of socio-economic circumstances in very early 
life on old-age mortality were observed, our results suggest a more important role of socio-
economic circumstances in adulthood and middle age in determining mortality up to high 
ages. 
 
The fact that socio-economic circumstances in very early life are not clearly related to old-
age mortality, while they have been reported to be related to middle age mortality, could 
possibly be explained by mortality selection. When mortality at middle ages is high, it tends 
to affect the frail individuals first, leaving a more selected and more robust population that 
survive up to old ages [50]. Due to this selection mechanism, adverse socio-economic 
circumstances in very early life might still have an effect on middle-age mortality, but this 
effect may no longer be visible in old-age mortality, where only a selected and robust part 
of the cohort have survived. However, there is little evidence to support a selection 
mechanism. If such a selection effect would operate, one would expect relatively higher 
levels of mortality at middle age to be followed by relatively low mortality at older ages. 
However, in a previous study on the same countries, we observed positive (instead of 
inverse) associations between trends in late middle-age mortality and trends in old-age 
mortality [51]. Thus, mortality selection effects, if any, probably do not have strong effects 
on trends in old age mortality [51]. 
 
When causes of death were distinguished, the direction of the effect was found to greatly 
vary. Independent negative associations of GDP prevailing at earlier ages on old-age 
mortality were found for ischaemic heart diseases, cerebrovascular diseases, stomach 
cancer, and lung cancer (men), whereas independent positive associations were found for 
prostate cancer, breast cancer, COPD (women), and lung cancer (women). These results 
are in line with previous studies on the direction of the associations observed for adult 
mortality and on the role of cause-specific risk factors. Higher adult mortality from 
ischaemic heart diseases, cerebrovascular diseases and stomach cancer has been related to 
adverse socio-economic circumstances [27]. Mortality from breast cancer and prostate 
cancer is known for its inverse associations with deprivation [52], and their positive socio-
economic gradients [53]. Lung cancer mortality among women also has been found to 
negatively correlate with deprivation [52]. The seemingly unfavourable effects of economic 
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growth on old-age mortality from COPD and lung cancer among elderly women could 
probably be linked to a high recent uptake of smoking and other unfavourable lifestyles 
among adolescent and adult women in prosperous countries [52].  
 
Conclusion / Implications 
 
Recent insights from life-course epidemiology stress the effects that experiences in early 
life may have on health and mortality in later life. Effects of mortality in early life on 
national mortality trends at later ages have been suggested by for example age-period-
cohort studies. This paper adds evidence on the specific role of socio-economic conditions 
in earlier phases of life on old-age mortality of subsequent cohorts. An independent, mostly 
negative effect of GDP prevailing at earlier ages of subsequent cohorts on old-age mortality 
was observed. The most relevant ages of exposure seem to be adulthood and middle age, 
rather than infancy or childhood. Further studies should aim to identify the specific 
mechanisms that are involved, including the development of health-related behaviour in 
early adulthood and the role of accumulation of wealth and other resources during late 
adulthood. 
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Appendix I. Reconstruction of trends in real national GDP per capita, 1865-1999 
 
For each country, for the period 1865 to 1999, trends in national real Gross Domestic Product per 
capita at constant 1995 prices in millions of national currency were reconstructed from historical 
national accounts data [29-31]. For the period 1865 to 1970, the historical national accounts data by 
Mitchell were used [29]. For the Netherlands, these historical data were available only from 1900 
onwards, and in addition, we used national accounts data from Statistics Netherlands (see [31]). Data 
from 1970 onwards were obtained from the "National Accounts of OECD Countries Database" [30]. To 
obtain estimates on GDP per capita (GDP/c), the GDP data were divided by the population estimates 
given by Mitchell (up to 1970) and by the OECD Database (from 1970 onwards). In the remainder of 
the text, GDP refers to GDP per capita at constant 1995 prices in millions of national currency. 
 
The reconstruction of the trends in national GDP entailed a number of problems. Changes over time 
occurred in both the national accounts data, for example due to changes in concepts, different pricing 
level years or different sources used, and in the population estimates. All countries experienced 
changes in the national accounts data, ranging from one change in Finland to seven changes in 
Norway. Changes in the population estimates data applied to France, Denmark, and the United 
Kingdom. In addition, for all countries, the data for 1970 by Mitchell had to be recalculated into the 
OECD data for 1970. We tackled these problems by reconstructing the different data into the most 
recent situation. In the majority of the cases, double counts were available for the year in which the 
change occurred, which simplified our reconstruction. In these cases, we calculated ratios, i.e. GDP 
after the change divided by GDP preceding the change, and we applied these ratios to the GDP data 
preceding the change.  When double counts were not available for the year in which the change 
occurred, we first estimated the double count by linearly extrapolating the data for the preceding five 
years, and then followed the same procedure as laid out before.  
 
An additional problem entailed the missing national accounts data during the First and Second World 
War, and shortly after the war period. This applied to France (1914-1919 and 1939-1948), to the 
Netherlands (1940-1947), and to Norway (1940-1945). First, we estimated the GDP data for the years 
shortly after the war period (France 1918-19 and 1945-48, the Netherlands 1945-47, and Norway 
1945) by linearly backward extrapolating the GDP values for the subsequent five years, for each year 
separately. For the war years we assumed that GDP in these years was equal to either the first year 
before the war or the first year after the war, depending on what year showed the lowest value of 
GDP. For France and Norway during the Second World War the reconstruction of the trend was further 
complicated by an additional change in concepts during that period which made the data before the 
War incomparable with the data after the War. In these two cases we assumed that the GDP values 
during the World War and for the first year after the World War were equal to the GDP value in the 
first year before the World War.  
 
For the United Kingdom, historical data on national accounts were available only for the country as a 
whole. Assuming that the time trends in GDP/c in the United Kingdom were broadly similar to those for 
England and Wales, we included the GDP/c trend data for the United Kingdom as a proxy for the 
GDP/c trend data for England and Wales. 
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Appendix II. Comparison of the independent association of GDPa measured at different ages of the 
subsequent cohorts born between 1865 and 1924 with mortality from specific causes of death among 
those aged 65-99, by country and sex 
 
Model: Age and …  Reduction in scaled deviances (%)b 
 Men Women 
 DK E&W FIN FR NL NO S DK E&W FIN FR NL NO S 
Ischaemic heart diseases             
GDPcurrent 0 10 3 31 2 4 2 29 59 10 17 44 31 47 
GDPcurrent GDP0005  66 17 4 34 48 25 66 85 59 10 17 57 47 90 
GDPcurrent GDP0619 83 20 71 77 37 32 82 80 60 60 59 74 52 91 
GDPcurrent GDP2049 85 46 64 85 67 25 88 84 69 46 66 84 44 96 
GDPcurrent GDP5064 76 46 56 85 43 31 79 92 73 40 73 80 47 96 
GDPcurrent GDPcohort 95 56 80 89 69 33 89 98 77 67 76 87 58 97 
Cerebrovascular diseases             
GDPcurrent 95 88 87 67 88 84 96 94 87 89 65 90 87 89 
GDPcurrent GDP0005  96 89 88 69 91 90 97 94 87 90 67 91 93 89 
GDPcurrent GDP0619 97 92 91 85 94 91 97 94 91 91 78 95 94 89 
GDPcurrent GDP2049 96 98 96 97 97 88 97 94 98 95 93 96 91 89 
GDPcurrent GDP5064 96 96 95 99 95 90 97 95 93 94 97 97 93 89 
GDPcurrent GDPcohort 97 99 96 100 97 94 97 96 99 96 98 97 97 89 
Stomach cancer               
GDPcurrent 91 87 92 87 91 97 90 94 95 93 88 93 99 93 
GDPcurrent GDP0005  97 88 93 87 93 98 98 99 (95) 94 88 93 99 99 
GDPcurrent GDP0619 98 93 95 93 97 99 98 99 97 95 91 97 99 98 
GDPcurrent GDP2049 98 99 98 97 98 98 99 99 99 98 96 98 99 99 
GDPcurrent GDP5064 98 94 98 98 98 98 99 98 98 98 99 99 99 99 
GDPcurrent GDPcohort 99 99 99 99 99 99 99 99 99 98 99 99 99 99 
Prostate cancer (men) / breast cancer (women)          
GDPcurrent 52 69 73 55 81 83 86 0* 79 83 88 49 76 11 
GDPcurrent GDP0005  81 (69) (74) (55) (81) 85 (86) 17 81 (83) 89 55 (78) 60 
GDPcurrent GDP0619 81 69 (73) 61 (81) 85 87 26 (79) 86 89 (49) (79) 59 
GDPcurrent GDP2049 80 70 (74) 62 (81) 84 87 56 (79) 88 91 (49) (78) 65 
GDPcurrent GDP5064 78 74 (74) 65 (81) 84 (86) 40 80 88 92 54 (79) 65 
GDPcurrent GDPcohort 88 75 82 67 (81) 89 90 67 86 91 93 78 (80) 68 
Lung cancer               
GDPcurrent 88 27 22 92 76 92 70 88 98 79 82 76 92 84 
GDPcurrent GDP0005  88 37 23 92 93 96 78 90 99 (79) 85 92 97 84 
GDPcurrent GDP0619 92 57 62 96 84 96 83 94 99 93 88 86 98 91 
GDPcurrent GDP2049 94 92 67 96 93 95 87 97 (98) 92 89 98 97 89 
GDPcurrent GDP5064 92 66 65 96 83 97 86 95 99 91 85 89 98 85 
GDPcurrent GDPcohort 99 94 79 97 96 98 90 98 99 94 92 98 98 95 
Chronic obstructive pulmonary diseases            
GDPcurrent 92 49 2 9 81 90 85 70 33 4 4 2 35 54 
GDPcurrent GDP0005  92 50 5 (9) 89 90 87 71 39 12 14 32 79 57 
GDPcurrent GDP0619 95 75 30 45 82 90 90 77 59 8 4 35 89 65 
GDPcurrent GDP2049 95 88 63 40 85 90 91 86 82 6 10 56 81 66 
GDPcurrent GDP5064 93 76 62 45 81 91 89 82 60 7 5 38 87 61 
GDPcurrent GDPcohort 96 89 69 50 92 94 93 95 83 37 19 57 91 73 
a With log transformation of the GDP variables. 
b Reduction in scaled deviance (a measure of unexplained variance) for the stepwise inclusion of GDP 
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at time of death, GDP at ages 0-5, 6-19, 20-49, and 50-64 in the model, compared to the model with 
age only. This reduction is expressed as percentage of the total reduction in scaled deviances between 
the model with age only and the model with age, period, and cohort terms. The higher the reduction 
in scaled deviances, the better the fit of the model has improved on including an additional variable. 
(..) Non-significant (p = 0.05) reduction in scaled deviances 
Underlined = highest reduction in scaled deviances for GDP prevailing at the specific ages in 
comparison to GDP prevailing at different ages of the cohorts. 
DK = Denmark; E&W = England and Wales; FIN = Finland; FR = France; NL = the Netherlands; NO = 
Norway; S = Sweden. GDPcurrent = GDP at time of death. GDPcohort = GDP0005 GDP0619 GDP2049 
GDP5064. 
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Appendix III. Scatterplots of cohort trends in GDP prevailing at age 0-5 and the all-cause mortality 
progress among men aged+ 65-99 over the successive cohorts born between 1865 and 1924, by 
country
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END-OF-LIFE DECISIONS AND OLD-AGE MORTALITY: A CROSS-
COUNTRY ANALYSIS 
 
 
Objective Although the life-shortening effect of medical end-of-life decisions on the 
individual has been estimated to be small, questions have been raised in literature on a 
possible association between end-of-life decision-making practices and mortality rates. We 
examined the association between physicians’ practices and attitudes concerning end-of-life 
decision-making and mortality by age and cause of death across six European countries. 
Methods We applied correlation analyses. Results Although no statistically significant 
associations were found, the prevalence of end-of-life decisions tended to correlate 
positively with mortality. Correlation coefficients were higher for mortality among the 
elderly (80+) and for the prevalence of doctor-assisted dying. The share of physicians who 
feel they should unconditionally preserve their patients’ lives tended to correlate negatively 
with mortality, especially with old-age mortality. No clear pattern was observed for the 
different causes of death. Conclusion We recommend further research into the possibility 
that national old-age mortality rates reflect attitudes concerning appropriate medical 
treatment for the elderly. 
 
BACKGROUND 
 
Medical decision-making for patients with life-threatening diseases involves a balanced 
consideration of medical, ethical, psychosocial and societal aspects. Advances in medicine 
have greatly improved the possibilities to treat seriously ill patients and to prolong life. 
However, it is increasingly recognised that prolonging life might not always be an 
appropriate goal of medicine and that other goals have to guide medical decision-making at 
the end of life, such as improving the quality of life of patients and their families through 
the prevention and relief of suffering [1]. In some cases, hastening of death may be an 
accepted or, by some, even appreciated consequence of end-of-life care. 
 
Currently, medical care for dying patients often involves decisions that may hasten death, 
mainly on withholding or withdrawing of life-prolonging treatments or on the administration 
of potentially life-shortening drugs for the alleviation of severe suffering [2].  
 
Although, the life-shortening effect of these medical end-of-life decisions on the individual 
has been estimated to be rather small [2], there is some evidence which suggests that 
cross-national differences in end-of-life decision making may be reflected in mortality rates. 
In the Netherlands, high neonatal mortality rates [3] and the stagnation of perinatal 
mortality decline [4] have been partly attributed to a higher frequency of withholding or 
withdrawing life-prolonging treatments in severely ill neonates and extremely preterm 
infants among Dutch physicians [3,5]. Further, an increasing prevalence of end-of-life 
decisions over time in the Netherlands [6] concurred with a stagnation of mortality decline 
among Dutch elderly since the 1980s [7].  
 
We therefore decided to examine the association between physicians’ practices and 
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attitudes concerning medical end-of-life decision-making, as observed in a recent study in 
six European countries, with mortality by age and cause of death.  
 
DATA AND METHODS 
 
Prevalence data on medical end-of-life decisions by age, sex, and cause of death of the 
patient were obtained for Belgium (Flanders), Denmark, Italy (areas of Emilia-Romagna, 
Trentino Alto Adige, Tuscany, and Veneto), the Netherlands, Sweden, and Switzerland 
(German-speaking part) in 2001/2002 (EURELD study I) [2]. Doctors reported which end-
of-life decisions had preceded dying, for an unselected sample of all deaths in the areas 
studied. We distinguished (a) physician-assisted dying, i.e. administration of drugs with the 
explicit intention of hastening death (b) use of drugs with a possible life-shortening effect 
to alleviate symptoms, and (c) non-treatment decisions, i.e. decisions to withhold or 
withdraw potentially life-prolonging treatment. Deaths of infants younger than 1 year of 
age were not included in the sample. In the Italian sample, age group 1-17 years was not 
included in the Italian sample. In addition, physicians were asked to what extent life might 
have been shortened by the different end-of-life decisions.  
 
The EURELD study also assessed physicians’ attitudes towards medical end-of-life decision-
making (EURELD study II) [8]. A stratified sample of doctors was asked to what extent 
they agreed with different statements on end-of-life decision-making. We used the 
weighted percentages of doctors who (strongly) agreed with the statement "in all 
circumstances physicians should aim at preserving the lives of their patient, even if patients 
ask for the hastening of the end of their lives".  
 
For the six countries included in the EURELD study, we collected data on (cause-specific) 
mortality and life expectancy, for the years 1998 to 2001 combined. These data were 
obtained through the Human Mortality Database, the WHO Mortality Data Base, ISTAT 
(Italy, same four areas combined), NIS (Flanders), Statistics Netherlands, and Statistics 
Denmark. Swiss mortality data were obtained for the entire country. For Denmark, cause-
specific mortality data were available for 1998-2000. For Switzerland mortality data for the 
total country was included, whereas the data on medical end-of-life decisions only applied 
to the German speaking part. For the Italian regions, the life tables for 2001 were 
provisional estimates. Based on these data, age-standardized mortality rates were 
calculated. The life expectancy data were averaged over the years 1998 to 2001. For Italy, 
complete life tables and population data by region, sex and single years of age were 
obtained in order to combine the life expectancy data for the four regions into a weighted 
average for the four regions combined. 
 
To these data, we applied correlation analyses using SPSS version 11.0 for Windows. 
 
RESULTS 
 
EURELD study I revealed that the percentage of deaths that was preceded by any end-of-
life decision ranged from 23% (Italy) to 44% (the Netherlands) and 51% (Switzerland) [2]. 
According to physicians’ estimates, these end-of-life decisions resulted in an average 
shortening of the patient’s life by 2.4 days for Italy and Sweden to 14.6 days for the 
Netherlands (Table 1). At the population level, this led to a reduction in life expectancy of 
at maximum 0.02 years in the Netherlands and Switzerland. (Table 1) 
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Table 1. Physicians’ estimates of the potential life shortening of the individual by any end-of-life 
decision and the average effect of end-of-life decision-making at the population level, by country 
 
  BE CH DK IT NL SE 
   
Frequencies of physicians’ estimates of the potential life shortening of the individual by any end-of-life 
decision (weighted %) 
   Life was probably not shortened at all 38 47 44 55 32 52 
   Less than 24 hours 14 10 18 7 17 14 
   Up to one week 25 22 16 7 22 13 
   One to four weeks 9 8 3 2 10 3 
   One to six months 3 4 1 0 4 0 
   More than six months 1 1 1 0 1 0 
   Unknown 11 8 17 29 14 18 
Average estimated life-shortening (days)* 8.93 12.66 5.08 2.40 14.57 2.42 
   
Prevalence of end-of-life decisions (%) [2] 38 51 41 23 44 36 
   
Average effect at population level (days)† 3.39 6.46 2.08 0.55 6.41 0.87 
Average effect at population level (years)† 0.01 0.02 0.01 0.00 0.02 0.00 
* Based on the assumptions: life was probably not shortened at all ≈ 0 days; less than 24 hours ≈ 1 
day; up to one week ≈ 4 days; one to four weeks ≈ 18.5 days; one to six months ≈ 106.5 days; More 
than six months ≈ 365 days; unknown has been excluded. 
† The average estimated life-shortening multiplied by the prevalence of end-of-life decisions. 
BE = Belgium (Flanders); CH = Switzerland (German-speaking part); DK = Denmark; IT = Italy (areas 
of Emilia-Romagna, Trentino Alto Adige, Tuscany, and Veneto); NL = the Netherlands; SE = Sweden. 
 
Our correlation analysis revealed weak negative correlations between the prevalence of 
end-of-life decisions and life expectancy at birth (Table 2), and weak positive correlations 
between the prevalence of end-of-life decisions and all-cause, all-age mortality. 
Correlations were higher for people dying at the age of 80 and over (Table 2). The 
prevalence of physician-assisted dying correlated more strongly with mortality than the use 
of potentially life-shortening drugs to alleviate symptoms, or than the prevalence of 
decisions to withhold or withdraw potentially life-prolonging treatment.  
 
The share of physicians who feel they should unconditionally preserve their patients’ lives 
correlated weakly positively with life expectancy, and weakly negatively with all-cause 
mortality (Table 2). Correlations were stronger for people dying at the age of 80 and over 
(Table 2, Figure 1). None of these correlations reached statistical significance, though.  
 
No clear pattern was found for different causes of death. Cancer is the cause of death that 
most often involves end-of-life decisions [2], but correlations for cancer were not higher 
than correlations for other causes of death. For cardiovascular disease mortality, 
correlations were small or reversed. (Table 2)  
 
DISCUSSION 
 
Thus, although the end-of-life decisions, based on the physicians’ estimates of the life-
shortening effect, did not result in a large effect on national life expectancy, a tendency 
towards association between physicians’ practices and attitudes concerning end-of-life 
decision-making and mortality appeared, especially for the elderly. 
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Figure 1. Physicians’ agreement with the life-preserving statement plotted against sex-specific 
remaining life expectancy at age 80 for the years 1998-2001, across six European countries 
 
Pearson’s correlation coefficient: 0.50 (men), 0.51 (women). 
BE = Belgium (Flanders); CH = Switzerland (German-speaking part); DK = Denmark; IT = Italy (areas 
of Emilia-Romagna, Trentino Alto Adige, Tuscany, and Veneto); NL = the Netherlands; SE = Sweden. 
 
Despite the non-significant results, our analysis does not preclude a possible relationship 
between the practice of end-of-life decision-making or the propensity to preserve life in 
elderly patients and national old-age mortality levels. Obviously, the small number of 
countries included limits the power of our analysis.  
 
In line with an association between the practice of end-of-life decision-making and 
mortality rates is the notion that the true effect of general medical management of severely 
ill or elderly patients on national mortality may not have been completely uncovered in our 
analysis. Cross-national differences in what is being regarded as appropriate medical 
treatment for chronically ill and elderly patients could lead to differences in what is defined 
as a decision to refrain from such treatment. As a result, some differences in medical 
management of severely ill or elderly patients may not be identified in studies on end-of-
life decision-making. This is supported by our finding that the correlations with mortality 
were slightly higher for physicians’ attitudes than for physicians’ practices. The observed 
lower correlations for non-treatment decisions, which are more prone to differences in 
what is being perceived as appropriate medical treatment, and higher correlations for 
doctor-assisted dying, a practice that probably better reflects the underlying attitude, are 
also in line with this hypothesis. 
 
On the other hand, the tendency for an association might be biased, because we did not 
take into account variables that may be more important than end-of-life decisions in 
determining cross-national differences in mortality, such as cardiovascular risk factors and 
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health care expenditure during the last year of life. The counterintuitive results for 
cardiovascular disease mortality, however, could indicate a likely underestimation of the 
observed association for all-cause mortality due to cross-national differences in 
cardiovascular risk factors, like unhealthy behaviour. With respect to health care 
expenditure, the contrast between Switzerland and the Netherlands can be used as an 
illustration. In Switzerland a relatively high prevalence of end-of-life decisions and a 
relatively low agreement with the life-preserving statement concur with a relatively high life 
expectancy, whereas in the Netherlands the same factors concur with a relatively low life 
expectancy. It is striking that in Switzerland, health care expenditure during the last year of 
life is extremely high and amounts to 30% of the total health-care budget [9]. In the 
Netherlands this percentage amounts to only 10% [10]. Thus, in these countries the health 
care expenditure during the last year of life may be more important in determining the 
mortality levels. On the other hand, however, the contrast between the Netherlands and 
Switzerland could also again be due to cross-national differences in what is being regarded 
as appropriate medical treatment for chronically ill and elderly patients.  
 
As yet, we cannot exclude the possibility that attitudes concerning appropriate medical 
treatment for the elderly can affect national old-age mortality rates. Further research into 
this issue is warranted.  
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GENERAL DISCUSSION 
 
 
The aim of this thesis was (a) to carefully describe trends in old-age mortality in seven 
European low-mortality countries from 1950 to 1999, and (b) to assess the role of specific 
factors in explaining the observed trends.  
 
For this purpose, we studied both all-cause mortality and mortality from 26 specific causes 
of death, we applied a life-course perspective – with emphasis on both immediate effects 
of circumstances prevailing at old age (= period effects) and possible long-lasting effects of 
determinants located earlier in life (=cohort effects) – and we performed comparative 
studies among seven countries, i.e. Denmark, England and Wales, Finland, France, the 
Netherlands, Norway, and Sweden. In a series of separate analyses, we assessed the role 
of smoking, mortality selection, socio-economic developments over the life-course, and 
medical end-of-life decision-making. Smoking and socio-economic factors are important 
determinants of adult mortality, but uncertain is their role in determining trends in old-age 
mortality. Mortality selection effects on old-age mortality have been posited in literature. 
The empirical evidence, however, is rather mixed, and largely restricted to the mortality 
experience of single cohorts, without a specific focus on old-age mortality. The potential 
effect of medical end-of-life decision-making on national mortality has not been studied 
before. It was hypothesized that its effect, if any, is larger among the elderly population. 
 
In this final chapter, we summarize the main results of this thesis, and evaluate the 
usefulness and possible limitations of our methodological approach in obtaining these 
results. Subsequently, we elaborate on the possible determinants of the stagnation of 
mortality decline among the elderly in the Netherlands, and what future trends in mortality 
we can anticipate. In addition, recommendations for further research are proposed.  
 
SUMMARY OF RESULTS 
 
Trends in old-age mortality in seven European countries, over the period 1950 
to 1999 
 
The trends in old-age mortality can be described by a combination of period and cohort 
patterns. The period patterns revealed an overall decline in all-cause mortality among those 
aged 80 and over from 1950 to 1999, with a convergence in the mortality level between 
countries over time. However, there was large heterogeneity in the pace of decline, with 
periods of stagnation being widespread. From the 1980s onwards, small mortality declines 
or even increases were observed in Denmark, the Netherlands, and among Norwegian 
men. In contrast, old-age mortality decline continued in England and Wales and France. 
For the subsequent cohorts (1865 to 1935), all-cause mortality among those aged 60 and 
over generally declined. This decline, however, stagnated among Danish, Dutch and 
Norwegian men born between 1890 and 1915, and among women from all countries born 
after 1920.  
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The role of the different determinants in explaining the observed trends 
 
Smoking 
The unfavourable cohort patterns in all-cause mortality among men born between 1890 
and 1915 in Denmark, the Netherlands, and Norway, and among women born after 1920 in 
all countries, were largely parallel to the less favourable cohort patterns from smoking-
related diseases for the same countries and the same cohorts. This implies that cohort 
changes in smoking exposure influenced recent trends in old-age mortality to a large 
extent. Period patterns for mortality from smoking-related diseases showed an overall 
pattern of long-term increases, for both men and women, which again points to a role of 
smoking in old-age mortality trends. However, among men, the increase in mortality from 
smoking-related diseases turned into a decrease since the 1980s, in all countries except 
Norway. Furthermore, when for the Netherlands the smoking-related diseases are excluded 
from period trends in all-cause mortality, mortality decline still stagnated, uniformly for 
men and women. Thus although smoking has had a marked influence on the trends in old-
age mortality, it cannot fully explain the observed stagnation in mortality decline since the 
1980s.  
 
Mortality selection 
Mortality from diseases specifically related to old age (infectious diseases, pneumonia, 
dementia, and all ill-defined causes) increased since the 1980s in all countries under study. 
This could potentially point to increased frailty among the elderly, as a result of decreased 
mortality selection. In further analyses, we tested whether mortality selection was indeed a 
dominant factor in determining trends in old-age mortality, by empirically studying the 
possible existence of a negative correlation between trends in late middle-age mortality and 
trends in old-age mortality for the same cohorts, i.e. those born around 1895, 1900, 1905, 
and 1910. However, in all countries and especially among men, all-cause mortality changes 
at ages 80-89 were strongly positively correlated with all-cause mortality changes at ages 
55-69 for the same cohorts. All-cause mortality changes at ages 80-89 also correlated 
strongly positive with circulatory disease mortality, a cause of death susceptible to mortality 
selection, at ages 55-69. Moreover, mortality changes at ages 80-89 from diseases 
specifically related to old age, also susceptible to mortality selection, showed no clear 
negative correlations with all-cause mortality trends at ages 55-69.  Mortality selection thus 
does not seem to be a driving factor behind old-age mortality trends in the countries under 
study.  
 
Socio-economic developments 
A possible role of socio-economic developments throughout the life-course was assessed by 
studying the association between old-age mortality levels for subsequent cohorts and levels 
of Gross Domestic Product (GDP) prevailing at different ages (i.e. 0-5, 6-19, 20-49, and 50-
64) of the same cohorts. For the birth cohorts 1865 to 1924, levels of GDP at time of death 
were strongly inversely associated with all-cause mortality at ages 65-99, especially among 
women, and among men in England and Wales, Finland, and France. In most countries, 
stronger associations were observed for GDP levels prevailing at earlier ages of the cohorts, 
which remained after control for GDP at time of death. GDP prevailing at ages 20-49 (men) 
and 50-64 (women) showed the strongest associations with old-age mortality, whereas no 
strong associations with old-age mortality were observed for GDP prevailing during infancy 
or childhood and for infant mortality. Thus, next to the inverse effects of current economic 
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developments on old-age mortality trends, independent inverse effects of economic 
developments during earlier ages of the cohort were found. Socio-economic circumstances 
during adulthood and middle age seem more important in determining old-age mortality 
trends than those during infancy or childhood.  
 
Medical end-of-life decision-making 
The increasing prevalence of medical end-of-life decisions over time in the Netherlands [1], 
might have contributed to the relatively unfavourable trends among Dutch elderly. 
Moreover, medical end-of-life decisions could possibly contribute to cross-national 
differences in old-age mortality. We showed, however, that the effects of the increasing 
prevalence of medical end-of-life decisions in the early 1990s on the mortality trends 
among Dutch elderly seemed negligible based on physicians’ estimation of its life-
shortening effect. More in general, a rather small effect of medical end-of-life decisions on 
national life expectancy was observed. Although no statistically significant associations 
were found, the prevalence of end-of-life decisions tended to correlate positively with 
mortality. Correlation coefficients were higher for mortality among the elderly and for the 
prevalence of doctor-assisted dying. The share of physicians who feel they should 
unconditionally preserve their patients’ lives tended to correlate negatively with mortality, 
especially with old-age mortality. Further research is recommended into the possibility that 
national old-age mortality rates reflect attitudes concerning appropriate medical treatment 
for the elderly.  
 
Other determinants  
Our different cohort analyses seem to suggest effects of early life circumstances carried 
throughout life, and, even more importantly, effects of prolonged exposure to, or long-
lasting effects of risk factors, such as smoking, emerging in adult life. 
 
In addition, mortality from cardiovascular diseases – the most important cause of death 
among the elderly - showed important cross-national variations in the pace of decline. In 
the last two decades declines for cardiovascular disease mortality among the elderly were 
strong in England and Wales and France and weak in Norway, the Netherlands, and 
Denmark. Previous research on trends in cardiovascular mortality [2-4] suggested the 
importance of several factors such as physical activity, hypertension control, diet, smoking, 
and accessibility of medical care. Possibly, the developments in some of these risk factors 
were more beneficial in England and Wales and France compared to the other countries. 
 
Overall 
 
Our results indicate large heterogeneity in the pace of mortality decline among the elderly 
in seven European countries, with stagnation since the 1980s in Denmark, the Netherlands 
and among Norwegian men, whereas mortality decline strongly continued in England and 
Wales and France. In determining these trends both period patterns and cohort patterns 
seem important. Smoking, an important cohort factor, has had a marked influence on old-
age mortality trends. However, it cannot fully explain the observed stagnation in mortality 
decline since the 1980s. Mortality selection, another cohort factor, has not been a driving 
factor behind old-age mortality trends in the countries under study. Next to a period effect 
of current economic developments on old-age mortality trends, a cohort effect of economic 
developments during earlier ages of the cohort, predominantly during adulthood and 
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middle age, was found. Cross-national differences in old-age mortality might to some 
extent be affected by differences in attitudes concerning appropriate medical treatment for 
the elderly, although further research is recommended.  
 
In conclusion, old-age mortality seems susceptible to both favourable and unfavourable 
circumstances either prevailing at old ages, or originating earlier in life, predominantly in 
adulthood or middle age. 
 
REFLECTIONS ON THE METHODOLOGICAL APPROACH 
 
Our approach of studying determinants of trends in old-age mortality trends was 
characterised by its emphasis on cause of death patterns, its life-course perspective, and 
comparative studies among seven countries. The usefulness and limitations of this 
approach is discussed below. 
 
Distinction of causes of death 
 
Studying the trends in cause-specific mortality generated clues on the determinants of all-
cause mortality trends. Examining specific causes of death helped to identify intermediate 
factors or risk factors that could determine old-age mortality trends. For example, we made 
ample use of the widely known link between smoking and lung cancer in our analyses 
(Chapters 3, 4, and 5). Moreover, the cross-national differences in cardiovascular mortality 
pointed to a possible role in determining old-age mortality trends of country-specific 
developments in cardiovascular risk factors (Chapter 4). In addition, our inclusion of causes 
of death susceptible to mortality selection (i.e. circulatory diseases and diseases specifically 
related to old age) proved useful for our study of mortality selection as a possible 
determinant of old-age mortality trends (Chapter 6). Our differentiation into causes of 
death also informed us about causal mechanisms, for example in our study of the 
association between GDP throughout the life-course and old-age mortality (Chapter 7). In 
studying the relationship between end-of-life decision-making and old-age mortality, the 
inclusion of causes of death not only facilitated a further test of our hypotheses, but also 
gave insight into the possibility and direction of confounding (Chapter 8). 
 
It should however be acknowledged that especially among elderly populations, the 
identification of a single underlying cause of death is complicated by the presence of more 
than one chronic disease contributing to death [5,6]. Particularly at older ages, the validity 
of the underlying cause of death may thus be questioned. Studying multiple causes of 
death has been proposed as an alternative [5-7]. However, in addition to the difficulty of 
obtaining these data, these studies are also limited because of the differences in the extent 
to which physicians list more than one cause on the death certificate [5]. Moreover, 
numerous methodological problems are involved due to the abundance of the data [7]. 
Studying multiple causes of death thus is not by definition the better solution.  
 
In studying long-term trends in causes of death, the comparability over time may be 
affected by cause-specific coding changes such as the numerous revisions of the 
International Classification of Diseases (ICD). We made considerable effort to bridge these 
ICD revisions by carefully constructing a concordance table based on three-digit codes and 
by identifying and controlling for the remaining biases due to coding changes both within 
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and between ICD revisions. However, remaining problems, such as changes in the 
reporting of cause of death by physicians [8,9], may result in gradual shifts that are more 
difficult to detect and to control for [9]. These problems could have especially influenced 
the trends for diabetes mellitus, pneumonia, dementia, and "symptoms and ill-defined 
conditions". The trends for diseases that have a more straightforward diagnosis, such as 
smoking-related cancers, and for broad groups of causes of death such as cardiovascular 
diseases, are less likely to be affected.  
 
Although not all problems mentioned above can be solved, adequately controlling for 
sudden cause-specific coding changes, such as the ICD related coding changes, is a 
prerequisite for the study of long-term cause-specific mortality trends. Moreover, when 
interpreting cause-specific mortality trends, potential remaining problems, such as changes 
in the reporting of causes of death by physicians and the quality of cause of death data, 
should always be kept in mind. In this way, distinction of the underlying causes of death 
can be a very useful tool in understanding all-cause mortality trends and in generating and 
testing hypotheses on its determinants. 
 
Life-course perspective  
 
By adopting a life-course perspective, we could distinguish between determinants occurring 
in late life (period determinants) and determinants originating in earlier phases of the life-
course (cohort determinants) [10,11]. This distinction provided us with a clear analytical 
framework. Moreover, the life-course perspective proved necessary, because cohort effects 
were indeed found to be important in determining old-age mortality trends (Chapter 5). 
Without adopting a cohort approach we would not have been able to appropriately 
understand the role of smoking in determining old-age mortality trends, given the long lag 
time between smoking and mortality from lung cancer [12] (Chapters 3 and 5). Moreover, 
the cohort approach enabled us to study the effect of mortality selection (Chapter 6). The 
observed strong positive association between mortality trends at late middle age and old-
age mortality trends among the same cohorts, again points to the importance of 
determinants that operate throughout the life-course of these cohorts. The life-course 
perspective also provided interesting insights when applied to the study of socio-economic 
determinants at different ages of subsequent cohorts on old-age mortality. Next to a period 
effect of current economic developments, a cohort effect of economic developments during 
earlier ages of the cohort, predominantly during adulthood and middle age, was found 
(Chapter 7). 
 
Age-period-cohort analyses are a useful method when the life-course perspective is applied 
to aggregate mortality data. However, a persistent problem in age-period-cohort analyses 
is the identification of the separate roles of age, period and cohort, due to the 
interdependency between these variables (period – age = cohort). This is referred to as the 
identification problem [13,14]. We have adopted different strategies to cope with this 
problem. In Chapter 3, the identification of non-linear trends through the use of splines 
helped us to partly overcome the identification problem, especially for causes of death 
showing non-linear trends. In Chapter 5, we used a more standard procedure in which 
mortality is decomposed into a common linear trend (drift), a non-linear cohort effect and a 
non-linear period effect [13]. Focus on non-linear patterns, however, will yield a 
conservative estimate of the contribution of the cohort and period effects, respectively. 
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Moreover, the identification problem could only be dealt with adequately if clear non-linear 
patterns existed.  
 
Not only can age-period-cohort analyses help in estimating the importance of period versus 
cohort effects in mortality trends, they can also contribute to the assessment of the role of 
specific determinants throughout the life-course. In Chapter 6, for example, we assessed 
the effects of GDP throughout the life-course on old-age mortality by substituting the 
period and cohort variables by GDP measures at time of death and GDP measures at earlier 
ages of the cohort, respectively.  
 
Thus, despite the difficulties associated with the identification of the separate roles of age, 
period, and cohort effects in mortality trends, applying both a period approach and a 
cohort approach to the study of old-age mortality trends is both necessary and useful. 
Furthermore, knowledge on the relative contribution of period versus cohort determinants 
in mortality trends is important for making projections of future developments in mortality. 
 
Comparative studies among seven European countries 
 
Our comparative studies among seven selected European countries proved very useful as it 
informed us about generalities of patterns, and possible country-specific deviations from 
these general patterns. Furthermore, this approach enabled us to examine both 
determinants unique to specific countries, and general determinants of old-age mortality 
trends.  
 
For example, the comparison of old-age mortality trends between countries revealed that 
the stagnation of old-age mortality decline in the Netherlands was not observed in all 
countries. This finding has important implications for whether a possible limit to life 
expectancy is already within reach (see section  "What can we expect for the future?").  
 
With regard to the determinants, the comparative analyses provided insight into the 
consistency of the observed national results, which facilitated a better judgment of the role 
of determinants in old-age mortality trends. For example, with respect to the role of socio-
economic developments, an association between macro-economic conditions in early life 
and mortality at older ages was observed in a recent study for the Netherlands [15]. In 
Chapter 7, we also observed an association between GDP prevailing at ages 0-5 and 
mortality among Dutch elderly. This association, however, was not observed in the other 
countries. In general, a more important role of socio-economic circumstances in adulthood 
and middle age, than those in infancy and childhood, on old-age mortality was found.  
 
An important limitation of our ecological study-design is that conclusions could only be 
formulated at the aggregate level, and cannot be simply generated to individuals. 
Furthermore, the use of aggregate data complicated the demonstration of causal 
mechanisms in our analyses, especially when both the trends in possible determinants and 
the trends in the outcome variable mortality were highly linear.  
 
Thus, although demonstrating causation proved sometimes difficult and our conclusions 
cannot be generated to individuals, our parallel analyses of seven European countries did 
provide us with some interesting generalities and interesting deviations and helped us in 
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generating interesting hypotheses on the role of determinants of old-age mortality trends.  
 
DETERMINANTS OF THE STAGNATION IN OLD-AGE MORTALITY DECLINE IN THE 
NETHERLANDS 
 
The levelling off of the increase in life expectancy in the 1980s among the elderly in the 
Netherlands has been observed in previous studies [16-18]. This phenomenon gave rise to 
the current study of the determinants of trends in old-age mortality. In this section, we 
elaborate on the insights our research has yielded into the determinants of the stagnation 
in old-age mortality decline in the Netherlands, and into its determinants. 
 
Chapter 3 showed that, around 1980, mortality decline among Dutch men and women 
aged 80 and over suddenly reversed into stagnation thereafter. Mortality increases were 
observed among men in the 1980s, and among men and women aged 90 and over in the 
1980s and 1990s. 
 
In explaining the observed stagnation, we consider both period determinants and cohort 
determinants, because both proved important in determining old-age mortality trends in 
the Netherlands. Age-period-cohort analyses showed that for Dutch men, the cohort 
patterns were more important than the period patterns, whereas for women linear patterns 
(drift) dominates, with in addition slightly larger effects of non-linear period patterns than 
non-linear cohort patterns (Chapters 3 and 5).  
 
Cohort determinants 
 
It has been stated before that although smoking has had a marked influence on the trends 
in old-age mortality, it cannot fully explain the observed stagnation in mortality decline 
since the 1980s. When, for the Netherlands, the most important smoking-related causes of 
death were excluded from period trends in all-cause old-age mortality, mortality decline 
levelled off in the 1980s, and stagnated completely in the 1990s, uniformly for men and 
women (Chapter 3). More generally, when trends in non-smoking related mortality – based 
on a simpler application of the indirect Peto-Lopez method [19,20] - are compared between 
the different countries (Table 1), the differences in the pace of the mortality decline 
between the countries disappear only partially. Recent trends in non-smoking related 
mortality in the Netherlands and among Danish men remain unfavourable, particularly in 
the 1990s, whereas recent trends in non-smoking related mortality continue to be 
favourable in France. The disappearance of the stagnation among Norwegian men and 
even more so among Danish women implies that the stagnation in Danish women and 
among Norwegian men is more closely related to smoking. 
 
Closer inspection of past trends in Gross Domestic Product (GDP) – an indicator of socio-
economic circumstances – showed stagnating trends in the Netherlands from 1890 to 1915 
(Figure 1). Trends in GDP in the other countries at that time were much more favourable. 
In Chapter 5, stagnation in all-cause mortality decline in the Netherlands was observed for 
the cohorts born in this period, although only for men. This suggests a long-lasting effect 
of GDP at infancy or childhood on mortality among Dutch elderly men. Our analysis on the 
role of GDP throughout the life-course on old-age mortality levels for subsequent cohorts 
(Chapter 7) showed, indeed, an association between GDP prevailing at ages 0-5 and old-
age mortality for male Dutch cohorts born between 1865 and 1924. 
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Table 1. Annual changes (%) for all-cause mortality and non-smoking related mortality, by country 
and sex, for those aged 80 and over 
 
  All-cause mortality Non-smoking related mortalitya 
 1950-59 1960-69 1970-79 1980-89 1990-99 1950-59 1960-69 1970-79 1980-89 1990-99 
Men     
     
Denmark 0.58 -1.16 -0.45 -0.19 -0.20 -0.49 -1.54 -1.42 -0.45 -0.23 
England&Wales -0.65 -0.79 -0.44 -1.44 -1.20 -0.56 -1.96 -1.27 -1.61 -0.51 
Finland -0.53 0.26 -2.45 -0.55 -1.11 -1.72 -0.41 -2.99 -0.40 -0.69 
France -1.27 -0.98 -0.73 -1.82 -1.66 -1.47 -1.45 -1.42 -2.18 -1.27 
Netherlands -0.60 -0.35 -0.93 0.38 -0.19 -1.03 -1.47 -2.09 -0.39 0.06 
Norway 0.76 0.14 -0.82 0.02 -0.51 0.42 -0.05 -0.91 -1.09 -0.45 
Sweden -0.17 -0.85 -0.20 -0.92 -0.98 -0.64 -1.26 -1.02 -0.66 -0.86 
     
Women 
     
Denmark -0.09 -2.25 -1.67 -0.47 -0.56 -0.72 -2.37 -2.09 -0.79 -1.30 
England&Wales -0.96 -1.30 -0.88 -1.90 -0.65 -1.18 -1.51 -1.48 -2.56 -0.99 
Finland -0.18 -0.70 -3.85 -0.34 -1.47 -0.29 -0.61 -3.95 -0.46 -1.89 
France -1.42 -1.40 -1.07 -2.23 -1.72 -1.45 -1.25 -1.29 -2.49 -1.59 
Netherlands -1.11 -0.85 -2.72 -0.47 0.01 -1.18 -0.88 -2.79 -0.86 -0.49 
Norway 0.43 -0.97 -1.80 -0.74 -0.71 0.25 -0.70 -1.38 -1.51 -0.94 
Sweden -0.61 -1.86 -1.51 -1.14 -1.05  -0.86 -2.00 -1.92 -0.94 -1.41 
a Non-smoking related mortality was estimated based on a simpler application of the indirect Peto-
Lopez method [19,20]. The prevalence of smoking in the different populations was determined by 
relating the lung cancer rates in these populations to the smoothed lung cancer rates among the never 
smokers of the ACS CPS-II study [19]. In addition, the fact was used that the etiologic fraction (EF) is 
a function of the proportion of the population that is exposed (p) and the relative risk (RR), i.e. EF = 
p(RR-1)/(p(RR-1)+1). The relative risk for smoking of total mortality was set at 2. To remove residual 
confounding and to obtain conservative estimates of the numbers of deaths attributable to smoking 
the etiological fractions were adjusted by 30% [21]. The adjusted etiological fractions were used to 
calculate non-smoking related mortality, i.e. all-cause mortality * (1-EF). 
 
A largely comparable result was found in an earlier study on the effects of macro-economic 
conditions at ages 1-7 on the individual all-cause mortality rate at ages above 50 among 
Dutch cohorts born between 1817 and 1907 [15]. Thus, stagnating socio-economic 
developments in infancy and childhood might have contributed to the observed stagnation 
of mortality decline among Dutch elderly. Its effect is however less clear among women, 
who also still exhibited stagnation for non-smoking related diseases. Furthermore, the 
mechanisms behind the possible effect of socio-economic developments in infancy and 
childhood on old-age mortality trends are still not fully understood. Possible mechanism 
mentioned in literature include disease processes associated with respiratory tuberculosis, 
hepatitis B and cirrhosis or liver cancer, rheumatic heart disease, and respiratory infections 
or bronchitis, and in addition persistent viruses, dietary practices, and the burden of 
infectious diseases in childhood [22]. 
 
Our different cohort analyses moreover seem to suggest effects of prolonged exposure to, 
or long-lasting effects of risk factors, other than smoking, originating in adult life or in 
middle age. Cardiovascular risk factors, among the middle aged, and especially among 
men, seem a likely candidate. 
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Figure 1. Trends in real Gross Domestic Product per capita at 1995 US Dollars, 1865-1935, by country 
 
DK = Denmark; FIN = Finland; F = France; NL = the Netherlands; NO = Norway; S = Sweden; UK = 
United Kingdom. 
 
In the Netherlands, age-standardized mortality from ischaemic heart disease (IHD) showed 
an enormous increase from 1950 to 1972, both among men and women, although less 
steeply among women [23]. This increase has been most dominant among those in middle 
age, and is largely linked to the uptake of adverse risk behaviour [23]. The mortality 
increases from IHD among the middle aged in the 1950s to the early 1970s, and the 
associated uptake of adverse risk behaviour could have contributed to the stagnation of 
mortality decline among Dutch elderly in the 1980s and 1990s, as they all belong to the 
same cohorts born roughly between 1890 and 1915. Increasing mortality rates from IHD 
since the 1950s were not restricted to the Netherlands, but observed in the majority of 
countries [24]. In Norway and the Netherlands, however, the increase was higher, at least 
among men [24]. 
 
Period determinants 
 
Contemporaneous socio-economic developments probably made a large contribute to the 
general decline in old-age mortality. However, for the Netherlands, no different 
developments in GDP since the 1980s were observed in comparison to the other countries 
(see Chapter 7, Figure 2). This suggests that contemporaneous socio-economic develop-
ments are unlikely to contribute to the observed stagnation. 
 
In Chapter 8, the possibility was raised that national old-age mortality rates might be 
affected to some extent by attitudes concerning appropriate medical treatment for the 
elderly. For the Netherlands, we observed a relatively high prevalence of medical end-of-
life decisions, and a relatively low share of physicians who feel they should unconditionally 
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preserve their patients’ lives were observed. This may be indicative of a different general 
attitude in the Netherlands concerning appropriate medical treatment for the elderly, that 
is, less than in other countries, directed towards unconditional life-prolonging of the elderly. 
Moreover, in the Netherlands, an increase in the prevalence of medical end-of-life decisions 
concerning elderly patients occurred in the early 1990s [1]. If we assume that behind this 
increasing prevalence also a change in attitude concerning appropriate medical treatment 
for the elderly exists, the effect of the increasing prevalence of medical end-of-life decisions 
may be higher than estimated in Chapter 3. This potential change in attitude could be the 
result of the intensification of the ongoing public debate on euthanasia in the Netherlands 
during the 1980s [25]. The increasing prevalence of medical end-of-life decisions in the 
early 1990s and possible associated changes in attitudes concerning appropriate medical 
treatment for the elderly thus might have contributed to some extent to the observed 
stagnation.  
 
In addition, it cannot be completely ruled out that an effect on old-age mortality trends 
exists of changes in health care and social services available to the elderly combined with 
an increase in the number of elderly living alone and a possible decline in social support. In 
the Netherlands between World War II and 1975, care for the elderly was a central issue of 
the welfare state. Considerable effort and resources were spent on institutionalisation and 
intramural care for the elderly [26]. Since 1975, however, Dutch policies have shifted their 
emphasis to facilities for the elderly that enable them to stay longer at home. Although de-
institutionalisation can enhance active ageing [27], it could also have made the elderly 
more reliant on informal or private care [26]. Combined with the increase in the number of 
elderly living alone [27] and the decrease in social support with age [28], de-institutionali-
sation may have resulted in more elderly people without sufficient care, which might have 
had a negative effect on their length of life. These developments are not merely restricted 
to the Netherlands. Very likely, cross-national differences in the timing and the impact of 
de-institutionalisation might have occurred. Recent data showed that of those aged 65 and 
over the proportion of disabled older people living in the community is fairly high in the 
Netherlands (12.6 %) as compared to other countries (e.g. France 8.0% and Sweden 
9.4%) [27].  
 
WHAT CAN WE EXPECT FOR THE FUTURE? 
 
Future trends in mortality 
 
Recently, a number of questions on possible future trends in mortality have gained interest. 
Particularly the extent to which today’s populations are approaching a limit to human life 
expectancy is extensively being debated upon. On the one hand, proponents of "the 
limited-lifespan paradigm" state that biological and practical constraints to reducing old-age 
mortality imply that future gains in life expectancy will occur at a slower pace, and that the 
limit to life expectancy is almost reached [29-31]. On the other hand, "the mortality-
reduction paradigm" is adhered to by researchers who argue that life expectancy will 
continue to increase for some time to come [32-34]. They support their view by referring 
to mortality developments in sub-populations with extreme good health, to foreseen 
biomedical progress, to historical observations that record life expectancy has been 
increasing at a constant rate, of a quarter of a year per year, for the past 160 years, and to 
the observation that past mortality predictions, assuming that life expectancy is 
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approaching a ceiling, have repeatedly been proven too pessimistic. In fact, the two groups 
have reached contrasting opinions by different analyses of the same empirical data.  
 
Our comparative studies among seven European countries provide no evidence that a limit 
to life expectancy is within reach. Stagnation of mortality decline in the Netherlands has 
sometimes been seen as a sign of such a limit, but our results indicate otherwise. Although 
mortality decline stagnated since the 1980s in the Netherlands, Denmark, and among 
Norwegian men, further improvements in old-age mortality decline occurred in England and 
Wales and France, i.e. countries that reached the same low level of mortality as Denmark, 
the Netherlands, and Norway around 1980. In addition, other interpretations (e.g. effects 
of smoking, socio-economic developments earlier in life, trends in cardiovascular diseases) 
seem more likely for the observed stagnation of mortality decline.  
 
Given the observed strong positive association between mortality trends in late middle age 
and those among the elderly for the same four cohorts born around 1895 to 1910 (see 
Chapter 6), considering recent changes in mortality at younger ages may be a useful 
approach to inform projections of future old-age mortality trends. Mortality trends in late 
middle age among Dutch men over the period 1975-1999 turned out to be quite favourable 
(-1.7%), and could indicate that the stagnation in mortality trends among elderly Dutch 
men is temporary. For women, however, recent trends in late middle age mortality were 
somewhat less favourable (-0.7%). This could imply that the stagnation of old-age 
mortality decline among Dutch women is likely to continue for some time to come. 
 
The exact prediction of future old-age mortality patterns or future developments in life 
expectancy, however, remains a difficult task. Past mortality predictions have repeatedly 
been proven too pessimistic [34] due to the occurrence of unforeseen positive 
developments. For example, the huge reduction in cardiovascular disease mortality from 
1970 onwards, as a result mainly of major advances in medical care and behavioural 
change, was not anticipated upon [24]. The possibility certainly exists that in the future 
medical and biomedical progress will again lead to large mortality declines. From the 
analyses performed in our study, it can be concluded that most gains from possible medical 
and biomedical progress will likely to be obtained from the further reduction of the case 
fatality of cardiovascular diseases and cancers, i.e. still the most important causes of death 
at old ages, but potentially also from reducing mortality from diseases specifically related to 
old age, for which recent mortality increases were observed. We would like to stress, 
however, that it is important to realize that not only favourable developments, but also 
unfavourable developments might occur. After all, the stagnation in old-age mortality 
decline as observed in Denmark, the Netherlands and Norway (men only) indicates that 
old-age mortality seems highly plastic and susceptible not only to factors with favourable 
effects, but also to factors with possible unfavourable effects. A current increasing threat is 
the obesity epidemic among young adults [35]. In addition, unfavourable developments are 
the re-emergence of infectious diseases [36], wars, and health effects of ecological 
changes [35].  
 
Future trends in morbidity 
 
How increasing life expectancy will affect future trends in morbidity is also still under 
debate. On the one hand, researchers argue that the number of years with morbidity will 
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eventually decrease (compression of morbidity). On the other hand, evidence is found for a 
lengthening period of disability associated with the increase in life expectancy (expansion 
of morbidity). Following Fries (1980), the original compression of morbidity hypothesis was 
based on two assumptions: (1) life expectancy at birth will stop increasing, because the 
upper limit to the human lifespan will soon be reached, and (2) the average age at which 
disability arises will continue to increase, because there is no near-by limit to preventing 
disease and disability [29]. Although, in the mean time, some alterations have been 
proposed to this hypothesis, it still seems valid that with the general increase in life 
expectancy, compression of morbidity is less likely to occur.  
 
RECOMMENDATIONS FOR FURTHER RESEARCH 
 
Research on the determinants of old-age mortality trends remains important for an 
understanding of mortality trends among the elderly, and for making inferences on possible 
future mortality developments. Consequently, understanding mortality trends among the 
elderly is highly valuable for the planning of health care services and for regulating pension 
systems. 
  
Our approach focussed on cause of death patterns, adopted a life-course perspective, and 
comparative studies among seven countries. This approach proved very useful for 
generating and testing relevant hypotheses on the role of determinants of old-age mortality 
trends. However, some issues remain unresolved, and need further research. We discuss 
these issues below. 
 
More detailed description of cause-specific mortality trends 
 
The study of the determinants of old-age mortality trends could be aided by extending the 
Kannisto-Thatcher Database on old-age mortality, i.e. the most important source of all-
cause mortality data specifically among the elderly, to cause-specific mortality. Larger 
availability of cause-specific mortality data specifically among the elderly could facilitate a 
more detailed description of cause-specific mortality trends among the elderly in a large 
number of countries. This could help in understanding all-cause mortality trends and in 
generating and testing hypotheses on its determinants. We, furthermore, recommend that 
studies on long-term cause-specific mortality trends attempt to identify and adjust for 
coding changes. 
 
More in-depth comparisons of populations 
 
To further test the hypotheses on the role of specific determinants in old-age mortality 
trends that were raised in our comparative population level study, more in-depth ecological 
research might be needed. Largely unknown remains as yet what exactly discriminates a 
country or a region with favourable mortality experiences from those with less favourable 
mortality experiences. Some insights already have been obtained on the stagnation of old-
age mortality decline in the Netherlands. The success story behind the continuation of old-
age mortality decline in England and Wales, and especially France, however, has not yet 
been revealed. Our observation that both England and Wales and France were charac-
terised by strong recent declines in cardiovascular diseases could indicate a contribution of 
cross-national differences in the developments of cardiovascular risk factors, such as 
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physical activity, hypertension control, diet, smoking, and accessibility of medical care [2-
4]. To further examine this, information on these risk factors from national surveys 
specifically addressed to the elderly could be used. Preferably, however, this information 
should be combined with country-specific information from largely comparable surveys at 
earlier ages of the life-course, in earlier times. In this way, for each country, cohort-specific 
risk factor levels could be estimated, which subsequently could be compared between 
countries. Note, however, that these historical comparable surveys are not widely available.  
 
Studying regional variations within a country could also provide additional clues on the 
determinants of old-age mortality decline. If a pattern of geographic variation in the onset 
of a deceleration or acceleration in old-age mortality decline has been identified, it will be 
easier to find the determinants of the observed trends, because these must have followed 
the same patterns. For example, by studying the variation in the year of onset of ischaemic 
heart disease mortality decline among regions in the Netherlands, Mackenbach et al. 
(1989) observed an early onset in the urbanized part of the country, whereas, a later onset 
of decline was found in more peripheral regions [23]. This pattern could subsequently be 
linked to the diffusion of changes in lifestyle in the population at large, leading the authors 
to conclude that the trend reversal is more likely to be determined by lifestyle changes than 
by medical care improvements [23]. 
 
Use of data from individual-level studies 
 
The use of aggregate data in our ecological studies complicated the demonstration of 
causal mechanisms with respect to the possible determinants of old-age mortality trends. 
Further epidemiological research specifically aiming at the elderly and using data from 
individual-level studies is, therefore, needed to demonstrate these causal mechanisms and 
to test the associated hypotheses on the determinants of old-age mortality trends. 
Additional research is also recommended on the exact impact of possible determinants on 
old-age mortality, and its changes over time. For this purpose, long-term prospective 
studies would be ideal. Important longitudinal studies among elderly populations are the 
Italian Longitudinal Study on Aging (ILSA) [37], the Longitudinal Aging Study Amsterdam 
(LASA) [38], and the FINE study [39]. A promising international initiative is the Survey of 
Health, Ageing and Retirement in Europe (SHARE) [40](www.share-project.org). However, 
much time is required before it is possible in the above-mentioned studies to study 
determinants of old-age mortality over a long time. Until that time, historical prospective 
cohort studies such as the Framingham Heart Study [41] and the study on male British 
doctors [12] might be used for this purpose. 
 
An alternative approach, in which elements of population level studies are combined with 
elements of individual level studies, is the linkage of the national cause of death registries 
with individual characteristics. Especially in research on socio-economic mortality dif-
ferences, population census linked vital registries are widely used [42]. Record-linkage 
research has had a long history in Scandinavian countries, and the United Kingdom. In the 
Netherlands, recent efforts from Statistics Netherlands have led to the construction of a 
Health Statistics Database ("Gezondheid Statistisch Bestand") through linkage of population 
registries with socio-economic databases and national health surveys [43]. However, not in 
all countries linkage has been introduced or, if introduced, it does not always fully capture 
total national populations. Through record-linkage research, differences in mortality trends 
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between, for example, socio-economic groups, ethnic groups, and groups by marital status, 
could be assessed, and linked to differences between the groups in trends in possible 
determinants. 
 
Synthesis: modelling the effects of determinants simultaneously 
 
Our separate analyses, although focusing on a number of countries, each focused on a 
single determinant. Very likely, however, the determinants in our study are not 
independent from one another. As a consequence, confounding may have occurred in our 
analyses. Furthermore, the contribution of the different determinants cannot be simply 
added.  
 
Further research should try to incorporate the effects of different determinants on mortality 
trends into a more comprehensive explanatory model. For this purpose, a prerequisite and 
a major challenge is to obtain information on interactions between different explanatory 
factors. Moreover, models need to be developed that can study data on different possible 
determinants simultaneously, taken into account their interactions. Here, a combination of 
demographic methods and epidemiological knowledge might be of use.  
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SUMMARY 
 
 
The aim of this PhD thesis was to carefully describe trends in old-age mortality in seven 
European low-mortality countries from 1950 to 1999, and to assess the role of specific 
factors in explaining the observed trends.  
 
For this purpose, we studied both all-cause mortality and mortality from 26 specific causes 
of death, we applied a life-course perspective – with emphasis on both immediate effects 
of circumstances prevailing at old age (= period effects) and possible long-lasting effects of 
determinants located earlier in life (=cohort effects) – and we performed comparative 
studies among seven countries, i.e. Denmark, England and Wales, Finland, France, the 
Netherlands, Norway, and Sweden. In a series of separate analyses, we assessed the role 
of smoking, mortality selection, socio-economic developments over the life-course, and 
medical end-of-life decision-making. 
 
The first part of the thesis, i.e. Chapters 2 to 5, deals with the description of long-term 
trends in both all-cause and cause-specific old-age mortality, and the identification of the 
role of period and cohort effects in the observed trends. Within these chapters, focus was 
as well on smoking as a potential determinant of old-age mortality trends.  
 
The study of long-term cause-specific mortality trends is hampered by cause-specific 
coding changes such as the numerous revisions of the International Classification of 
Diseases (ICD). In Chapter 2, we explained and illustrated our new method to identify and 
adjust for coding-related mortality discontinuities, both between and within the different 
ICD revisions. Starting point was the construction of a concordance table – i.e. a table 
linking the codes for specific causes of death through each successive ICD revision - by 
three-digit ICD codes. As a second step, we evaluated the occurrence of mortality 
discontinuities by visually inspecting cause-specific trends, by using country-specific 
background information on these trends, and by the quantification of the discontinuities in 
cause-specific (log-linear) Poisson regression models. By comparing the observed cause-
specific mortality trends with the trends after adjustment for the identified coding-related 
mortality discontinuities, it was found that despite the use of a carefully constructed 
concordance table on the basis of three-digit codes, mortality discontinuities due to coding 
changes – both between and within ICD revisions – can lead to substantial changes of 
long-term mortality trends in specific causes of death. Evaluation of and controlling for 
these coding changes, thus, is essential when describing long-term cause-specific mortality 
trends. Therefore, we applied this method in all our subsequent analyses on cause-specific 
mortality patterns.  
 
Chapter 3 focuses on the description of all-cause and cause-specific old-age mortality 
trends in the Netherlands, from 1950 to 1999. We observed that, around 1980, all-cause 
mortality decline among Dutch men and women aged 80 and over suddenly reversed into 
stagnation and even mortality increases. Stagnation was most pronounced among elderly 
aged 90 and over, and among men in the 1980s. Regarding the causes of death, either 
stagnating mortality decline, or recent or sustained increases was observed for smoking-
related cancers, chronic obstructive pulmonary diseases (COPD), and a number of diseases 
specifically related to old age (infectious diseases, pneumonia, dementia, and "symptoms 
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and ill-defined conditions"). These causes of death, thus, seem to have contributed to the 
observed stagnation in all-cause mortality. When, for the Netherlands, the smoking-related 
diseases – i.e. smoking-related cancers and COPD - are excluded from period trends in all-
cause mortality, mortality decline levelled off in the 1980s, and stagnated completely in the 
1990s, uniformly for men and women. Smoking behaviour thus only partly seems to explain 
the stagnation of old-age mortality in the Netherlands.  
 
In Chapter 4, we described period trends in all-cause and cause-specific old-age mortality 
in seven northwestern European countries, i.e. Denmark, England and Wales, Finland, 
France, the Netherlands, Norway, and Sweden. In these countries, mortality among those 
aged 80 and over generally declined from 1950 to 1999. However, there was large 
heterogeneity in the pace of decline. In Denmark, the Netherlands, and among Norwegian 
men, we observed stagnation of mortality decline or even mortality increases since the 
1980s, whereas mortality decline continued strongly in England and Wales and France. 
Long-term mortality increases for smoking-related diseases turned into decline since the 
1980s among men in all countries, except Norway. Thus, although smoking has had a 
marked influence on old-age mortality trends, it cannot fully explain the observed 
stagnation in mortality decline since the 1980s. In addition, we observed important cross-
national variations in the pace of the decline in mortality from cardiovascular diseases, with 
largest declines in England and Wales and France. This could point to a role of cross-
national differences in the development of risk factors for cardiovascular diseases, such as 
physical activity, diet, smoking, and accessibility of medical care. Mortality from diseases 
specifically related to old age increased recently in all selected countries, which may 
indicate increased frailty among the elderly. 
 
Chapter 5 reports on our identification and description of cohort patterns – i.e. patterns 
by the year of birth of the deceased - in the mortality trends among elderly (60+) in the 
same seven countries. Age-period-cohort analyses revealed a statistically significant 
contribution of cohort effects in all countries, for both sexes, and for virtually all causes of 
death. Old-age mortality trends thus seem to be determined not only by period effects but 
also by cohort effects. The cohort patterns revealed a general decline in all-cause mortality 
for the subsequent cohorts born between 1865 and 1935. This decline, however, stagnated 
among Danish, Dutch and Norwegian men born between 1890 and 1915, and among 
women from all countries born after 1920. Where all-cause mortality decline stagnated, 
cohort patterns in mortality from lung cancer, COPD, and to a lesser extent ischaemic heart 
diseases, were unfavourable as well. This points again to a role of smoking in old-age 
mortality trends. For infectious diseases, stomach cancer, and cerebrovascular diseases, 
mortality increased among cohorts born before 1890, and decreased strongly thereafter. 
This cohort mortality pattern might be related to changing living conditions in childhood.  
 
In the second part of the thesis, Chapters 6 to 8, further explanations for the observed 
old-age mortality trends in the seven countries were examined, by assessing the role of 
mortality selection, socio-economic developments throughout the life-course, and medical 
end-of-life decision-making. 
 
In Chapter 6, we assessed the role of mortality selection. Mortality selection implies that 
high mortality at younger ages tends to affect the frail individuals first, leaving a more 
selected and more robust elderly population. Consequently with decreasing mortality at 
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younger ages, the increasing proportion of the elderly population might be less healthy 
when compared with their more selected predecessors, and subsequently could experience 
comparatively higher mortality. We tested whether mortality selection was a dominant 
factor in determining trends in old-age mortality, by empirically studying the possible 
existence of a negative correlation between trends in late middle-age mortality and trends 
in old-age mortality for the same cohorts, i.e. those born around 1895, 1900, 1905, and 
1910. In all countries and especially among men, all-cause mortality changes at ages 80-89 
were strongly positively correlated with all-cause mortality changes at ages 55-69 for the 
same cohorts. All-cause mortality changes at ages 80-89 also correlated strongly positive 
with circulatory disease mortality, a cause of death susceptible to mortality selection, at 
ages 55-69. Mortality changes at ages 80-89 from diseases specifically related to old age, 
also susceptible to mortality selection, showed no clear negative correlations with all-cause 
mortality trends at ages 55-69. These consistently positive correlations indicate that trends 
in old-age mortality in northwestern Europe in the late 20th century were determined 
predominantly by the prolonged effects of exposures carried throughout life, and not by 
mortality selection. 
 
Chapter 7 reports on our exploration of the role of socio-economic developments 
throughout the life-course on old-age mortality trends. We assessed whether old-age 
mortality levels for subsequent cohorts are associated with levels of Gross Domestic 
Product (GDP) prevailing at different ages (i.e. 0-5, 6-19, 20-49, and 50-64) of the same 
cohorts. For the birth cohorts 1865 to 1924, levels of GDP at time of death were strongly 
inversely associated with all-cause mortality at ages 65-99, especially among women, and 
among men in England and Wales, Finland, and France. In most countries, stronger 
associations were observed for GDP levels prevailing at earlier ages of the cohorts, which 
remained after control for GDP at time of death. Thus, next to the inverse effect of current 
economic developments on old-age mortality trends an independent, mostly inverse effect 
of economic developments during earlier ages of the cohort was found. GDP measured at 
ages 20-49, for men, and 50-64, for women, showed the largest associations with old-age 
mortality. This indicates that socio-economic circumstances during adulthood and middle 
age seem more important in determining old-age mortality trends than those during 
infancy or childhood.  
 
In Chapter 8, we examined the association between physicians’ practices and attitudes 
concerning end-of-life decision-making and mortality by age and cause of death across six 
European countries, i.e. Belgium, Denmark, Italy, the Netherlands, Sweden, and 
Switzerland. Note that medical end-of-life decisions mainly involve the withholding and 
withdrawing of life-prolonging treatments or the administration of potentially life-shortening 
drugs for the alleviation of severe suffering. In general, we observed a rather small effect 
of medical end-of-life decisions on national life expectancy. Although no statistically 
significant associations were found, the prevalence of end-of-life decisions tended to 
correlate positively with mortality. Correlation coefficients were higher for mortality among 
the elderly (80+) and for the prevalence of doctor-assisted dying. The share of physicians 
who feel they should unconditionally preserve their patients’ lives tended to correlate 
negatively with mortality, especially with old-age mortality. Further research is 
recommended into the possibility that national old-age mortality rates reflect attitudes 
concerning appropriate medical treatment for the elderly. 
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In Chapter 9, we summarized the main results of this thesis, and evaluated the usefulness 
and possible limitations of our methodological approach in obtaining these results. In 
addition, we elaborated on the determinants of the stagnation in mortality decline among 
elderly in the Netherlands, and on possible future trends in old-age mortality. Lastly, 
recommendations for further research were proposed.  
 
Our results indicate large heterogeneity in the pace of mortality decline among the elderly 
in seven European countries, with stagnation since the 1980s in Denmark, the Netherlands 
and among Norwegian men, whereas mortality decline strongly continued in England and 
Wales and France. In determining these trends both period patterns and cohort patterns 
seem important. Smoking, an important cohort factor, has had a marked influence on old-
age mortality trends. However, it cannot fully explain the observed stagnation in mortality 
decline since the 1980s Mortality selection, another cohort factor, has not been a driving 
factor behind old-age mortality trends in the countries under study. Next to a period effect 
of current economic developments on old-age mortality trends, a cohort effect of economic 
developments during earlier ages of the cohort, predominantly during adulthood and 
middle age, was found. Cross-national differences in old-age mortality might to some 
extent be affected by differences in attitudes concerning appropriate medical treatment for 
the elderly, although further research is recommended.  
 
In conclusion, old-age mortality seems susceptible to both favourable and unfavourable 
circumstances either prevailing at old ages, or originating earlier in life, predominantly in 
adulthood or middle age.  
 
Our more in-depth study of the possible explanations for the stagnation of mortality decline 
among Dutch elderly revealed again that smoking could not fully explain the observed 
stagnation. With regard to other cohort factors, stagnating socio-economic developments in 
infancy and childhood might also have contributed in the Netherlands to the observed 
stagnation. Moreover, the mortality increases from ischaemic heart diseases among the 
middle aged in the 1950s to the early 1970s, and the associated uptake of adverse risk 
behaviour, could have contributed to the stagnation of mortality decline among Dutch 
elderly in the 1980s and 1990s. Concerning possible period determinants, the increase in 
the prevalence of medical end-of-life decisions in the early 1990s in the Netherlands and 
possible associated changes in attitudes concerning appropriate medical treatment for the 
elderly might have contributed to some extent to the observed stagnation. In addition, an 
effect of changes in health care and social services available to the elderly together with an 
increase in the number of elderly living alone and a possible decline in social support 
cannot be completely ruled out.  
 
Concerning possible future old-age mortality patterns, an important current debate is the 
extent to which today’s populations are approaching a limit to human life expectancy. Our 
comparative studies among seven European countries provide no evidence that a limit to 
life expectancy is within reach. Stagnation of mortality decline in the Netherlands has 
sometimes been seen as a sign of such a limit, but our results indicate otherwise. Although 
mortality decline stagnated since the 1980s in the Netherlands, Denmark, and among 
Norwegian men, further improvements in old-age mortality decline occurred in England and 
Wales and France, i.e. countries that reached the same low level of mortality as Denmark, 
the Netherlands, and Norway around 1980. In addition, other interpretations (e.g. effects 
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of smoking, socio-economic developments earlier in life, trends in cardiovascular diseases) 
seem more likely for the observed stagnation of mortality decline.  
 
The prediction of future old-age mortality patterns or future developments in life 
expectancy remains a difficult task. Although past mortality predictions have repeatedly 
been proven too pessimistic due to unforeseen positive developments, we stress the 
possibility that unfavourable developments, such as the obesity epidemic, and the re-
emergence of infectious diseases, might also influence the future course of old-age 
mortality and life expectancy.  
 
Studying old-age mortality trends and its possible determinants remains important to 
inform politicians and health care professionals on possible mortality developments in the 
future. Our approach that focused on cause of death patterns, adopted a life-course 
perspective, and used comparative studies among different countries, proved very useful 
for generating and testing relevant hypotheses on explanations of old-age mortality trends. 
The further study of the determinants of old-age mortality trends could be aided by a more 
detailed description of cause-specific mortality trends, in a larger number of countries. To 
study more specifically the factors that discriminate a country or a region with favourable 
mortality experiences from those with less favourable mortality, more in-depth comparative 
research is recommended in which cohort-specific risk factor levels are reconstructed from 
existing surveys both among the elderly and among the younger population in earlier 
times. Studying regional variations within a country could also provide additional clues on 
the determinants of old-age mortality trends. To demonstrate the exact impact and the 
causal mechanisms of possible determinants on old-age mortality, and its changes over 
time, long-term prospective studies - using individual-level data – would be ideal. An 
alternative approach is the linkage of the national cause of death registries with individual 
characteristics. As a final step, further research should try to incorporate the effects of 
different determinants on mortality trends into a more comprehensive explanatory model. 
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SAMENVATTING 
 
 
Dit proefschrift had tot doel enerzijds de ontwikkelingen in de sterfte op oude leeftijd in 
zeven Europese landen van 1950 tot 1999 te beschrijven en anderzijds de rol van 
specifieke mogelijk verklarende factoren in de waargenomen trends te achterhalen. 
 
Hiertoe hebben we zowel totale sterfte als sterfte aan 26 specifieke doodsoorzaken 
bestudeerd, hebben we een levensloopbenadering gehanteerd – met aandacht voor zowel 
factoren op hoge leeftijd (= periode factoren) als ook factoren eerder in het leven (= 
cohort factoren) – en hebben we vergelijkende studies uitgevoerd in zeven landen te weten 
Denemarken, Engeland en Wales, Finland, Frankrijk, Nederland, Noorwegen en Zweden. In 
een aantal afzonderlijke analyses hebben we achtereenvolgens de rol van roken, 
sterfteselectie, sociaal-economische ontwikkelingen gedurende de levensloop en medische 
beslissingen rondom het levenseinde onderzocht. 
 
Het eerste deel van dit proefschrift, Hoofdstuk 2 t/m 5, beschrijft de lange-termijn 
ontwikkelingen in zowel totale als doodsoorzaakspecieke sterfte onder ouderen en omvat 
onze analyse naar de rol van periode dan wel cohort effecten in de waargenomen trends. 
In deze hoofdstukken werd daarnaast de rol van roken als mogelijke determinant van de 
sterftetrends op hoge leeftijd onderzocht. 
 
Het bestuderen van lange-termijn doodsoorzaakspecifieke sterftetrends wordt bemoeilijkt 
door doodsoorzaakspecifieke coderingsveranderingen zoals de talrijke revisies van de 
International Classification of Diseases (ICD) van de Wereldgezondheidsorganisatie (WHO). 
In Hoofdstuk 2 hebben we onze nieuwe methode om coderingsgerelateerde sterfte-
onregelmatigheden te achterhalen en te controleren, uiteengezet en geïllustreerd. Hierbij 
hebben we zowel coderingsveranderingen tussen ICD revisies als overige coderingsveran-
deringen binnen ICD revisies geëvalueerd. Uitgangspunt van onze methode was de 
constructie van een concordantietabel (een tabel die de doodsoorzaakspecifieke ICD codes 
voor de verschillende ICD revisies aan elkaar koppelt) op basis van 3-cijferige ICD codes. 
Vervolgens hebben we onregelmatigheden in de sterftetrends opgespoord aan de hand van 
(a) visuele inspectie van de doodsoorzaakspecifieke sterftetrends, (b) additionele landen-
specifieke informatie betreffende de sterftetrends en (c) kwantificering van de onregelma-
tigheden in doodsoorzaakspecifieke log-lineaire regressiemodellen (Poisson). Vergelijking 
van de waargenomen doodsoorzaakspecifieke sterftetrends met de trends na controle voor 
de geïdentificeerde coderingsgerelateerde sterfteonregelmatigheden toonde aan dat, 
ondanks het gebruik van een concordantietabel op basis van 3-cijferige ICD codes, sterfte-
onregelmatigheden als gevolg van coderingsveranderingen, zowel tussen als binnen ICD 
revisies, kunnen leiden tot aanzienlijke vertekeningen van sterftetrends voor specifieke 
doodsoorzaken. Het opsporen van en het controleren voor deze coderingsveranderingen is 
dan ook essentieel voor een adequate beschrijving van lange-termijn doodsoorzaakspeci-
fieke sterftetrends. In onze resterende analyses met betrekking tot doodsoorzaakspecifieke 
sterftetrends hebben we voor de geïdentificeerde coderingsgerelateerde sterfteonregel-
matigheden gecontroleerd.  
 
Hoofdstuk 3 omvat de beschrijving van totale en doodsoorzaakspecifieke sterftetrends 
van 1950 tot 1999 onder ouderen in Nederland. We vonden dat de afname in totale sterfte 
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onder Nederlandse mannen en vrouwen van 80 jaar en ouder rond 1980 plotseling 
omsloeg in stagnatie en zelfs sterftetoename. Stagnatie kwam vooral voor onder 90-
plussers en onder mannen in de jaren tachtig. Wat de doodsoorzaken betreft, werd 
stagnerende sterfteafname dan wel recente of voortdurende sterftetoename waargenomen 
voor de rookgerelateerde kankers, chronisch obstructieve longziekten, en voor een aantal 
specifieke ouderdomsziekten ('infectieuze en parasitaire ziekten', 'pneumonie en influenza', 
'dementie en Alzheimer' en 'symptomen en onvolledig omschreven ziektebeelden'). Deze 
doodsoorzaken lijken dus een bijdrage geleverd te hebben aan de stagnatie voor totale 
sterfte. Bekijken we de totale sterftetrends zonder de rookgerelateerde doodsoorzaken 
(rookgerelateerde kankers en chronisch obstructieve longziekten) dan is voor zowel oudere 
mannen als oudere vrouwen nog steeds een stagnerende sterfteafname in de jaren tachtig 
en een complete stagnatie in de jaren negentig zichtbaar. Rookgedrag lijkt dan ook slechts 
deels de stagnatie in de sterftedaling onder Nederlandse ouderen te kunnen verklaren.  
 
In Hoofdstuk 4 hebben we de periode ontwikkelingen in totale en doodsoorzaakspecifieke 
sterfte beschreven onder ouderen in zeven Noordwest Europese landen, te weten 
Denemarken, Engeland en Wales, Finland, Frankrijk, Nederland, Noorwegen en Zweden. 
Voor deze landen nam de totale sterfte onder 80-plussers over de periode 1950 tot 1999 
over het algemeen af. Er bleek echter een grote verscheidenheid in de mate van afname te 
bestaan. Onder Denen, Nederlanders en Noorse mannen werd sinds 1980 stagnatie van de 
sterfteafname en zelfs sterftetoename waargenomen, terwijl in Engeland en Wales en 
Frankrijk de sterke sterfteafname voortduurde. Wat betreft de doodsoorzaken vonden we 
dat de langdurige sterftetoename in rookgerelateerde kankers en chronisch obstructieve 
longziekten onder mannen veranderde vanaf de jaren tachtig in sterfteafname in alle 
landen behalve Noorwegen. Dus ook al heeft roken de totale sterftetrends onder ouderen 
duidelijk beïnvloed, de rol van roken lijkt minder van belang voor de verklaring van de 
stagnatie vanaf de jaren tachtig. Daarnaast vonden we belangrijke verschillen tussen de 
landen in het afname tempo van sterfte aan hart- en vaatziekten, met de grootste afname 
in Engeland en Wales en Frankrijk. Dit zou kunnen wijzen op verschillen tussen landen in 
ontwikkelingen in risicofactoren van hart- en vaatziekten, zoals lichaamsbeweging, 
bloeddrukcontrole, eetpatroon, roken en toegankelijkheid van medische zorg. Sterfte aan 
ouderdomsgerelateerde ziekten, als 'infectieuze en parasitaire ziekten', 'pneumonie en 
influenza', 'dementie en Alzheimer' en 'symptomen en onvolledig omschreven ziekte-
beelden', nam recentelijk toe in alle landen. Mogelijk dat hier toegenomen frailty oftewel 
een zwakkere constitutie van ouderen aan ten grondslag ligt. 
 
Hoofdstuk 5 bericht over onze identificering en beschrijving van cohort patronen 
(patronen naar geboortejaar van de overledenen) in sterftetrends onder ouderen (60+) in 
de zeven onderzochte landen. Onze leeftijd-periode-cohort analyse openbaarde een 
statistisch significante bijdrage van cohort effecten in de sterftetrends in alle landen, voor 
beide seksen en voor vrijwel alle doodsoorzaken. Sterftetrends onder ouderen blijken dus 
naast periode effecten ook bepaald te worden door cohort effecten. De cohort patronen 
lieten een algemene afname in totale sterfte voor de opeenvolgende geboortecohorten van 
1865 tot 1935 zien. Deze afname stagneerde echter onder Deense, Nederlandse en Noorse 
mannen geboren tussen 1890 en 1915 en onder vrouwen geboren na 1920 in alle landen. 
Voor die cohorten waar de afname in totale sterfte stagneerde, waren de cohort patronen 
voor longkankersterfte, chronisch obstructieve longziekten en in mindere mate ischemische 
hartziekten ook minder gunstig. Dit wijst opnieuw op een rol van roken in de bepaling van 
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sterftetrends onder ouderen. Voor 'infectieuze en parasitaire ziekten', maagkanker en 
cerebrovasculaire ziekten nam de sterfte over het algemeen toe voor de cohorten geboren 
vóór 1890 en af voor de latere cohorten. Dit cohort patroon zou te maken kunnen hebben 
met veranderde levensomstandigheden in de kindertijd. 
 
In het tweede deel van dit proefschrift, Hoofdstuk 6 t/m 8, zijn we op zoek gegaan naar 
nadere verklaringen van de waargenomen sterftetrends onder ouderen in de zeven landen 
onder studie. Hiertoe hebben we de rol van sterfteselectie, sociaal-economische 
ontwikkelingen gedurende de levensloop en medische beslissingen rondom het levenseinde 
onderzocht.  
 
Hoofdstuk 6 betrof onze studie naar de rol van sterfteselectie. Sterfteselectie houdt in dat 
hoge sterfte op jongere leeftijd mogelijk een meer geselecteerde oudere bevolking met zich 
meebrengt. Bij afnemende sterfte op jongere leeftijd zou het toenemende aandeel ouderen 
mogelijk minder geselecteerd kunnen zijn dan eerdere cohorten ouderen, met als gevolg 
relatief meer morbiditeit en sterfte. We hebben geanalyseerd of sterfteselectie een 
prominente rol heeft gespeeld in de bepaling van sterftetrends onder ouderen door voor 
vier opeenvolgende groepen geboortecohorten (geboren rond 1895, 1900, 1905 en 1910) 
na te gaan of er een negatieve correlatie bestaat tussen sterftetrends op middelbare 
leeftijd en sterftetrends op oudere leeftijd van de cohorten. Voor alle zeven landen en 
vooral voor mannen blijken totale sterftetrends onder 80-89 jarigen sterk positief te 
correleren met totale sterftetrends eerder in het leven onder 55-69 jarigen. Totale 
sterftetrends onder 80-89 jarigen correleerden ook sterk positief met trends in sterfte aan 
hart- en vaatziekten, een sterfteselectie gevoelige doodsoorzaak, onder 55-69 jarigen. De 
correlatie van sterftetrends in specifieke ouderdomsziekten, ook sterfteselectie gevoelig, 
onder 80-89 jarigen met totale sterftetrends onder 55-69 jarigen was niet duidelijk 
negatief. De consistent waargenomen positieve correlaties duiden erop dat sterftetrends 
onder ouderen in Noordwest Europa aan het eind van de twintigste eeuw vooral beïnvloed 
worden door verstrekkende gevolgen van blootstellingen eerder in het leven en niet zozeer 
door sterfteselectie.  
 
De rol van sociaal-economische ontwikkelingen gedurende de levensloop op sterftetrends 
onder ouderen werd nader onderzocht in Hoofdstuk 7. Hiertoe hebben we vastgesteld of 
sterfteniveaus onder ouderen voor opeenvolgende cohorten gerelateerd zijn aan niveaus 
van Bruto Binnenlands Product (BBP) per capita op verschillende leeftijden (0-5, 6-19, 20-
49 en 50-64) van diezelfde cohorten. Voor de geboortecohorten van 1865 tot 1924 was 
BBP ten tijde van het overlijden sterk omgekeerd gerelateerd aan totale sterfte onder 65-
99 jarigen, vooral voor vrouwen, maar ook voor mannen in Engeland en Wales, Finland en 
Frankrijk. In de meeste landen werden sterkere associaties gevonden voor BBP op eerdere 
leeftijden van de cohorten, die bleven bestaan na controle voor BBP ten tijde van het 
overlijden. Naast een omgekeerd effect van huidige economische ontwikkelingen op 
sterftetrends onder ouderen bleek er dus een onafhankelijk overwegend omgekeerd effect 
te bestaan van economische ontwikkelingen gedurende eerdere leeftijden van de 
bestudeerde cohorten. Terwijl voor mannen BBP op 20-49 jarige leeftijd de grootste 
associatie met sterfte onder ouderen liet zien, was voor vrouwen BBP op leeftijd 50-64 
belangrijk. Dit geeft aan dat sociaal-economische omstandigheden gedurende het 
volwassen leven en gedurende de middelbare leeftijd belangrijker lijken voor het bepalen 
van sterftetrends onder ouderen dan die gedurende het eerste levensjaar of de kindertijd. 
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In Hoofdstuk 8 hebben we de associatie tussen de praktijk en de opvattingen van artsen 
ten aanzien van medische beslissingen rond het levenseinde enerzijds en sterfte naar 
leeftijd en doodsoorzaak anderzijds onderzocht voor zes Europese landen samen, te weten 
België, Denemarken, Italië, Nederland, Zweden en Zwitserland. Merk op dat medische 
beslissingen rond het levenseinde vooral het niet-instellen of staken van levensverlengende 
behandelingen en potentieel levensbekortende pijn- of symptoombestrijding betreffen. Ons 
onderzoek liet zien dat het effect van medische beslissingen rond het levenseinde op de 
nationale levensverwachting klein was. Toch was er aanwijzing voor een positieve relatie 
tussen het percentage medische beslissingen rond het levenseinde en sterfte, vooral in 
relatie tot de sterfte onder ouderen en in relatie tot levensbeëindigend handelen (hulp bij 
zelfdoding, euthanasie, levensbeëindigend handelen zonder uitdrukkelijk verzoek van de 
patiënt). Ook vonden we aanwijzingen voor de verwachte negatieve relatie tussen sterfte 
en het aandeel artsen dat het leven van de patiënt in alle omstandigheden wil behouden, 
opnieuw vooral in relatie tot sterfte onder ouderen. Echter in al deze gevallen waren de 
correlatiecoëfficiënten niet statistisch significant. Nader onderzoek naar de mogelijkheid dat 
nationale sterfte onder ouderen beïnvloed zou kunnen worden door opvattingen ten 
aanzien van gepast medisch handelen onder ouderen is raadzaam.  
 
In Hoofdstuk 9 worden de belangrijkste resultaten van dit proefschrift samengevat en de 
positieve en negatieve aspecten van onze methodologische benadering op een rij gezet. 
Daarnaast zijn we nader ingegaan op de mogelijke determinanten van de stagnatie van de 
sterfteafname onder ouderen in Nederland en op verwachtingen ten aanzien van 
toekomstige sterfteontwikkelingen. Tot slot zijn aanbevelingen voor verder onderzoek 
gedaan.  
 
Onze bevindingen duiden op een enorme heterogeniteit in de mate van sterfteafname 
onder ouderen in zeven Europese landen, met stagnatie in Denemarken, Nederland en 
onder Noorse mannen sinds 1980, maar voortdurende sterfteafname in Engeland en Wales 
en Frankrijk. Deze trends blijken zowel door periode patronen als door cohort patronen 
bepaald te worden. Roken, een belangrijke cohortfactor, heeft een belangrijke rol gespeeld 
in de sterftetrends onder ouderen, maar kan de waargenomen stagnatie niet volledig 
verklaren. Sterfteselectie, een andere cohortfactor, heeft geen doorslaggevende rol 
gespeeld in de sterftetrends onder ouderen in de zeven onderzochte landen. Naast een 
periode effect van huidige sociaal-economische ontwikkelingen op sterftetrends onder 
ouderen werd een cohort effect van sociaal-economische ontwikkelingen gedurende 
jongere leeftijden van de verschillende cohorten gevonden. Vooral sociaal-economische 
ontwikkelingen gedurende de volwassenheid en de middelbare leeftijd bleken belangrijk. 
Daarnaast zouden verschillen in sterfte onder ouderen tussen landen enigszins beïnvloed 
kunnen worden door verschillen tussen landen in de opvattingen ten aanzien van gepast 
medisch handelen onder ouderen. Dit laatste vereist echter nader onderzoek. 
 
Al met al blijkt sterfte op hoge leeftijd beïnvloed te worden door zowel gunstige als 
ongunstige factoren die zich voor kunnen doen op hoge leeftijd of al eerder in de 
levensloop kunnen ontstaan en dan vooral op volwassen of middelbare leeftijd.  
 
Onze meer gedetailleerde studie naar de mogelijke verklaringen van de stagnatie van de 
sterftedaling onder Nederlandse ouderen toonde opnieuw dat roken niet de enige 
determinant van de waargenomen stagnatie geweest kan zijn. Wat andere cohortfactoren 
betreft, lijkt het erop dat stagnerende sociaal-economische ontwikkelingen gedurende de 
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kindertijd in Nederland toch ook bijgedragen kunnen hebben aan de waargenomen 
stagnatie. Tevens zou de sterftetoename voor ischemische hartziekten onder mannen en 
vrouwen in de middelbare leeftijd in de jaren vijftig tot begin jaren zeventig en het daaraan 
gerelateerde risicogedrag bijgedragen kunnen hebben aan de stagnatie van de 
sterfteafname onder Nederlandse ouderen in de jaren tachtig en negentig. Qua periode 
factoren zou de toename in de prevalentie van medische beslissingen rondom het 
levenseinde begin jaren negentig in Nederland en de mogelijk daaraan gerelateerde 
veranderingen in opvattingen ten aanzien van gepaste medische zorg voor de ouderen 
enigszins bijgedragen kunnen hebben aan de waargenomen stagnatie. Daarnaast kunnen 
we een mogelijk effect van veranderingen in de gezondheidszorg en sociale voorzieningen 
voor ouderen, gekoppeld aan een toename van het aantal alleenwonende ouderen en een 
mogelijke afname in sociale steun, niet volledig uitsluiten.  
 
Wat betreft mogelijke toekomstige sterfteontwikkelingen onder ouderen, is het actuele 
wetenschappelijke debat over de mate waarin huidige samenlevingen een mogelijke limiet 
aan de levensverwachting van de mens naderen van belang. Onze vergelijkende studies in 
zeven Europese landen leveren geen bewijs voor het binnen bereik zijn van een limiet aan 
de levensverwachting. De stagnatie van de sterfteafname in Nederland werd wel eens als 
bewijs voor zo’n limiet gezien, maar onze resultaten laten het tegendeel zien. Ook al 
stagneerde de sterfteafname sinds de jaren tachtig in Nederland, Denemarken en onder 
Noorse mannen, de sterfteafname continueerde voor Engeland en Wales en Frankrijk die 
rond 1980 het zelfde lage sterfteniveau hadden als Denemarken, Nederland en Noorwegen. 
Andere verklaringen voor de waargenomen stagnatie van de sterfteafname zoals roken, 
sociaal-economische ontwikkelingen eerder in het leven, ontwikkelingen in risicogedrag ten 
aanzien van hart- en vaatziekten e.d. lijken meer waarschijnlijk.  
 
Het voorspellen van toekomstige sterftepatronen onder ouderen of toekomstige 
ontwikkelingen in levensverwachting blijft lastig. Ondanks dat sterfteprojecties uit het 
verleden achteraf herhaaldelijk te pessimistisch zijn gebleken door onvoorziene gunstige 
ontwikkelingen, willen we erop wijzen dat toekomstige sterftetrends onder ouderen en 
ontwikkelingen in levensverwachting ook beïnvloed kunnen worden door ongunstige 
ontwikkelingen zoals de obesitas epidemie en het opnieuw optreden van infectieziekten.  
 
Het bestuderen van sterftetrends onder ouderen en mogelijke determinanten blijft 
belangrijk om beleidsmakers en professionals in de gezondheidszorg adequaat over 
mogelijke toekomstige sterfteontwikkelingen te informeren. Onze benadering met zijn 
nadruk op sterftetrends voor verschillende doodsoorzaken, de hantering van een 
levensloopbenadering en het uitvoeren van vergelijkende studies in zeven landen bleek erg 
nuttig voor het verkrijgen en testen van relevante hypothesen met betrekking tot 
verklaringen van sterftetrends onder ouderen. De verdere studie naar de determinanten 
van sterftetrends onder ouderen zou geholpen kunnen worden door een meer 
gedetailleerde beschrijving van doodsoorzaakspecifieke sterftetrends in een groter aantal 
landen. Om meer specifiek de factoren te bestuderen die een land of regio met gunstige 
sterfte-ervaringen onderscheid van een land of regio met minder gunstige ontwikkelingen 
raden we een meer gedetailleerd vergelijkend onderzoek aan waarin cohortspecifieke 
niveaus van risicofactoren gereconstrueerd worden aan de hand van bestaande surveys 
zowel recentelijk uitgevoerd onder ouderen als eerder uitgevoerd onder de toenmalige 
jongere bevolking. Het bestuderen van regionale verscheidenheid binnen een land zou ook 
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tot nieuwe aanwijzingen kunnen leiden over de determinanten van sterftetrends onder 
ouderen. Voor het bestuderen van de exacte effecten en causale mechanismen van 
mogelijke determinanten van sterfte onder ouderen en veranderingen hierin over tijd 
zouden lange-termijn prospectieve studies, waarbij gegevens op individueel niveau 
verzameld worden, ideaal zijn. Een alternatieve benadering is het koppelen van nationale 
doodsoorzaken registers aan individuele informatie. Het uiteindelijke doel van nader 
onderzoek zou de ontwikkeling van een alomvattend verklarend model dienen te zijn 
waarin de effecten van verschillende determinanten op sterftetrends onder ouderen 
tegelijkertijd meegenomen worden. 
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